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Abstract	(English)	
Molecular	 chirality	 plays	 an	 important	 role	 in	 discovery	 and	 manufacture	 of	
pharmaceutical	 candidates,	 products	 as	 well	 as	 their	 biological	 activities	 in	 vivo.	 The	
tragedy	of	thalidomide	in	the	1960s	is	still	reminding	us	to	synthesize	bioactive	molecules	in	
enantioselective	 way.	 Asymmetric	 catalysis	 has	 changed	 the	 procedures	 of	 chemical	
development	 dramatically	 and	 provides	 a	 state-of-the-art,	 environmentally	 sustainable	
strategy	 to	 reach	 this	 goal.	 The	 research	 contained	 in	 this	 thesis	 is	 focusing	 on	 the	 total	
synthesis	 of	 two	 series	 of	 bioactive,	 structurally	 complex	 natural	 products	 utilizing	
enantioselective	catalysis,	which	can	be	divided	into	the	following	parts:	
Part	I:	
	
Alkaloids	from	the	picrotoxane	family	are	biologically	potent	natural	products	that	show	
hypertensive,	 antipyretic,	 analgesic	 and	 anti-influenza	 A	 virus	 activities.	 Herein	 a	 concise	
catalytic,	 enantioselective	 total	 synthesis	 of	 (-)-dendrobine,	 (-)-mubironine	 B	 and	 (-)-
dendroxine	 is	 described	 with	 an	 overall	 yield	 of	 6.7%,	 7.8%	 and	 7.4%,	 respectively.	 This	
represents	a	significantly	improved	yield	as	compared	to	synthetic	approaches	reported	in	
the	past,	and	it	is	the	first	report	on	the	total	synthesis	of	(-)-dendroxine.	Importantly,	the	
asymmetric	 Yb-catalyzed	 Diels-Alder	 reaction	 between	 Danishefsky’s	 diene	 and	 an	
oxazolidinone	moiety	allowed	 for	an	enantioselective	synthesis	of	 the	natural	products	 in	
the	 enantioselective	 way,	 while	 the	 Fe-catalyzed	 aerobic	 oxidation,	 Cu-	 or	 Au-catalyzed	
cycloisomerization	 and	 hydroazidation	 underlined	 the	 strength	 of	 modern	 synthetic	
sequences	in	total	synthesis.			
Abstract	
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Part	II:	
	
Englerin	 A	 is	 a	 guaiane	 sesquiterpene	 natural	 product	 that	 shows	 antitumor	 activity	
when	binding	to	the	TRPC4/5	target	(a	new	target	for	antitumor	compounds)	in	vitro.	In	this	
part	 a	 bio-inspired,	 catalytic	 enantioselective	 strategy	 towards	 the	 total	 synthesis	 of	 (-)-
englerins	A	and	B	in	12	or	13	steps	with	6.7%	or	4.8%	yield,	respectively,	is	described.	The	
success	 was	 initialized	 by	 a	 biomimetic	 catalytic	 enantioselective	 decarboxylative	 aldol	
reaction	 for	 chirality	 introduction.	 A	 [4+3]	 cycloaddition	 with	 neighboring	 group	
participation	 was	 used	 for	 the	 construction	 of	 the	 central	 core	 structure,	 which	 was	
inspired	by	the	biogenesis	of	tropinone.	A	 late	stage	one-pot	Heck	coupling-regioselective	
hydrosilylation-Fleming	oxidation	cascade	sequence	afforded	the	cyclopentane	core	while	a	
kinetic	CBS	reduction	enriched	enantiopurity	and	eventually	delivered	the	natural	products.		
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Abstract	(German)	
Die	molekulare	Chiralität	spielt	eine	wichtige	Rolle	bei	der	Entdeckung	und	Herstellung	
von	 Arzneimitteln	 sowie	 bei	 deren	 biologischen	 Aktivitäten	 in	 vivo.	 Die	 Tragödie	 von	
Thalidomid	 in	 den	 1960er	 Jahren	 erinnert	 uns	 immer	 noch	 daran,	 bioaktive	Moleküle	 in	
enantiomerenreiner	Form	zu	synthetisieren.	Die	asymmetrische	Katalyse	hat	die	Verfahren	
der	 chemischen	 Entwicklung	 grundlegend	 verändert	 und	 bietet	 eine	 hochmoderne,	
ökologisch	nachhaltige	 Strategie	um	dieses	 Ziel	 zu	erreichen.	Die	 Forschung	dieser	Arbeit	
befasst	 sich	 mit	 der	 Totalsynthese	 von	 zwei	 bioaktiven,	 strukturell	 komplexen	
Naturstoffgruppen	unter	Verwendung	der	enantioselektiven	Katalyse.	Die	Arbeit	 ist	 in	die	
folgenden	Teile	aufgeteilt:	
Teil	I:	
	
Alkaloide	aus	der	Picrotoxan-Familie	sind	bioaktive	Naturstoffe,	die	blutdrucksteigernde,	
fiebersenkende,	schmerzlindernde	und	Anti-Influenza-A-Virus	Aktivitäter	zeigen.	In	diesem	
Teil	 wird	 eine	 kurze	 katalytische	 enantioselektive	 Totalsynthese	 von	 (-)-Dendrobin,	 (-)-
Mubironin	 B	 und	 (-)-Dendroxin	 mit	 Gesamtausbeuten	 von	 6,7%,	 7,8%	 bzw.	 7,4%	
beschrieben.	 Diese	 stellen	 deutlich	 verbesserte	 Ausbeuten	 im	 Vergleich	 zu	 bisher	
bekannten	Syntheseansätzen	dar	und	es	ist	zudem	die	erste	berichtete	Totalsynthese	von	(-
)-Dendroxin.	 Hierbei	 ist	 wichtig,	 dass	 die	 asymmetrische	 Yb-katalysierte	 Diels-Alder-
Reaktion	 zwischen	 Danishefskys	 Diene	 und	 einem	 Oxazolidinon	 eine	 enantioselektive	
Synthese	 der	 Naturstoffe	 in	 enantiomerenreiner	 Form	 ermöglicht,	 während	 die	
eisenkatalysierte,	aerobe	Oxidation,	kupfer-	oder	gold-katalysierte	Cycloisomerisierung	und	
Abstract	
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Hydroazidierung	 die	 Stärke	 moderner	 Synthesesequenzen	 in	 der	 Totalsynthese	
unterstrichen	haben.	
Teil	II:	
	
Englerin	 A	 ist	 ein	 Guaian-Sesquiterpen-Naturstoff,	 das	 auf	 den	 TRPC4	 /	 5-Rezeptor	 (ein	
neues	 Ziel	 für	 Antitumorverbindungen)	 in	 vitro	 abzielt	 und	 Antitumoraktivität	 zeigt.	 In	
diesem	 Teil	 der	 Arbeit	 wird	 eine	 biologisch	 inspirierte,	 katalytische	 enantioselektive	
Strategie	zur	Totalsynthese	von	(-)	-	Englerinen	A	und	B	in	12	oder	13	Stufen	mit	Ausbeuten	
von	6,7%	bzw.	4,8%	beschrieben.	Der	Erfolg	wurde	durch	eine	biomimetische	katalytische		
enantioselektive	decarboxylierende	Aldol	reaktion	zur	Einführung	der	Chiralität	initialisiert.	
Für	 die	 Konstruktion	 des	 zentralen	 Gerüsts	 wurde	 eine	 [4	 +	 3]	 -Cycloaddition	 mit	
Nachbarbeteiligung	verwendet,	die	von	der	Biogenese	des	Tropinons	inspiriert	wurde.	Eine	
Eintopf	 Heckkupplung-regioselektive	 Hydrosilylierungs-Fleming-
Oxidationskaskadensequenz	 gegen	 Ende	 der	 Synthese	 lieferte	 den	 Cyclopentan-Kern,	
während	 eine	 kinetische	 CBS-Reduktion	 die	 Enantiomerenreinheit	 erholt	 auf	 95%	 ee	
angereichert	und	schließlich	den	Naturstoff	geliefert.	
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1. Introduction	
1.1. Chirality	and	Asymmetric	Catalysis	
Chirality	 is	 the	 property	 of	 asymmetry	 which	 is	 an	 fundamental	 feature	 in	 chemical	
structure,	macroscopic	anatomy	as	well	as	 living	organisms’	behavior.[1]	Organisms	usually	
show	highly	rigid	stereospecificity	in	their	metabolism	process,	in	which	one	chiral	molecule	
recognizes	 two	 different	 enantiomeric	 molecules	 in	 different	 ways.	 Particularly	 in	 drug	
discovery,	manufacture	 and	 biological	 activities	 in	 vivo,	 bio-receptors	 interact	with	 drugs	
that	having	the	proper	stereochemical	properties,	while	the	inappropriate	binding	between	
receptors	 and	 the	 other	 enantiomers	 might	 result	 in	 remarkable	 differences	 in	 the	
pharmacological	activities.[2]	For	instance,	Darvon	(dextropropoxyophene)	1.1	is	an	μ-opioid	
receptor	 agonist	 which	 acts	 as	 analgesic,	 whereas	 its	 enantiomer,	 Novrad	
(levopropoxylphene)	1.2	is	an	antitussive	(Scheme	1-1).[3]		
	
Scheme	1-1.	Examples	of	enantiomers	with	different	biological	actions	
However,	in	some	cases	the	non-therapeutical	enantiomer	can	cause	serious	side	effects.	
In	 cases	 of	 penicillamine,	 the	 S-enantiomer	1.3	 is	 used	 for	 treatment	 of	 primary	 chronic	
arthritis,	while	its	R-enantiomer	1.4	is	proven	to	be	highly	toxic	(Scheme	1-1).[4]	In	the	1960s,	
insufficient	research	on	the	enantiomers’	pharmacological	actions	in	vivo	led	to	the	tragedy	
of	 thalidomide,	 which	 is	 still	 vivid	 in	 mind	 after	 several	 decades.	 Thalidomide	 was	 first	
marketed	 in	 1957	 in	 the	 racemic	 form	 to	 act	 against	 nausea	 and	 morning	 sickness	 of	
pregnant	women.	However,	shortly	after	thalidomide	was	approved	throughout	the	world,	
about	10,000	 infants	were	born	with	phocomelia	and	only	50%	of	 the	10,000	survived.	 It	
was	unknown	in	the	1960s	that	only	R-thalidomide	1.5	is	pharmacologically	useful	while	S-
thalidomide	1.6	 causes	 the	 inhibition	of	 the	cereblon	enzyme	and	 further	 leads	 to	severe	
teratogenicity	 in	 fetal	 development	 (Scheme	 1-2).[5]	 Even	 though	 extensive	 research	 on	
thalidomide	showed	that	the	R-enantiomer	is	metabolized	to	its	racemic	mixture	in	vivo,[6]	
Introduction	
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this	is	a	tragic	lesson	invoking	more	research	on	the	adverse	drug	reaction	of	chiral	drugs,[7]	
and	 urging	 synthetic	 chemists	 to	 synthesize	 the	 potentially	 bioactive	 compounds	 in	 their	
enantiomerically	pure	form.		
	
Scheme	1-2.	Enantiomers	of	thalidomide	with	different	pharmacological	actions	
In	1992,	 the	US	FDA	 (Food	and	Drug	Administration)	approved	 the	“racemic	switches”	
guideline	 to	 initialize	 the	 commercialization	 of	 enantiomerically	 pure	 drugs.[1,	 8]	 This	
guideline,	together	with	the	tremendous	accomplishment	in	organic	synthesis	over	the	past	
decades,	has	dramatically	 improved	the	development	of	the	synthesis	of	enantiomerically	
pure	bioactive	compounds.	Traditional	methods	in	stereoselective	synthesis	included	using	
stoichiometric	 amounts	 of	 ex-chiral-pool	 substances	 for	 kinetic	 resolution,	 as	 building	
blocks	or	auxiliaries,	which	limited	the	scope	of	the	variation	of	products	and	increased	the	
cost-efficiency	ratio.	The	2001	Nobel	Prize	in	chemistry	has	witnessed	the	dramatic	growth	
of	 asymmetric	 catalysis,	 which	 provides	 an	 alternative	 shortcut	 to	 the	 enantiomerically	
enriched	products	from	prochiral	compounds	using	catalytic	amounts	of	chiral	compounds	
as	catalysts	or	 ligands.	Thanks	to	 its	extensive	products	scope,	 low	cost-efficiency	ratio	as	
well	as	low	energy	consumption,	asymmetric	catalysis	is	nowadays	widely	used	in	academia	
as	well	as	in	industry.	[1]	
This	 part	 of	 introduction	 will	 focus	 on	 two	 types	 of	 enantioselective	 catalytic	
transformations:	 the	 catalytic	 asymmetric	 Diels-Alder	 cycloaddition	 and	 the	 catalytic	
asymmetric	 aldol	 reaction,	 which	 are	 relevant	 to	 the	 topics	 described	 in	 this	 thesis.
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1.1.1. Catalytic	Enantioselective	Diels-Alder	Cycloaddition	
In	1950,	the	Nobel	Prize	in	chemistry	was	awarded	to	Otto	Paul	Hermann	Diels	and	Kurt	
Alder	 for	 their	 contribution	 in	 the	 discovery	 and	 development	 of	 diene	 synthesis	
methodology,	which	is	today	known	as	the	Diels-Alder	(DA)	cycloaddition.	Studies	towards	
this	 cycloaddition	 were	 commenced	 with	 the	 reaction	 between	 benzoquinone	 1.7	 and	
cyclopentadiene	 1.8	 (Scheme	 1-3),[9]	 and	 were	 focused	 on	 mechanistic	 investigations	 as	
well	as	non-enantiomeric	research	before	1950s.	However,	since	the	landmark	Nobel	Prize,	
great	 progress	 in	 this	 area	 has	 been	 achieved	 in	 exploration	 and	 application	 of	 the	
enantioselective	 version	 of	 the	 DA	 cycloaddition	 due	 to	 its	 capacity	 to	 afford	 complex	
enantioenriched	structures	rapidly	from	very	simple	substrates.	
	
Scheme.	1-3.	The	first	reported	DA	cycloaddition	
Initially,	the	enantioselective	Diels-Alder	reaction	was	investigated	with	a	chiral	auxiliary	
on	 the	 dienophile	 to	 favor	 the	 formation	 of	 one	 enantiomer	 over	 the	 other.	 In	 1963,	
Walborsky’s	 group	 published	 the	 first	 enantioselective	 DA	 cycloaddition	 with	 chiral	
auxiliaries	 to	 achieve	high	 enantioselectivity	 (Scheme	1-4).[10]	 However,	 the	 drawbacks	 of	
auxiliary	 assisted	 stereoselective	 DA	 are	 evident:	 the	 substrate	 scope	 is	 limited	 and	
stoichiometric	 amounts	 of	 ex-chiral	 compound	 are	 necessary	 (though	 the	 chiral	 auxiliary	
can	be	recycled,	in	this	case	a	further	separation	step	is	required).		
	
Scheme.	1-4.	Walborsky’s	chiral	auxiliaries	assisted	enantioselective	DA	cycloaddition	
Hence,	 it	 was	 found	 that	 Lewis	 acids	 could	 catalyze	 the	 DA	 cycloaddition,	 and	 the	
activation	 process	 involves	 the	 coordination	 of	 the	 Lewis	 acid	 to	 an	 electron	 deficient	
dienophile.[11]	 If	 the	corresponding	chiral	Lewis	acid	 for	this	process	could	be	synthesized,	
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its	coordination	to	the	dienophile	might	further	lead	to	the	catalysis	in	an	enantioselective	
fashion.	 With	 this	 concept,	 Koga	 reported	 the	 first	 catalytic	 enantioselective	 DA	
cycloaddition	 with	 catalyst	 1.13	 prepared	 in	 situ	 from	 (-)-menthol	 and	 ethylaluminum	
dichloride,	which	promoted	the	stereoselective	cycloaddition	of	cyclopentadiene	1.8	and	2-
ethyl-2-propenal	1.12	 to	afford	 the	exo-adduct	1.14	 in	69%	yield	and	72%	ee	 (Scheme	1-
5).[12]		
	
Scheme.	1-5.	Koga’s	first	catalytic	enantioselective	DA	cycloaddition	
Accordingly,	it	is	possible	to	develop	effective	chiral	catalysts	for	the	stereoselective	DA	
cycloaddition,	 and	 to	 design	 chiral	 catalysts	 with	 high	 asymmetric	 induction	 is	 crucial	 to	
achieve	 high	 stereoselectivity.	 Over	 the	 past	 decades,	 several	 types	 of	 chiral	 Lewis	 acid-
based	 complexes	 have	 dominated	 the	 field	 of	 asymmetric	 catalysis,	 which	 have	 been	
extensively	 explored	 and	 applied	 to	 the	 asymmetric	 DA	 cycloaddition,	 while	 the	
organocatalyzed	DA	cycloaddition	is	still	an	ongoing	major	research	topic	in	organocatalysis	
since	2000.[13]	
In	this	chapter,	examples	of	the	Diels-Alder	reactions	with	simple	substrates	will	be	the	
main	focus,	and	hetero-Diels-Alder	cycloadditions	(oxa-DA	and	aza-DA)	will	not	be	covered.	
1.1.1.1. Lewis	acid	Catalyzed	Asymmetric	Diels-Alder	Cycloaddition	
Chiral	Lewis	acid	catalyzed	asymmetric	reactions	represent	a	powerful	method	to	afford	
enantioenriched	 compounds.	 For	 DA	 cycloadditions,	 many	 excellent	 results	 have	 been	
achieved	by	applying	various	chiral	Lewis	acids.	
A. Chiral	Boron	Complex	Catalyzed	Asymmetric	DA	Cycloaddition	
Traditionally,	chiral	boron	complexes	were	synthesized	via	dehydration	of	boronic	acid	
derivatives	 (such	 as	 phenylboronic	 acid	or	methylboronic	 acid)	 and	 chiral	 ligands	 (usually	
tartrate	 or	 amino	 acid	 derivatives)	 (Scheme	 1-6).	 Yamamoto’s	 group	 reported	 the	 first	
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series	 of	 practical	 chiral	 boron	 catalysts	 1.15	 derived	 from	 tartrates	 for	 the	 DA	
cycloadditions	 between	 α,β-unsaturated	 dienophiles	 and	 cyclic	 dienes	 (Scheme	 1-6a).[14]	
Corey’s	 group	 found	 that	 chiral	 oxazaborolidinones	 1.18	 facilitated	 the	 DA	 cycloaddition	
with	up	to	95%	yield	and	99%	ee	before	they	were	investigated	for	stereoselective	ketone	
reduction	 (Scheme	 1-6b).	 The	 steric	 repulsion	 between	 catalyst	 and	 diene	 led	 to	 high	
stereodifferentiation	and	resulted	in	high	enantioselectivity	(Scheme	1-6,	1.19).[15]	
	
Scheme	1-6.	Boron	complexes	catalyzed	asymmetric	DA	cycloadditions	
	
Scheme.	1-7.	Cationic	chiral	oxazaborolidines	as	asymmetric	DA	cycloaddition	catalysts	
Cationic	chiral	oxazaborolidines	are	a	series	of	versatile	and	electron-deficient	catalysts	
(Scheme	 1-7),	 which	 were	 obtained	 easily	 from	 the	 corresponding	 optically	 pure	 amino	
alcohols	by	dehydration	with	boronic	acid	derivatives	to	afford	oxazaborolidines,	followed	
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by	 subsequent	 activation	 with	 Brønsted	 acids	 or	 strong	 Lewis	 acids	 (usually	 triflic	 acid,	
triflimide	or	AlBr3).	[16]	The	intramolecular	acid	was	found	to	be	essential	in	accelerating	the	
rate	 of	 the	 DA	 cycloaddition	 and	 in	 obtaining	 a	 high	 level	 of	 enantioselectivity	 due	 to	
intramolecular	hydrogen	bonding	effect	(Brønsted	acid)	or	π-π	donor-acceptor	 interaction	
(Lewis	acid)	(Scheme	1-7,	1.23).[16]	Trifimide	complexes	were	proven	to	be	more	stable	than	
the	triflic	acid	complexes.	In	the	work	of	Corey’s	group,	these	catalysts	were	tested	with	the	
DA	 cycloadditions	 between	 a	 wide	 range	 of	 dienophiles	 including	 acrylates,	 quinones,	
enones,	 fumarates	and	cyclic	or	acyclic	dienes	 to	give	 the	corresponding	products	 in	high	
yields	and	ee.[17]		
	
Scheme	1-8.	Synthesis	of	natural	products	via	cationic	oxazaborolidines	catalyzed	
asymmetric	DA	cycloadditions	
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However,	 this	 series	of	 catalysts	are	highly	moisture-sensitive	and	have	 to	be	handled	
carefully	 in	moisture-free	conditions.	 [18]	 In	2005,	Yamamoto’s	report	demonstrated	that	a	
slight	modification	 of	 the	 oxazaborolidine	 backbone	 afforded	 the	moisture-	 and	 oxygen-
stable	cationic	chiral	oxazaborolindine	1.26	(Scheme	1-7),	which	had	wide	implications	for	
versatile	catalysts	design.[18]		
The	 cationic	 oxazaborolidines	 catalyzed	 asymmetric	 DA	 cycloadditions	 have	 been	
applied	to	the	total	synthesis	of	several	natural	products	by	Corey’s	group	at	the	time	of	its	
initial	investigation	(Scheme	1-8a)[19]	and	very	recently	by	Yang’s	group	(Scheme	1-8b)[20].		
B. Chiral	Metal	Complex	Catalyzed	Asymmetric	DA	Cycloaddition	
	
Scheme.	1-9.	Narasaka’s	catalytic	enantioselective	DA	cycloaddition	with	a	bidentate	
dienophile	
As	 previously	 mentioned,	 the	 dienophiles	 involved	 in	 boron	 complex	 catalyzed	 DA	
cycloadditions	 are	 acrylates,	 quinones,	 enones	 and	 fumarates,	 which	 are	 monodentate	
dienophiles.	 However,	 the	 implement	 of	 a	 coordinating	 chiral	 ligand	 to	 the	 Lewis	 acidic	
center	usually	reduces	its	Lewis	acidity,	since	the	electron	density	is	shifted	from	the	chiral	
ligand	to	the	active	center,	which	results	in	weaker	coordination	to	the	dienophile.	In	chiral	
boron	complex	catalysis,	this	issue	is	successfully	solved	by	introducing	an	external	acid	for	
the	 generation	of	 a	 reactive	 chiral	 complex.[16-20]	 In	 the	 case	of	 chiral	metal	 complex,	 the	
general	strategies	are	to	replace	the	monodentate	dienophile	with	its	bidentate	equivalent	
or	to	use	a	strongly	coordinating	diene	(i.e.	Rawal’s	diene).[21]	Selected	examples	for	chiral	
metal	complexes	catalyzed	enantioselective	DA	cycloadditions	will	be	discussed	below.		
N-acryloyl	 oxazolidinone	 is	 the	 bidentate	 substrate	 and	 is	 widely	 used	 in	 asymmetric	
catalysis.[16]	 The	 bidentate	 substrate	 provides	 additional	 coordination	 site	 to	 the	 chiral	
center,	and	can	be	conveniently	converted	 into	multiple	 functional	groups	such	as	esters,	
amides	 and	 alcohols.[16]	 The	 first	 stereoselective	 DA	 cycloaddition	 using	 N-
acryloxazolidinone	was	reported	by	Narasaka’s	group	in	1989	(Scheme	1-9).[22]	The	strongly	
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coordinating	 property	 of	 N-acrylyloxazolidinone	 allowed	 sufficient	 compensation	 to	 the	
weak	 Lewis	 acidity	 of	 titanium	 complex	 1.45,	 which	 resulted	 in	 the	 DA	 cycloaddition	
product	1.46	in	high	yield	and	enantiomeric	excess.	
	
Scheme	1-10.	Copper-BOX	complexes	catalyzed	DA	cycloadditions		
Evans’	 group	 showed	 that	 bis(oxazoline)	 compounds	 (Scheme	 1-10)	 were	 a	 series	 of	
highly	 coordinating	bidentate	 ligands	 to	metal	 centers.[23]	 Systematical	 research	 indicated	
that	 bis(oxazoline)	 compounds	 have	 broad	 compatibility	 with	 different	 metals	 (including	
copper,	 iron,	 magnesium	 and	 zinc),	 and	 the	 complexes	 are	 effective	 catalysts	 for	 DA	
cycloadditions	between	bidentate	dienophiles	(including	acryloylpyridine-oxides,	N-acryloyl	
pyrazolidinones	 and	 α-tosyl-enones)	 and	 different	 dienes	 with	 good	 yields	 and	 excellent	
enantioselectivities.[23]	Dienes	like	1,3-butadiene	or	cyclopentadiene	are	highly	compatible	
with	this	series	of	catalysts,	while	Danishefsky’s	diene	is	too	labile	towards	Lewis	acid	to	be	
used,	as	the	strong	Lewis	acidity	might	lead	to	decompositio	of	Danishefsky’s	diene.	AgSbF6	
is	usually	used	as	an	additive	because	counterions	 like	SbF6-	are	critically	essential	for	this	
reaction.[23]		
Based	on	Evans’	BOX	ligands,	Fukuzawa’s	group	disclosed	that	chiral	pyBOX	complexes	
(1.54,	 Scheme	 1-11)	 have	 a	 wide	 range	 of	 application	 in	 the	 rare-earth	 metal	 catalyzed	
enantioselective	DA	cycloadditions.[24]	With	 isopropyl-pyBOX-Sc	complex	 (1.54,	 Scheme	1-
11),	 the	 reaction	 between	 N-acryloyl	 oxazolidinone	 bidentate	 dienophiles	 and	 cyclic	 or	
acyclic	 dienes	 yielded	 the	 corresponding	 DA	 products	 in	 moderate	 yields	 and	 good	
enantioselectivities	(up	to	90%	ee).	In	the	report	of	Desimoni’s	group,	with	diphenyl-pyBOX-
Eu(OTf)3	(1.54e,	Scheme	1-11)	as	catalytic	complex,	diastereoselective	DA	product	1.56	was	
obtained	 from	 the	 reaction	 between	N-acryloyl	 oxazolidinone	 bidentate	 dienophile	 1.55	
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with	cyclopentadiene	1.8	in	99%	ee	(Scheme	1-11).[25]	The	additional	phenyl	group	at	the	R2	
position	of	1.54e	was	believed	 to	 induce	 the	high	 enantioselectivity.	 Further	 studies	 also	
showed	 that	 the	 substituents	 on	 the	 pyBOX	 backbone	 and	 the	 lanthanide	 cations	
significantly	 affect	 the	 reactivity	 as	 well	 as	 the	 enantioselectivity	 of	 the	 reaction	 due	
variations	in	electronic	and	steric	properties.[25]	
	
Scheme.	1-11.	Enantioselective	DA	cycloadditions	catalyzed	by	pyBOX-rare-earth	metal	
complexes	
	
Scheme	1-12.	Total	synthesis	of	(+)-muirononlide	A	via	intramolecular	DA	cycloaddition	
Meanwhile,	 chiral	 rare-earth	metal	 complexes	are	more	 stable	 towards	moisture	 than	
the	 corresponding	 chiral	 transition	metal	 complexes,[16]	 they	 can	 be	 handled	more	 easily	
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and	are	more	practical	for	application	in	total	synthesis.	In	2015,	Zakarian’s	group	reported	
the	enantioselective	total	synthesis	of	the	exceedingly	rare	natural	product	(+)-muironolide	
A	 1.59	 (Scheme	 1-12),	 in	 which	 a	 diastereoselective	 intramolecular	 Diels-Alder	
cycloaddition	catalyzed	by	a	La(OTf)3-pyBOX	complex	was	used	to	construct	the	backbone	
structure	1.58	of	the	macrolide	(Scheme	1-12).	[26]	
	
Scheme	1-13.	Salen-metal	complexes	catalyzed	DA	cycloadditions	
Additionally,	a	highly	enantioselective	DA	cycloaddition	with	salen-Cr(III)	1.60	or	salen-
Co(III)	 complexes	 1.61	 was	 reported	 by	 Rawal’s	 group	 (Scheme	 1-13).[27]	 Importantly,	
monodentate	dienophiles	 (acrolein	 for	example)	1.63	 can	be	used	 in	 the	 catalysis,	 as	 the	
bidentate	 Rawal’s	 dienes	 1.62	 might	 provide	 additional	 coordination	 to	 the	 chiral	
complexes.	 Furthermore,	 the	 catalysis	 was	 conducted	 at	 room	 temperature	 under	 air	
atmosphere	 conveniently,	 which	 is	 highly	 desirable	 for	 total	 synthesis	 and	 industrial	
applications.[27]	
Other	progresses	 in	DA	cycloadditions	catalyzed	by	chiral	metal	complexes	 include	the	
development	 of	 BINOL-titanium	 complex	 1.65[28],	 BINOL-aluminum	 complex	 1.66[29]	 and	
BINAMIDE-rare-earth	 complex	 1.67[30]	 (Scheme	 1-14).	 The	 BINOL-titanium	 and	 BINOL-
aluminum	 complexes	 can	 be	 used	 for	 the	 reaction	 of	 monodentate	 dienophiles	 with	
different	dienes,	as	titanium	and	aluminum	exhibit	a	relatively	higher	Lewis	acidity.	Nishida’	
group’s	 recent	 investigation	 of	 BINAMIDE-rare-earth	metal	 catalysis	 represented	 the	 first	
highly	enantioselective	DA	cycloaddition	of	electron-rich	Danishefsky’s	diene	with	electron-
deficient	bidentate	dienophiles,	as	the	electron-rich	Danishefsky’s	diene	is	stable	with	this	
less	 Lewis	 acidic	 complex	 1.67	 (Scheme	 1-14).[30]	 The	 DA	 cycloaddition	 catalyzed	 by	 the	
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BINAMIDE	 derived	 BINUREA-Yb(OTf)3	 has	 been	 successfully	 applied	 to	 the	 catalytic	
enantioselective	total	synthesis	of	picrotoxane	alkaloids	by	our	group.[31]	
	
Scheme	1-14.	Chiral	biaryl-metal	complexes		
1.1.1.2. Organocatalyzed	Asymmetric	Diels-Alder	Cycloaddition	
In	nature,	enzymes	are	the	biocatalysts	for	DA	cycloaddition,	however	in	the	laboratory	
the	reactions	are	too	complex	and	too	specific	to	be	used.[32]	Small	organic	molecules	used	
as	 organocatalysts	 emerged	 as	 good	 surrogates	 for	 enzymes	 during	 the	 past	 decades	
because	 they	 are	 environmentally	 friendly,	 can	 be	 synthesized	 in	 large	 scale	 and	 show	
broad	tolerance	towards	different	substrates.[32]		
Organocatalyzed	DA	cycloaddition	can	be	divided	into	three	categories	according	to	the	
general	 catalytic	 mechanisms:[33]	 chiral	 base	 catalysis,	 hydrogen-bond	 catalysis	 and	
heterocyclic	carbene	catalysis.	Typically,	chiral	base	catalysts	contain	secondary	or	primary	
amines;	they	can	condense	with	the	carbonyl	group-containing	dienophiles	to	give	iminium	
ions	or	imines	as	the	reactive	intermediates	for	the	cyclization	with	dienes.	Small	molecules	
capable	 of	 forming	 hydrogen-bond	 interactions	 with	 the	 substrates	 are	 hydrogen-bond	
catalysts.	By	activating	the	dienophiles	through	hydrogen-bond	interactions,	cyclization	can	
be	 promoted	 stereo-	 and	 diastereoselectively.	 Heterocyclic	 carbenes	 are	 powerful	
organocatalysts	in	multi-bond	formation	reactions	and	domino	reactions.	They	can	catalyze	
(mainly)	 asymmetric	 hetero-DA	 reactions	 in	 a	 similar	 way	 as	 chiral	 base	 catalysts	 by	
nucleophilic	addition	to	the	dienophiles.[34]		
A. Chiral	Base	Catalyzed	DA	Cycloaddition	
MacMillan	 pioneered	 the	 first	 chiral	 base	 catalyzed	 DA	 cycloaddition	 by	 using	
imidazolidinone	1.69	as	organocatalyst	to	provide	the	DA	adducts	 in	very	good	yields	and	
excellent	enantioselectivities	(Scheme	1-15).[13b]	Accordingly,	the	activation	of	acrolein	1.72	
Catalytic	Enantioselective	Diels-Alder	Cycloaddition	
	
23	
by	amine-containing	catalyst	1.69	leads	to	the	formation	of	iminium	ion	intermediate	1.71	
with	a	 lower	LUMO	energy,	which	can	facilitate	the	reaction.	DA	cycloaddition	then	takes	
place	to	give	the	iminium	ion-containing	product	1.70,	which	upon	hydrolysis	provides	the	
final	 product	 1.73	 with	 high	 enantiomeric	 excess	 and	 regenerates	 the	 catalyst	 1.69.	 The	
activation	of	 corresponding	α,β-unsaturated	ketone	was	proven	 to	be	more	difficult	 than	
acrolein.	However,	by	modifying	the	organocatalyst,	the	organocatalyzed	DA	cycloadditions	
between	 different	 α,β-unsaturated	 ketones	 and	 dienes	 were	 achieved	 by	 MacMillan’s	
group	with	high	yields	and	enantioselectivities.[35]	
	
Scheme	1-15.	MacMillan’s	imidazolidinone	catalysis	in	DA	cycloaddition	
MacMillan’s	group	then	applied	this	protocol	 to	 the	enantioselective	total	synthesis	of	
marine	metabolite	solanapyrone	D	(Scheme	1-16),	which	is	a	phytotoxic	polyketide	isolated	
from	the	fungus	Altenaria	solani.	[36]	
	
Scheme	1-16.	Total	synthesis	of	solanapyrone	D	via	organocatalyzed	DA	cycloaddition	
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Besides	 imidazolidinone,	 the	 chiral	 aziridines	 1.77	 were	 employed	 to	 catalyze	 the	 DA	
cycloadditions	by	Bonini’s	group	albeit	with	moderate	diastereoselectivity	(mixture	of	exo-	
and	endo-	products).[37]	 Similar	 results	were	obtained	by	 Lemay	and	Ogilvie’s	 report[38]	 as	
well	as	Lee’s[39]		camphor-based	hydrazine	catalysis	(1.78	and	1.79,	Scheme	1-17).		
	
Scheme	1-17.	Organocatalyzed	DA	cycloadditions	via	chiral	aziridines	or	hydrazines	
According	to	the	Alder	rule,	endo-selectivity	is	generally	considered	the	attribute	of	the	
DA	cycloaddition	due	to	the	favorable	interaction	between	the	π-systems	of	the	diene	and	
the	 dienophile	 substituent.[16]	 However,	 stereoselective	 DA	 cycloaddition	 with	 exclusive	
exo-selectivity	can	be	achieved	by	modifying	the	catalyst	and	the	reaction	system.	Hayashi’s	
group	 developed	 the	 diarylprolinol	 catalysts	 1.81	 that	 afforded	 the	 exo-DA	 adducts	 with	
good	diastereo-	 and	 enantioselectivities	 in	 acidic	 conditions	 (Scheme	1-18).[40]	 A	 practical	
procedure	was	 successfully	 investigated	 to	 allow	 the	 reaction	 to	 be	 carried	 out	 in	water	
(hydrogen-bond	 atmosphere)	 and	 an	 improvement	 of	 enantioselectivity	was	observed.[41]	
Maruoka	investigated	the	binaphthyl-based	diamine	catalyst	1.82	to	synthesize	the	exo-DA	
cycloaddition	 products	 with	 high	 diastereo-	 and	 enantioselectivities.	 The	 reaction	 was	
usually	 carried	 out	 in	 trifluoromethylbenzene	 and	 in	 the	 presence	 of	 catalytic	 amount	 of	
TsOH,	which	were	believed	to	induce	the	reversed	diastereoselectivity.[42]	
	
Scheme	1-18.	Exo-selective	asymmetric	DA	cycloaddition	
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Accordingly,	 secondary	 amines	 are	 efficient	 catalysts	 for	 sterically	 less-demanding,	
unsaturated	 carbonyl	 compounds.	 However,	 they	 are	 usually	 inactive	 towards	 the	
synthetically	useful	 but	 sterically	hindered	α-substituted	acroleins	1.63	 (precursors	 to	 all-
carbon	quaternary	center	containing	products)	due	to	their	bulkiness,	hence	preventing	the	
iminium	ions	formation.[16]	In	this	case,	less	hindered	catalysts	are	desirable.		
	
Scheme	1-19.	Primary	amine	catalyzed	DA	cycloaddition	
With	primary	amine	catalyst	1.83,	Ishihara’s	group	reported	the	DA	cycloadditions	of	α-
substituted	acroleins	1.63	with	different	dienes	 to	afford	 the	adducts	1.85	 in	 good	yields	
and	ee	 (Scheme	1-19).[43]	 Importantly,	α-acryloxyacroleins	are	synthetic	equivalents	of	the	
unstable	α-haloacroleins,	which	can	be	used	in	the	synthesis	of	organohalide	compounds.[44]	
The	 asymmetric	 DA	 cycloaddition	 between	 α-acryloxyacroleins	 with	 dienes	 to	 afford	 the	
organohalide	precursors	1.86	can	be	achieved	with	primary	amine	catalyst	1.83	or	primary	
BINAM	catalyst	1.84.[43,	45]	
Chiral	 primary	 amine	 1.87	 derived	 from	 natural	 cinchona	 alkaloid	 has	 recently	 been	
reported	 to	 catalyze	 the	 asymmetric	Diels-Alder	 reaction	 to	 afford	 the	 highly	 substituted	
cyclohexanones	 1.90	 (Scheme	 1-20).[46]	 This	 catalysis	 can	 also	 be	 regarded	 as	 a	 cascade	
sequence	consisting	of	double	conjugate	additions.	
	
Scheme	1-20.	Cinchona	type	primary	amine	catalyzed	DA-type	cycloaddition	
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B. Hydrogen-bond	Catalyzed	DA	Cycloaddition	
	
Scheme	1-21.	Rawal’s	TADDOL	catalyzed	DA	cycloaddition	
Hydrogen-bond	catalysts	are	Brønsted	or	Lewis	acid	containing	chiral	compounds	such	
as	chiral	thioureas,	amidinium	ions,	diols	as	well	as	chiral	phosphoric	acids	that	can	be	used	
as	 hydrogen-bond	 donors.[34]	 They	 are	 more	 widely	 used	 in	 catalytic	 enantioselective	
hetero-Diels-Alder	(oxa-DA	or	aza-DA)	cycloadditions	because	the	corresponding	aldehydes	
and	imines	tend	to	be	activated	easily	by	hydrogen-bond	donors.[16]	Rawal’s	group	reported	
the	first	highly	enantioselective	(all-carbon)	DA	cycloaddition	catalyzed	by	TADDOL	1.94	as	
hydrogen-bond	donor	(Scheme	1-21).[47]	Rawal’s	diene	1.91	and	different	bulky	dienophiles	
1.92	 were	 used	 to	 afford	 the	 cyclohexenone	 products	 1.93	 with	 up	 to	 92%	 ee.	 The	
proposed	transition	state	of	the	catalysis	is	shown	in	Scheme	1-21,	in	which	the	dienophile	
is	 activated	 by	 intermolecular	 hydrogen-bond	 interaction,	 and	 the	 intramolecular	
hydrogen-bond	 interaction	 of	 the	 catalyst	 allows	 the	 formation	 of	 a	 stable	 seven-
membered	 ring,	 which	 is	 a	 rigid	 catalytic	 transition	 state	 that	 lead	 to	 the	 high	
enantioselectivity.[47]	
	
Scheme	1-22.	DA	cycloaddition	catalyzed	by	chiral	phosphoramide	
Due	 to	 the	 weak	 hydrogen-bond	 interaction	 between	 chiral	 phosphoric	 acid	 and	
dienophile,	 only	 a	 few	 reports	 are	 available	 on	 chiral	 phosphoric	 acid	 catalyzed	
enantioselective	 (all-carbon)	 DA	 cycloaddition.	 However,	 by	 converting	 the	 chiral	
phosphoric	acid	into	the	stronger	hydrogen-bond	donor	biaryl-N-triflyl	phosphoramide	1.95,	
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Yamamoto’s	group	developed	the	enantioselective	DA	cycloaddition	between	EVK	1.97	and	
Danishefsky’s	diene	1.96	to	yield	the	enantioenriched	silyl-enol	ether	1.98	(Scheme	1-22)[48].	
Additionally,	 the	 less	 acidic	 phosphoramide	 1.95	 (compared	 to	 the	 corresponding	
phosphoric	acid)	avoids	the	decomposition	of	Danishefsky’s	diene	1.96,	which	is	the	key	for	
the	success	of	this	protocol.[48]	
C. Bifunctional	Organocatalyst	for	DA	Cycloaddition	
	
Scheme	1-23.	Cinchona-based	bifunctional	organocatalysts	for	asymmetric	DA	
cycloadditions	
Catalysts	activating	dienophiles	through	ion	pair	and	hydrogen-bond	can	be	regarded	as	
bifunctional	 catalysts,	 which	 usually	 contain	 tertiary	 amines	 as	 basic	 moieties	 as	 well	 as	
amides	or	alcohols	as	hydrogen-donors.		Cinchona	alkaloids	and	their	derivatives	have	been	
widely	 used	 as	 bifunctional	 organocatalysts	 because	 of	 their	 abundance	 in	 nature.[16]	
Meanwhile,	 the	 presence	 of	 cinchona	 alkaloids	 as	 pseudoenantiomeric	 pairs	 (i.e.	 quinine	
and	quinidine)	allows	for	stereoselective	synthesis	with	both	enantiomers.		
With	 bifunctional	 catalysts	 derived	 from	 different	 cinchona	 alkaloids,	 Deng’s	 group	
investigated	 the	 enantioselective	 DA	 cycloadditions	 of	 2-pyrones	 1.99	 with	 different	
dienophiles	1.100	to	afford	the	products	1.101	in	high	yields	and	ee	(Scheme	1-23).	As	seen	
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in	the	transition	state,	the	cinchona	catalyst	activates	both	diene	and	dienophile	via	the	ion	
pair	 and	 hydrogen-bond	 interactions,	 and	 the	 rigid	 structure	 of	 the	 cinchona	 backbone	
further	 induces	 the	 high	 enantioselectivity.[49]	 Meanwhile,	 controlling	 the	 endo/exo	
selectivity	 can	 be	 achieved	 by	 modification	 of	 the	 cinchona	 catalyst	 (1.105	 or	 1.106,	
Scheme	 1-23).[49a]	 When	 3-vinylindoles	 1.102	 and	 maleimides	 1.103	 were	 used	 as	
substrates,	the	cycloadditions	were	promoted	by	ionic	pair	interactions	between	the	basic	
moiety	of	1.106	and	the	acidic	indole	N-H	bonds	as	well	as	the	hydrogen-bond	interactions	
between	 thiourea	motif	of	1.106	 and	 the	maleimides	1.103.[50]	The	 resulting	heterocycles	
1.104	are	potentially	important	for	the	synthesis	of	interesting	biologically	alkaloids.	
	
Scheme	1-24.	Key	intermediate	of	RPR-107880	synthesis	via	cinchona	catalysis	
Accordingly,	the	enantio-	and	diastereoselective	cycloaddition	between	pyrone	1.99	and	
maleimide	1.103	was	achieved	to	afford	tricyclic	scaffold	1.108,	which	is	a	key	intermediate	
in	 the	 synthesis	 of	 RPR	 107880,	 which	 is	 a	 neurotransmitter	 that	 act	 as	 a	 substance-P	
antagonist	 [51]	 (Scheme	 1-24).[52]	 Other	 bifunctional	 organocatalysts	 include	 the	 tertiary	
amine-containing	binol	1.110[53]	 and	 the	bicyclic	 guanidine	1.111[54]	 (Scheme	1-25),	which	
promote	the	asymmetric	DA	cycloaddition	effectively	as	well.	
	
Scheme	1-25.	Examples	of	other	bifunctional	organocatalysts
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1.1.2. Catalytic	Enantioselective	Aldol	Reaction	
	
Scheme	1-26.	Timeline	of	the	aldol	reaction[57]	
The	aldol	reaction,	discovered	independently	by	Borodin	(1869)[55]	and	Wurtz	(1872)[56],	
represents	a	significantly	powerful	transformations	 in	organic	chemistry.	 In	aldol	reaction,	
β-hydroxylketones	with	up	to	two	new	stereocenters	are	formed	when	it	comes	with	two	
carbonyl-containing	 substrates	 as	 reactant.[57]	 The	 aldol	 reaction	 encountered	 various	
challenges	and	difficulties	since	its	discovery,	including	issues	of	chemo-,	regio-,	diastereo-	
and	enantioselectivity,	which	have	promoted	the	development	of	many	elegant	protocols	
to	 solve	 these	 difficulties	 (Scheme	 1-26).[57]	 Though	with	 the	 problems	 of	 chemo-,	 regio-	
and	diastereoselectivities	initially,	they	were	gradually	solved	in	the	1950s	with	preformed	
metal-enolate[58]	or	boron-enolate[59]	to	increase	the	aforementioned	selectivities.	With	the	
Zimmermann-Traxler	 model,	 the	 prediction	 or	 explanation	 of	 the	 formation	 of	 syn-	 and	
anti-aldol	products	became	possible	(Scheme	1-27).[60]	
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Scheme	1-27.	Aldol	reactions	with	preformed	enolates[57]	
	
Scheme	1-28.	Evans’	and	non-Evans’	asymmetric	aldol	reactions	with	chiral	auxiliaries[57]	
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Preformation	 of	 boron-enolates	 is	 a	 powerful	 method	 to	 approach	 highly	
diastereoselective	aldol	chemistry	due	to	the	relatively	short	and	stable	boron-oxygen	bond,	
which	 leads	 to	 a	 relatively	 tight	 six-membered	 transition	 state.[61]	 Accordingly,	 by	
introducing	a	chiral	oxazolidinone	auxiliary,	a	non-catalytic	asymmetric	aldol	reaction	with	
high	 enantio-	 and	 diastereoselectivities	 was	 successfully	 developed	 by	 Evans’	 group	
(Scheme	 1-28a).[62]	 Since	 enolization	 of	 the	N-acyl	 oxazolidinone	 1.118	 leads	 to	 the	 (Z)-
boron-enolate,	 the	 syn-aldol	 product	 1.119	 always	 predominates,	 and	 the	 high	
enantioselectivity	 can	 be	 explained	 by	 the	 dipole	 minimized	 transition	 state.[62]	 N-acyl	
oxazolidinone	 can	be	 further	 functionalized	 to	 the	 corresponding	 alcohol,	 aldehyde,	 acid,	
ester	or	Weinreb	amide,	which	renders	Evans’	aldol	 reaction	synthetically	useful.[63]	Apart	
from	Evans’-type	aldol	reaction,	the	groups	of	Heathcock[64]	and	Crimmins[65]	developed	the	
non-Evans’-type	asymmetric	aldol	reaction	by	the	introduction	of	a	Lewis	acid	as	additive	to	
expand	the	scope	of	chiral	auxiliary-assisted	aldol	chemistry	(Scheme	1-28b).[66][67]		
	
Scheme	1-29.	Mukaiyama	aldol	reaction	
In	 the	 course	 of	 catalysis,	 metal-enolates	 and	 boron-enolates	 are	 too	 labile	 towards	
moisture,	hard	to	purify,	and	their	reactivities	in	asymmetric	catalysis	are	difficult	to	control.	
However,	 the	 silyl-enolate	 as	 an	 alternative	 surrogate	 in	 aldol	 chemistry	 was	 first	
introduced	by	Mukaiyama’s	group	in	1973	and	overcame	the	aforementioned	problems.[68]	
The	aldehyde	1.117	 is	activated	with	Lewis	acid	(such	as	TiCl4,	SnCl4	or	TMSOTf),	 followed	
by	a	nucleophilic	addition	of	silyl-enolates	1.122	to	afford	the	aldol	products	1.123.[68]	The	
transition	state	of	the	Mukaiyama	reaction	should	be	explained	with	a	linear	model	instead	
of	 the	 Zimmermann-Traxler	 model,	 because	 the	 formation	 of	 a	 six-membered	 transition	
state	is	very	difficult	in	the	case	of	silyl-enolates	due	to	the	weak	Lewis	acidity	of	silicon.[57,68]	
Consequently,	the	diastereoselectivity	of	the	Mukaiyama	aldol	reaction	could	be	poor	and	
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is	 greatly	 influenced	 by	 the	 substrates,	 catalysts,	 solvents	 and	 additives	 (Scheme	 1-29).	
However,	the	less	reactive	silyl-enolates	are	more	amenable	for	a	controlled	reaction	since	
the	use	of	an	additional	activating	reagent	can	modulate	the	reactivity	of	the	aldol	reaction.	
This	 means	 that	 an	 enantioselective	 fashion	 of	 the	 Mukaiyama	 aldol	 reaction	 can	 be	
performed	when	a	chiral	activating	reagent	is	introduced.[68-69]	
1.1.2.1. Catalytic	Asymmetric	Mukaiyama	Aldol	Reaction	
	
Scheme	1-30.	Mukaiyama’s	catalytic	asymmetric	aldol	reaction	
In	Mukaiyama	aldol	 chemistry,	 a	 silicon	 transfer	 to	 the	hydroxyl	 group	on	 the	 formed	
product	was	observed	(Scheme	1-30).	This	is	an	important	observation	which	explained	the	
regeneration	 of	 the	 catalyst	 when	 a	 catalytic	 amount	 of	 a	 chiral	 Lewis	 acid	 complex	 is	
used.[57,68]	In	1990,	the	first	catalytic	asymmetric	Mukaiyama	aldol	reaction	was	reported.[70]	
With	 a	 chiral	 tin	 complex	 derived	 from	 Sn(OTf)2	 and	 the	 proline-derived	 chiral	 diamine	
1.126,	 Mukaiyama	 demonstrated	 that	 high	 enantio-	 and	 diastereoselectivities	 can	 be	
achieved	 with	 preformed	 silyl-enolates	 1.124	 to	 obtain	 the	 syn-aldol	 products	 1.125	
(Scheme	 1-30).[70]	 This	 well-developed	 protocol	 was	 successfully	 applied	 to	 the	 total	
synthesis	of	Taxol	1.136	(Scheme	1-31).[71]		
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Scheme	1-31.	Mukaiyama’s	total	synthesis	of	Taxol	
As	 in	 DA	 cycloaddition,	 boron-complex	 catalysis	 is	 also	 applicable	 in	 asymmetric	
Mukaiyama	 aldol	 chemistry.	 Corey’s	 group	 developed	 the	 chiral	 tryptophan-derived	
oxazaborolidinone	 1.139	 as	 catalyst	 for	 enantioselective	 Mukaiyama	 aldol	 reactions	
(Scheme	 1-32).[72]	 The	 reaction	 of	 different	 aldehydes	 1.121	 with	 the	 cyclic	 silyl-enolate	
1.137	 led	 to	 the	 desired	 products	 1.138	 in	 good	 yields	 with	 high	 syn-	 and	
enantioselectivities.	 Introduction	 of	 a	 3,5-bis(trifluoromethyl)phenyl	 group	 on	 the	 boron	
center	 in	1.140	enhanced	 the	 stability	of	 the	catalyst,	which	 lead	 to	 the	 reduction	of	 the	
catalyst	loading	to	5	mol%.[73]	Meanwhile,	asymmetric	Mukaiyama	aldol	reaction	catalyzed	
by	the	chiral	oxazaborolidinium	complex	1.141	has	also	been	reported.[74]			
	
Scheme	1-32.	Mukaiyama	enantioselective	aldol	reactions	catalyzed	by	chiral	boron-
complexes	
Chiral	bisoxazoline	compounds	are	privileged	multidentate	ligands	to	metal	centers	that	
have	been	widely	used	 in	asymmetric	 catalysis.[57]	With	 the	chiral	 copper-pyBOX	complex	
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1.145	as	catalyst,	Evans’	group	developed	the	enantioselective	Mukaiyama	aldol	reactions	
with	 α-benzoyloxyacetaldehyde	 1.142	 as	 the	 electrophile	 (Scheme	 1-33a).[75]	 Research	 in	
Evans’	 group	 indicated	 that	 the	 bidentate	 coordination	 of	 the	 aldehyde	 to	 the	 copper	
center	 was	 crucial,	 and	 aldehydes	 without	 the	 α-benzoyloxy	 group	 didn’t	 afford	 any	
products.[76]	In	addition,	the	diastereoselectivity	was	found	to	be	independent	of	the	Z/E	of	
silyl-enolates	(1.143	and	1.147,	Scheme	1-33).[76]	Meanwhile,	1,2-diketone	compounds	like	
pyruvates	1.146	were	found	to	be	compatible	with	the	above-mentioned	catalytic	complex	
to	 afford	 products	 in	 high	 regio-,	 diastereo-	 and	 enantioselectivities,	 which	 further	
confirmed	the	importance	of	the	bidentate	coordination	role	in	catalysis	(Scheme	1-33b).[77]	
Interestingly,	 Evans’	 group	 also	 reported	 that	 the	 catalysis	 of	 the	 chiral	 pyBOX	 ligand-
Sn(OTf)2	complex	1.153	afforded	products	1.152	in	the	anti-selectivitive	fashion	(Scheme	1-
33c),	which	 represented	 the	 first	highly	enantio-,	anti-selective	Mukaiyama	aldol	 reaction	
and	served	to	complement	the	syn-selective	Mukaiyama	aldol	chemistry.[78]		
	
Scheme	1-33.	Asymmetric	Mukaiyama	aldol	reactions	catalyzed	by	chiral	metal-pyBOX	
complexes	
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In	 2000,	 Kobayashi	 reported	anti-selective	Mukaiyama	 aldol	 reaction	 catalyzed	 by	 the	
chiral	zirconium-BINOL	complex	1.156	(Scheme	1-34).[79]	The	presence	of	propanol	and	H2O	
was	 found	 to	 be	 necessary	 for	 the	 silicon	 transfer,	 which	 is	 essential	 to	 promote	 the	
catalytic	cycle.[57,68]		
	
Scheme	1-34.	Chiral	zirconium	complex	catalyzed	Mukaiyama	aldol	reaction	
It	 can	 be	 seen	 above	 that	 the	 substituted	 silyl-enolates	 were	 predominantly	 used	 as	
nucleophiles,	which	resulted	in	high	enantioselectivity	in	the	catalysis.	Nevertheless	a	highly	
enantioselective	 Mukaiyama	 aldol	 reaction	 with	 non-substituted	 silyl-enolates	 such	 as	
1.157	was	still	troublesome	due	to	lack	of	effective	enantiocontrol.[80]		
	
Scheme	1-35.	Mukaiyama	aldol	reactions	with	non-substituted	substrates	
This	 long-standing	puzzle	was	 solved	by	Carreira’s	 group	 in	1994	 (Scheme	1-35).[80]	 By	
introducing	 the	 bulky	 chiral	 titanium	 catalyst	1.159,	 the	 less	 hindered	 silyl-enolate	1.157	
became	 suitable	 for	 highly	 enantioselective	 aldol	 reactions.	 The	 salicylic	 acid	 moiety	 in	
complex	1.159	was	significantly	important	as	it	promotes	the	intramolecular	silicon	transfer	
process,	which	improved	the	reaction	rate	and	enantioselectivity.[80]	This	protocol	has	been	
used	to	synthesize	(R)-epinephrine	1.163	with	95%	ee.[81]		
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Scheme	1-36.	Asymmetric	Mukaiyama	aldol	reactions	with	ketones	as	electrophiles	
Another	 long-standing	 issue	 in	Mukaiyama	 aldol	 chemistry	was	 the	 low	 reactivity	 and	
selectivity	of	ketones	when	they	were	used	as	electrophiles.[82]	 In	2002,	Denmark’s	group	
took	 the	 first	 step	 to	 report	 the	 chiral	 bis-N,N’-dioxide	 complex	 1.67	 to	 catalyze	 the	
Mukaiyama	aldol	reaction	in	an	enantioselective	fashion	(Scheme	1-36a).	The	more	reactive	
trichlorosilyl-enolate	 1.165	 was	 reported	 to	 be	 essential	 albeit	 with	 limited	 substrate	
scope.[82]	Later	in	2006,	Shibasaki’s	group	expanded	the	scope	to	more	hindered	trimethyl	
silyl-enolates	1.168	using	the	chiral	copper(I)	complex	1.170	as	catalyst	(Scheme	1-36b).[83]		
	
Scheme	1-37.	Asymmetric	Mukaiyama	aldol	reactions	catalyzed	by	chiral	metal	complex	in	
water	
It	 is	commonly	accepted	that	Lewis	acids	are	rapidly	deactivated	 in	water	due	to	 their	
high	affinity	towards	oxygen.[84]	However	Kobayashi’s	group	developed	the	first	Mukaiyama	
aldol	 reaction	catalyzed	by	a	chiral	praseodymium	complex	and	performed	 in	an	aqueous	
solution	(Scheme	1-37),	which	provided	the	first	concept	 for	 the	design	of	chiral	catalysts	
functioning	effectively	in	aqueous	media.[84]	
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1.1.2.2. Catalytic	Asymmetric	Decarboxylative	Aldol	Reaction	
	
Scheme	1-38.	Polyketides	biosynthesis	
In	 nature,	 poliketides	 are	 biosynthesized	 via	 decarboxylative	 processes	 from	 malonic	
acid	half	thioesters	(MAHTs)	with	polyketide	synthases	(Scheme	1-38).[85]	Similar	to	MAHTs,	
β-carbonyl	 carboxylic	 acids	 are	 a	 series	of	 reactive	 acids	 that	 can	be	 regarded	as	 enolate	
surrogates	after	decarboxylation	and	might	be	used	in	aldol	chemistry.	Inspired	by	nature,	
the	 catalytic	 enantioselective	 decarboxylative	 aldol	 chemistry	 was	 investigated	 over	 the	
past	decade.[57]		
	
Scheme	1-39.	Enantioselective	decarboxylative	aldol	reaction	with	MAHTs	
Shair’s	group	extensively	developed	the	Cu(II)-BOX	complex	catalyzed	enantioselective,	
decarboxylative	aldol	reaction	between	methyl-MAHT	1.177	and	aldehydes	1.121,	yielding	
the	aldol	products	in	high	yields	as	well	as	high	diastereo-	and	enantioselectivities	(Scheme	
1-39a).[86]	Unlike	nature’s	decarboxylation-C-C	bond	formation	mechanism,	this	biomimetic	
transformation	was	confirmed	to	be	a	deprotonation-aldol-decarboxylation	process.[86]	The	
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reaction	proceeded	smoothly	with	aliphatic	aldehydes	at	room	temperature	without	base.	
Recently,	the	group	of	List	and	Song	reported	a	similar	process	with	cinchona	base-derived	
catalyst	 1.183	 (Scheme	 1-39b),	 which	 allowed	 the	 reactions	 to	 proceed	 with	 non-
substituted	MAHTs	1.180	and	aromatic	aldehydes	1.181	as	substrates.[87]	
Compared	 to	MAHTs,	application	of	β-ketone	carboxylic	acids	 in	 this	 transformation	 is	
relatively	difficult	due	to	a	lack	of	effective	stereocontrol	and	unimolecular	decomposition	
of	 β-ketone	 carboxylic	 acids.[88]	 Ma	 disclosed	 the	 first	 asymmetric	 decarboxylative	 aldol	
reaction	 involving	 β-ketone	 carboxylic	 acids	 1.184	 (Scheme	 1-40a)	 employing	 cinchona	
base-derived	 (DHQD)2AQN	 1.187	 as	 organocatalyst.[88]	 However,	 the	 scope	 of	 the	
electrophiles	 was	 limited	 to	 trifluoromethylaryl	 ketones	 1.185.	 Very	 recently	 a	 similar	
process	with	phBOX	1.191	as	organocatalyst	was	reported	by	the	same	group	(Scheme	1-
40b),	 with	 the	 electrophiles	 being	 limited	 to	 α-trifluoromethylaldehyde	 hemiacetals	
1.189.[89]	
Scheme	1-40.	Enantioselective	decarboxylative	aldol	reaction	with	β-ketone	acids	
	
1.1.2.3. Catalytic	Asymmetric	Direct	Aldol	Reaction	
The	 use	 of	 preformed	 silyl-enolate	 in	 catalytic	 enantioselective	 aldol	 chemistry	 is	
extensively	investigated,	however	the	preformation	of	silyl-enolate	requires	stoichiometric	
amounts	of	base	and	organosilane	compound,	which	 is	 less	atom	economic	 compared	 to	
the	 direct	 aldol	 reaction.[57]	 The	 direct	 aldol	 reactions	 can	 be	 regarded	 as	 a	 proton	
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migration	process	with	the	whole	atom	utilization	and	no	side	product.	This	represents	the	
ideal	organic	transformation	in	view	of	atom	economy	and	green	chemistry.[90]		
	
Scheme	1-41.	Challenges	and	solutions	in	metal-catalyzed	direct	aldol	reactions[57]	
The	 employment	 of	 metal	 complex	 for	 the	 direct	 aldol	 reaction	 is	 inspired	 by	 type-II	
aldolase,	 which	 possesses	 a	 zinc	 ion	 cofactor	 to	 facilitate	 the	 deprotonation	 process.[91]	
Besides	 issues	 of	 chemo-	 and	 regioselectivities	 in	 direct	 aldol	 chemistry,	 the	 turnover	
problem	has	to	be	addressed.[57]	As	shown	in	Scheme	1-41,	the	direct	aldol	process	includes	
the	formation	of	metal-enolate	intermediate	1.194,	 followed	by	a	nucleophilic	addition	to	
the	 aldehyde	 1.193	 to	 give	 the	 bidentate	 alkoxide	 intermediate	 1.195,	 which	 undergoes	
metal-proton	 exchange	 to	 afford	 the	 aldol	 product	 and	 to	 recycle	 the	 metal	 catalyst.	
However,	due	 to	 the	stability	of	 the	metal-alkoxide	 intermediate	1.195,	 the	quenching	of	
this	intermediate	to	achieve	the	turnover	of	the	metal	catalyst	was	a	puzzle	to	be	solved.[57]	
Approaches	to	this	 issue	 include	the	 incorporation	of	a	proton	shuttle	 in	the	catalyst	 that	
can	transfer	the	proton	from	the	catalyst	to	the	alkoxide	(Scheme	1-41a),	and	the	trapping	
of	the	nascent	alkoxide	with	a	protecting	group	(Scheme	1-41b).[57]	Additionally,	the	use	of	
an	 organocatalyst	 can	 avoid	 the	 formation	 of	 the	 alkoxide	 directly,	 which	 initializes	 the	
development	of	organocatalyzed	direct	aldol	chemistry	(Scheme	1-41c).[57]		
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Scheme	1-42.	Asymmetric	direct	aldol	reactions	catalyzed	by	proton	shuttle	catalysts[57]		
The	 first	 breakthrough	 was	 accomplished	 by	 the	 group	 of	 Shibasaki	 in	 1999	 with	 a	
lanthanum-lithium-bis(binaphthoxide)	complex	as	proton	shuttle	(1.204,	Scheme	1-42a).[92]	
The	Brønsted	basic	 lithium	alkoxide	moiety	deprotonates	the	substrates	1.202	 to	give	the	
enolates,	then	the	Lewis	acidic	lanthanum	center	activates	the	aldehydes	1.121	to	promote	
the	C-C	bond	formation.	The	proton	can	be	transferred	back	to	the	alkoxide	afterwards	to	
release	 the	products	and	 recycle	 the	catalyst.	The	moderate	diastereoselectivity	and	high	
enantioselectivity	is	controlled	by	the	rigid	backbone	structure	of	catalyst.	According	to	the	
same	inspiration,	Trost’s	group	designed	a	similar	proton	shuttle	catalyst	(1.207,	Scheme	1-
42b)	that	consists	of	a	dinuclear	Zinc-alkoxide	center	and	a	chiral	ligand,	which	afforded	the	
products	 in	 high	 enantioselective	 fashion.[93]	 These	 two	 pioneering	 works	 influenced	 the	
following	design	of	metal	catalysts	in	asymmetric	direct	aldol	chemistry.	
In	2009,	Nishiyama’s	group	reported	that	the	chiral	rhodium-BOX	complex	catalyzed	the	
enantioselective	 direct	 aldol	 reactions	 between	 cyclic	 enone	 1.209	 and	 aldehydes	 1.210	
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(Scheme	1-43).	Meanwhile,	stoichiometric	amounts	of	acetic	anhydride	were	necessary	to	
quench	 the	 alkoxide,	 which	 represents	 another	 strategy	 to	 solve	 the	 catalyst	 turnover	
problem.[94]		
	
Scheme	1-43.	Catalytic	asymmetric	direct	aldol	reaction	by	incorporation	of	a	acetyl	group	
As	discussed	above,	the	formation	of	metal-alkoxide	intermediates	can	be	avoided	when	
an	 organocatalyst	 is	 used.	 However,	 the	 power	 of	 this	 type	 of	 catalysis	 was	 not	 fully	
appreciated	until	 the	report	by	the	group	of	List	and	Barbas	 in	2000	employing	proline	as	
the	organocatalyst.[13a]	As	shown	in	Scheme	1-44,	the	organocatalyzed	direct	aldol	reactions	
are	compatible	with	ketones	or	aldehydes	and	lead	to	the	corresponding	products	in	highly	
regio-,	chemo-,	diastereo-	and	enantioselective	fashion.	No	additives	or	protecting	groups	
are	 required	 in	 the	 reaction	 systems.	 Organocatalysts	 are	 easily	 available	 and	 non-toxic	
compared	 to	 metal	 complexes,	 which	 provide	 an	 ideal	 alternative	 for	 direct	 aldol	
chemistry.[95]	 Over	 the	 past	 decades,	 numerous	 improved	 proline-type	 organocatalysts	
(Scheme	 1-44)	 have	 been	 developed	 and	 their	 potency	 has	 been	 fully	 demonstrated.	
Research	on	the	organocatalyzed	direct	aldol	reaction	is	still	an	ongoing	topic	especially	in	
the	development	of	new	types	of	catalysts	and	substrate	scope	expansion.		
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Scheme	1-44.	Organocatalyzed	direct	aldol	reactions	and	representative		
proline-type	catalysts	
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2. Catalytic	Enantioselective	Total	Synthesis	of	Picrotoxane	Alkaloids	
2.1. Introduction	to	the	Picrotoxane	Alkaloids	
Chinese	medicine	has	a	2000	year-old	tradition,	its	medical	treatment	relies	on	the	use	
of	crude	extracts	mostly	from	plants.	The	plant	Dendrobium	nobile	belongs	to	the	family	of	
Orchidaceae,	named	“Shi	Hu”	in	Chinese,	which	has	been	used	as	a	tonic	and	antipyretic	for	
a	 long	time.	 In	the	Chinese	pharmacopoeia,	the	fresh	or	dried	stem	of	Dendrobium	nobile	
was	recorded	as	the	traditional	herb	with	hypotensive,	antipyretic,	analgesic	effect,	[96]	and	
it	was	recently	found	to	possess	anti-influenza	A	virus	activity.[97]	
	
Scheme	2-1.	Natural	products	belonging	to	the	picrotoxane	family	
Dendrobium	nobile	 possesses	diverse	pharmacological	 activities	 as	 it	 contains	multiple	
chemical	components	including	alkaloids	and	sesquiterpenoids.	As	the	most	abundant	one	
and	 the	 main	 component	 for	 Dendrobium	 nobile’s	 biological	 activities,	 (-)-dendrobine	
(Scheme	2-1,	2.1)	was	first	isolated	in	1932[98].	Structurally	speaking,	it	bears	a	picrotoxane-
type	 skeleton,	which	 consists	of	 a	highly	 condensed	5,5,6,5-tetracyclic-ring	 system	with	a	
nitrogen	 atom,	 a	 lactone	 bridge	 and	 seven	 continuous	 stereocenters.	 The	 structural	
complexity	renders	(-)-dendrobine	a	challenging	synthetic	target.	Since	the	identification	of	
(-)-dendrobine,	 the	 structurally	 related	 alkaloids	 and	 sesquiterpenoids	were	 continuously	
isolated,[99]	among	which	(-)-dendroxine	(2.3,	Scheme	2-1)	owning	an	additional	and	more	
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congested	aza-hemiketal	moiety.	The	eight	naturally	occurring	compounds	can	be	divided	
into	 two	 families	 according	 to	 their	 structure:	 (-)-dendrobine	2.1,	 (-)-mubirone	A	2.2,	 (-)-
mubironine	 B	 2.4,	 (-)-dendroxine	 2.3,	 and	 (-)-nobilonine	 2.5	 belong	 to	 the	 picrotoxane	
alkaloid	 family	 whereas	 the	 others	 (2.6	 –	 2.9)	 are	 picrotoxane	 sesquiterpenoids	 with	
different	oxidation	states.	Their	structural	similarities	 imply	that	they	arise	from	the	same	
biogenetic	pathway.		
	
Scheme	2-2.	Biosynthesis	of	picrotoxane	alkaloids		
Terpenoids	are	a	large	class	of	naturally	occurring	organic	molecules	that	represent	60%	
of	the	known	organic	natural	products.	Though	structurally	diverse	and	complicated,	they	
all	 derive	 biogenetically	 from	 very	 simple	 precursors	 such	 as	 isopentenyl	 pyrophosphate	
and	 its	 isomer	 dimethylallyl	 pyrophosphate.[100]	 As	 illustrated	 in	 Scheme	 2-2,	 farnesyl	
pyrophosphate	 synthase	 catalyzes	 the	 condensation	 between	 DMAPP	 and	 IPP	 to	 afford	
geranyl	 pyrophosphate	 2.13,	 followed	 by	 condensation	 with	 another	 molecule	 of	 IPP	 to	
form	 farnesyl	 pyrophosphate	 2.14	 via	 the	mevalonate	 pathway.	 Farnesyl	 pyrophosphate	
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2.14	 undergoes	a	 sequence	of	polyene	cyclization	and	 subsequent	 ring	 rearrangement	 to	
the	 bicyclo[4.3.0]	 core	 2.16	 that	 is	 common	 to	 all	 picrotoxane	 natural	 products.	 Site-
selective	 oxidations	 of	 the	 C-5/C-9	 methyl	 groups	 and	 the	 adjacent	 C-2/C-3	 methylene	
groups	afford	the	tricyclic	skeleton	2.17	 found	in	the	aforementioned	subfamilies.	Further	
site-selective	late-stage	oxidations	lead	to	picrotoxane	sesquiterpenoids	like	(-)-amotin	2.6,	
(-)-aduncin	 2.7,	 (+)-flakinin	 A	 2.8	 and	 	 (+)-flakinin	 B	 2.9,	 while	 late-stage	 amination-
oxidation	sequence	affords	 the	corresponding	alkaloids	 (-)-dendrobine	2.1,	 (-)-mubironine	
A	 2.4,	 (-)-mubironine	 B	 2.2,	 (-)-dendroxine	 2.3,	 or	 (-)-nobilonine	 2.5.[101]	 The	 proposed	
biogenetic	pathway	was	confirmed	by	Yamazaki’s	experimental	results.[102]	
2.2. Prior	Synthetic	Strategies	towards	Picrotoxane	Alkaloids	
Dendrobine	received	considerable	attention	over	the	past	decades	due	to	its	promising	
biological	activities.	Meanwhile,	it	is	a	challenging	synthetic	target	owing	to	the	presence	of	
seven	 continuous	 stereocenters	 on	 a	 congested	 carbon	 skeleton.	 The	 promising	
bioactivities	plus	 the	 intriguing	 structure	 render	dendrobine	 the	 ideal	 target	 to	verify	 the	
practicality	of	novel	synthetic	methodologies.		
	
Scheme	2-3.	Inubushi’s	first	total	synthesis	of	(±)-dendrobine	
Inubushi	reported	the	first	total	synthesis	of	(±)-dendrobine	employing	a	hydrocyanation	
reaction	 to	 introduce	 the	 lactone	 moiety.[103]	 As	 illustrated	 in	 Scheme	 2-3,	 the	 lactam	
moiety	in	2.21	was	first	constructed	via	a	sequence	of	nucleophilic	substitution,	an	enone	
isomerization	 and	 a	 conjugate	 addition.	 The	 introduction	 of	 the	 isopropyl	 group	 and	 the	
lactone	moiety	lacked	regio-	and	diastereocontrol,	though	the	cyanide	compound	2.23	was	
synthesized	via	 a	novel	hydrocyanation	 reaction.	After	 reductive	 lactonization	and	 lactam	
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reduction,	(±)-dendrobine	was	synthetically	obtained	for	the	first	time.	However,	the	regio-	
and	 diastereoselective	 introduction	 of	 functional	 groups	 was	 still	 an	 issue	 to	 be	 further	
investigated.	
A	Diels-Alder	cycloaddition	was	first	used	in	the	total	synthesis	of	dendrobine	by	Kende	
in	1974.[104]	As	shown	in	Scheme	2-4,	a	sequence	of	Diels-Alder	cycloaddition,	oxidative	C=C	
bond	 cleavage	 and	 aldol	 reaction	 afforded	 2.26	 with	 the	 cyclopentane	 moiety	 of	
dendrobine,	 and	 the	 pyrrolidine	 ring	 in	 2.28	 was	 installed	 with	 a	 reductive	 amination	
strategy.	After	 enone	 isomerization	and	 conjugate	addition	 to	 access	 the	 lactone	moiety,	
the	total	synthesis	of	dendrobine	was	achieved	within	13	steps.	It	is	noteworthy	that	Corey	
reported	 the	 catalytic	 asymmetric	 Diels-Alder	 cycloaddition	 between	 2.24	 and	 1,3-
pentadiene	2.25	 in	2004,	with	the	cationic	chiral	oxazaborolidinium	2.32	as	catalyst.	With	
this	 reaction,	 Kende’s	 intermediate	 2.26	 was	 obtained	 in	 95%	 yield	 and	 99%	 ee,	 which	
represented	the	first	catalytic	enantioselective	formal	synthesis	of	(-)-dendrobine.[19]		
	
Scheme	2-4.	Kende’s	total	synthesis	of	(±)-dendrobine	and	Corey’s	catalytic	asymmetric	
formal	synthesis	
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The	 Diels-Alder	 cycloaddition	 was	 further	 utilized	 for	 the	 total	 synthesis	 of	 (±)-
dendrobine	by	Roush	in	1978	(Scheme	2-5).[105]	A	series	of	Wittig	reactions	were	carried	out	
to	afford	the	Diels-Alder	precursor	2.34,	which	annulated	into	the	bicyclic	product	2.33	 in	
refluxing	 toluene	 with	 3:3:1	 dr.	 The	 isomers	 epimerized	 to	 the	 desired	 2.36	 as	 a	 single	
isomer	during	 Swern	oxidation.	 Similar	 to	 Kende’s	 end-up	 strategy,	 the	 total	 synthesis	 of		
(±)-dendrobine	was	finished	in	19	steps.	
Scheme	2-5.	Roush’s	total	synthesis	of	(±)-dendrobine	
A	 completely	 novel	 approach	 towards	 (±)-dendrobine	 was	 described	 by	 Livinghouse’s	
group	via	an	acylnitrilium	ion-initiated	cyclization,	which	afforded	the	bicyclic	scaffold	2.46	
(Scheme	2-6).[106]	Construction	of	the	central	six-membered	ring	in	2.48	was	first	attempted	
via	an	intramolecular	reductive-aldol	reaction	sequence	but	failed	to	give	any	products,	as	
the	 substrate	was	 inactive	 towards	 conjugate	 reductive	 reactions.	 Eventually	 a	 samarium	
iodide-mediated	 reductive	 coupling	 was	 applied	 to	 afford	 the	 densely	 fused	 tricyclic	
scaffold	2.48,	with	which	the	total	synthesis	of	 (±)-dendrobine	was	accomplished	after	an	
additional	isomerization	and	lactone	construction	sequence.	
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Scheme	2-6.	Livinghouse’s	total	synthesis	of	(±)-dendrobine	
As	 discussed	 before,	 synthesizing	 bioactive	 compounds	 in	 their	 enantiomerically	 pure	
form	is	still	an	ongoing	research	topic	in	organic	chemistry.	Sha’s	group	communicated	the	
first	enantioselective	 total	 synthesis	of	 (-)-dendrobine	 in	1997	 (Scheme	2-7)	 starting	 from	
the	ex-chiral-pool	compound	(S)-dihydrocarvone	2.50[107].	The	hemiketal	moiety	in	2.51	was	
constructed	 by	 a	 FeCl3-mediated	 Mukaiyama-type	 aldol	 reaction-cyclization	 sequence,	
while	 the	 cyclopentane	 scaffold	 2.54	 containing	 an	 all-carbon	 quaternary	 center	 was	
obtained	through	a	free-radical	mediated	cycloaddition.	The	nitrogen	atom	was	introduced	
in	the	form	of	the	azido	compound	2.56,	which	was	then	elaborated	into	(-)-mubironine	B	
and	(-)-dendrobine	via	a	Staudinger-aza-Wittig	reaction	followed	by	reductive	work-up.		
	
Scheme	2-7.	Sha’s	first	asymmetric	total	synthesis	of	(-)-dendrobine	
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Scheme	2-8.	Zard’s	asymmetric	total	synthesis	of	(-)-dendrobine	
Verbenols,	another	series	of	naturally	occurring	monoterpene	alcohols	that	contain	the	
desired	 stereocenters	 of	 dendrobine,	 have	 been	 used	 by	 Zard’s	 group	 as	 the	 ex-chiral	
material	for	the	total	synthesis	of	(-)-dendrobine	(Scheme	2-8).[108]	As	illustrated	in	Scheme	
2-8,	trans-verbenol	2.57	was	converted	into	the	protected	N-hydroxyl	amide	2.58,	followed	
by	 amine	 introduction	 via	 a	 novel	 nitrogen-centered	 free	 radical	 cyclization	 reaction.	
Simple	 alkylation	 and	protection	of	2.59	 delivered	enyne	2.60,	which	was	 cyclized	 to	 the	
densely	fused	tricyclic	moiety	2.61	through	a	cobalt-Pauson	Khand	reaction.	This	synthesis	
featured	 the	 first	 use	 of	 enyne-cycloisomerization	 in	 picrotoxane	 type	 natural	 products’	
syntheses	although	stoichiometric	amounts	of	cobalt	complex	were	used.	The	subsequent	
lactone	construction	was	similar	to	Inubushi’s	strategy,	which	allowed	the	synthesis	of	(-)-
dendrobine	within	17	steps.	
	
Scheme	2-9.	Carreira’s	asymmetric	total	synthesis	of	(-)-dendrobine	
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Recently,	Carreira	reported	another	novel	total	synthesis	of	(-)-dendrobine	(Scheme	2-9),	
which	 highlighted	 the	 3,3-rearrangement	 to	 afford	 the	 poly-substituted	 cyclohexene	
2.68.[109]	 A	 conjugate	 addition-hydrogenation	 sequence	 was	 used	 to	 install	 the	
cyclopentane	 with	 an	 all-carbon	 quaternary	 center	 in	 2.70,	 and	 a	 regioselective	 ketone	
bromination-pyrrolidine	formation	reaction	afforded	the	pyrrolidine	core	in	2.31.	
It	can	be	seen	above	that	each	work	represents	its	particular	excellent	methodologies	in	
the	 total	 synthesis,	 however	 synthetic	 efficiency	 has	 become	more	 important	 in	modern	
chemistry.	 By	 comparing	 these	 representative	 synthetic	 strategies	 with	 their	 synthetic	
efficiencies,	 Christmann’s	 color-coded	 flowchart-method	 is	 utilized	 to	 visualize	 the	
differences	in	efficiency	and	help	us	to	evaluate	our	own	project.		
	
Figure2-1.	Step-efficiency	analysis	according	to	Christmann’s	method	
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If	 we	 compare	 the	 three	 available	 enantioselective	 total	 syntheses	with	 Christmann’s	
method,	Sha’s	synthesis	represents	the	shortest	LLS	(18	steps)	with	the	least	non-strategic	
manipulations.	 In	 Carreira’s	 work,	 the	 natural	 product	 was	 obtained	 in	 the	 highest	 yield	
though	 trivial	 functional	 group	 manipulations	 and	 protecting-group	 chemistry	 were	
employed.	 However,	 despite	 its	 relatively	 high	 yield,	 the	 amounts	 of	 waste	 and	 atom-	
redox-	 efficiencies	 in	 the	 synthesis	 are	 more	 inflected	 by	 the	 number	 of	 steps.	 Thus,	 a	
efficient	 synthesis	 inherently	 requires	 less	 protecting	 group	manipulations	 and	 less	 non-
strategic	redox	or	functional	group	interconversions.[110]		
2.3. Project	Design	and	Retrosynthetic	Analysis	
	
Scheme	2-10.	Retrosynthetic	analysis	
As	 previously	 discussed,	 all	 the	 available	 total	 syntheses	 of	 dendrobine	 are	 either	
racemic	 or	 ex-chiral-pool	 oriented	 enantioselective	 versions,	 and	 no	 reports	 on	 catalytic,	
enantioselective	total	synthesis	of	dendrobine	or	other	picrotoxane	alkaloids	are	available.	
Ex-chiral-pool	compounds	are	cheap,	however	the	defined	structures	 limit	their	variability	
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compared	to	asymmetric	catalysis,	which	can	create	multiple	compounds	with	 the	similar	
core	 scaffold.	 In	 the	 view	 of	medicinal	 chemistry,	 structural	 proliferation	 is	 the	 essential	
part	 for	structure-activity	 relationship	assessment	and	might	 lead	to	 identification	of	new	
leading	 compounds.	 Meanwhile,	 traditional	 methods	 are	 less	 efficiency,	 which	 require	
multiple	 steps	 for	 a	 simple	 transformation	 as	 well	 as	 stoichiometric	 amounts	 of	 metal	
catalysts	that	might	be	replaced	by	modern	synthetic	methods.	For	the	sake	of	developing	
a	 “state-of-the-art”	 catalytic	 strategy	 towards	 the	 picrotoxane	 alkaloids	 as	 well	 as	 their	
derivatives,	we	disclosed	our	synthetic	analysis	as	shown	in	Scheme	2-10.	
Retrosynthetically,	 we	 envisioned	 that	 dehydropyrrolidine	 2.71	 might	 serve	 as	 a	
common	intermediate	for	picrotoxane	alkaloids.	With	this	dehydropyrrolidine	intermediate,	
the	 alkaloids	 could	 be	 obtained	 with	 either	 reductive	 or	 redox-neutral	 conditions.	 Imine	
disconnection	in	2.71	led	to	the	nitrogen-containing	compound	2.72,	which	was	planned	to	
be	 synthesized	 from	 olefin	 2.73	 via	 a	 direct	 anti-Markovnikov	 hydroamination,	 a	 very	
challenging	and	seldomly	used	transformation	in	total	synthesis.	The	olefin	in	2.73	with	an	
adjacent	all-carbon	quaternary	center	might	be	accessed	from	lactone	2.75	via	a	conjugate	
addition	followed	by	a	metal-catalyzed	cycloisomerization.	Before	 lactonization	to	 lactone	
2.75,	 the	 central	 structure	 of	 cyclohexenone	 2.76	 was	 envisioned	 to	 originate	 from	
Danishefsky’s	 diene	 by	 diastereo-	 and	 enantioselective	 catalytic	 [4+2]-cycloaddition.	
Significantly,	 Diels-Alder	 cycloadditions	 using	 different	 dienophiles	 2.78	 might	 lead	 to	
different	 5-substituted	 cyclohexenones	 2.79,	 which	 could	 proliferate	 the	 library-pool	 of	
picrotoxane	alkaloids	2.80	for	further	structure-activity	relationship	assessment.		
2.4. Synthesis	of	Three	Picrotoxane	Alkaloids	
				The	synthesis	commenced	with	the	investigation	of	asymmetric	Diels-Alder	cycloaddition	
between	 Danishefsky’s	 diene	 2.77	 and	 the	 bidentate	 dienophile	 2.81	 catalyzed	 by	 chiral	
metal	 complexes	 (Table	 2-1).	 However,	 the	 initial	 attempt	 with	 Evans’	 cationic	 Cu2+-
bis(oxazoline)	complex	(Cu2+-ligand	L2.1)	 led	to	decomposition	of	Danishefsky’s	diene	2.77	
(Table	 2-1,	 entry	 1).[23a,	 23b,	 111]	 Extensive	 literature	 research	 showed	 that	 no	 literature	
precedence	of	DA	cycloaddition	between	Danishefsky’s	diene	and	oxazolidinone	dienophile	
catalyzed	 by	 a	 Cu2+-bis(oxazoline)	 complex	 has	 been	 reported	 due	 to	 the	 lability	 of	
Danishefsky’s	 diene	 towards	 Lewis	 acidic	 conditions.	 Shibasaki’s	 recent	 report	 on	 the	
cationic	Fe3+-bis(oxazoline)	complex	(Fe3+-	ligand	L2.2)	catalysis	was	then	tested	and	to	our	
delight	 the	 product	was	 produced	 diastereoselectively	with	moderate	 yield	 although	 the	
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enantioselectivity	 was	 underprivileged	 (Table	 2-1,	 entry	 2).[112]	 Slightly	 decreasing	 the	
temperature	 to	 -50	 oC	 did	 increase	 the	 enantioselectivity	 however	 at	 the	 cost	 of	 more	
decomposition	of	Danishefsky’s	diene	(Table	2-1,	entry	3),	which	indicated	that	the	catalyst	
was	partially	deactivated	over	time.	It	was	noteworthy	that	compared	to	ligand	L2.1,	ligand	
L2.2	 gave	 the	 product	with	 opposite	 enantioselectivity	 (Table	 2-1,	 entry	 4),	 even	 though	
ligand	screening	was	proven	to	be	unfruitful	to	increase	enantioselectivity	(Table	2-1,	entry	
1-5).	Meanwhile,	 low	 to	moderate	 yield	 for	 Fe3+	 complex	 catalysis	 further	 demonstrated	
that	non-acidic	catalytic	systems	might	allow	the	transformation	to	be	more	feasible	in	this	
case.		
Table	2-1.	Asymmetric	catalytic	Diels-Alder	cycloaddition	
	
Entrya	 Catalyst	 Ligand	 Additive	 Temperature	
(oC)	
Yield	
(%)b	
eec	
(%)	
1	 Cu(OTf)2	 L2-1	 AgBF4	 -40	 -	 -	
2		 FeBr3	 L2-2	 AgBF4	 -40	 47	 0	
3		 FeBr3	 L2-2	 AgBF4	 -50	 25	 17	
4		 FeBr3	 L2-1	 AgBF4	 -40	 33	 -25	
5		 FeBr3	 L2-3	 AgBF4	 -40	 44	 11	
6	 Yb(OTf)3	 L2-4	 DBU	 0	 78	 91	
a	The	reaction	was	stirred	at	indicated	temperature	for		7	h;	b	Isolated	yield;	c	Enantiomeric	excess	was	
determined	by	chiral	HPLC;	d	The	reaction	was	stirred	at	0	oC	for	3	h.	
	
To	overcome	this	problem,	rare-earth	metal	salts	were	found	to	be	the	key	to	avoid	the	
decomposition	of	Danishefsky’s	diene,	 as	 they	are	not	 as	 Lewis	 acidic	 as	 transition	metal	
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salts.[30]	Finally,	with	Nishida’s	recently	reported	Yb-(S)-BINUREA	complex	(Yb3+-ligand	L2-4),	
the	desired	product	was	isolated	in	a	highly	diastereoselective	fashion	in	78%	yield	(Table	2-
1,	entry	6).[113]	The	labile	silyl-enolate	product	could	not	be	further	purified	and	was	treated	
with	acid	to	give	the	rearranged	enone	2.82.	The	enantiomeric	excess	was	determined	by	
chiral	HPLC	to	be	91%,	which	might	be	further	improved	by	late-stage	recrystallization.	The	
reaction	was	 scaled	 up	 to	 5	mmol	without	 erosion	 of	 enantiomeric	 excess.	 The	 catalytic	
complex	 is	 sensitive	 towards	moisture,	 and	 in	 situ	 formation	 of	 active	 catalyst	 should	 be	
carefully	handled	under	absolutely	moisture-free	conditions	(see	experimental	part).	With	
the	 optimized	 conditions	 in	 hand,	 oxazolidinone	 2.78	with	 different	 substituent	 patterns	
could	be	employed	 to	produce	different	oxazolidinones	2.79,	hence	enriching	 the	 library-
pool	of	picrotoxane	alkaloids	(Scheme	2-10).		
	
Scheme	2-11.	Attempts	on	direct	lactonization	
With	 the	Diels-Alder	cycloaddition	product	 in	hand,	we	attempted	 to	start	 from	
the	oxazolidinone	motif	in	2.82	for	a	direct	lactone	formation	(Scheme	2-11).	Direct	
treatment	of	the	enone	2.82	with	LDA	at	-78	oC	 led	to	a	fast	decomposition.	Crude	
NMR	 analysis	 revealed	 the	 formation	 of	 aromatic	 side-products,	 which	 was	 the	
result	 of	 competitive	 deprotonation	 at	 the	 more	 acidic	 γ-enone-α-oxazolidinone	
position,	 followed	 with	 fast	 aromatization.	 We	 then	 speculated	 that	 the	
oxazolidinone	auxiliary	in	2.82	could	be	hydrolyzed	under	oxidative	and	moderately	
basic	 conditions	 (LiOH,	H2O2	 or	 t-BuOOH)	 to	 afford	 the	 peracid	2.83	 in	 situ,	which	
might	 in	 turn	 be	 able	 to	 undergo	 an	 intramolecular	 Rubottom-oxidation-
lactonization	sequence	without	competitive	deprotonation.	Unfortunately,	under	all	
tested	 conditions	 no	 lactone	product	was	 detected	 by	GC-MS	while	 the	 carboxylic	
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acid	 2.85	 was	 isolated	 as	 the	 only	 product	 in	 62%	 yield	 because	 the	 preacid	 2.83	
tends	to	decompose	to	the	corresponding	carboxylic	acid	in	basic	conditions.		
	
Scheme	2-12.	Effective	lactone	construction	protocols	
Considering	that	the	presence	of	the	oxazolidinone	auxiliary	is	problematic	under	
oxidative	 lactonization	 conditions,	 we	 turned	 back	 to	 reduce	 the	 oxazolidinone	
immediately	after	the	Diels-Alder	cycloaddition.	As	shown	in	Scheme	2-12,	the	Diels-
Alder	 cycloaddition	was	 performed	 under	 the	 optimized	 conditions,	 and	 the	 labile	
silyl-enolate	product	was	reduced	with	lithium	borohydride	followed	by	acidic	work-
up	to	the	rearranged	enone	2.87	with	74%	overall	yield	and	91%	ee.[114]	Gratifyingly,	
deprotonation	 of	 the	 alcohol	2.87	with	 two	 equivalents	 of	 LDA	 at	 -78	 oC	 gave	 the	
corresponding	enolate	 smoothly,	which	was	oxidized	with	Davis’	oxaziridine	 to	 the	
diol	 2.88	 in	 68%	 yield.	 The	 oxidation	 was	 diastereoselectively	 controlled	 by	 the	
adjacent	 iPr-group,	 probably	 due	 to	 the	 directing	 effect	 of	 the	 primary	 alcohol.	
Employing	 Rubottom	oxidation	 conditions	 after	 further	 optimization	 allowed	 us	 to	
Total	Synthesis	of	Picrotoxane	Alkaloids	
	
56	
isolate	the	diol	2.88	in	82%	overall	yield.	The	oxidative	lactonization	was	first	tested	
with	the	Macho-ruthenium	catalyzed	hydrogen-transfer	strategy.	To	our	delight,	the	
desired	 lactone	 2.75	 was	 isolated	 with	 76%	 yield	 under	 hydrogen	 acceptor-free	
conditions	(Scheme	2-12,	conditions	1).	Literature	research	indicated	that	a	catalytic	
dehydrogenative	coupling	occurred	with	evolution	of	H2	gas,	which	can	be	expelled	
in	 refluxing	 toluene.[115]	 However,	 the	 harsh	 conditions	 (refluxing	 toluene)	
undoubtedly	led	to	the	moderate	yield,	which	pushed	us	to	explore	milder	catalytic	
conditions.	 Finally,	Ma’s	 recently	 reported	 iron	 nitrate-catalyzed	 aerobic	 oxidation	
(Scheme	 2-12,	 conditions	 2)	 provided	 the	 alternative	 option	 to	 afford	 the	 lactone	
product	2.75	with	89%	yield	with	water	as	the	only	byproduct.[116]	In	both	cases,	the	
primary	 alcohol	 in	 2.88	 was	 chemoselectively	 oxidized	 to	 the	 corresponding	
aldehyde	2.89	that	condensed	with	the	secondary	alcohol	at	C-6	to	hemiacetal	2.90,	
which	 was	 further	 oxidized	 to	 the	 lactone	 2.75.	 Compared	 to	 the	 traditional	
oxidative	strategies	 in	which	stoichiometric	amounts	of	oxidants	are	necessary,	the	
two	 catalytic	 lactonization	protocols	 are	highly	 eco-friendly,	while	 the	 latter,	more	
energy-effective	 iron-catalyzed	approach	 is	more	applicable	 in	total	synthesis.	With	
lactone	2.75	in	hand,	we	set	out	to	install	the	cyclopentane	scaffold	2.73	containing	
the	 all-carbon	 quaternary	 center	 (Scheme	 2-13).	 Diastereoselective	 conjugate	
addition	 of	 2.92-derived	 cuprate	 trans	 to	 the	 iPr-group	 led	 to	 the	 formation	 of	
enolate	 2.93,	 which	 was	 quenched	 by	 methyl	 iodide	 followed	 with	 deprotection,	
affording	the	diastereomerically	pure	ketone	2.74	 in	64%	yield.	The	use	of	terminal	
protected	alkyne	2.91	was	necessary	to	avoid	homocoupling	byproducts	during	the	
organocuprate	 reagent	 synthesis.	 Transformation	 of	 2.74	 into	 the	 corresponding	
TBS-enol	 ether	 2.94	 was	 performed	 under	 thermal	 conditions	 (Scheme	 2-13,	
conditions	1),	as	the	kinetic	conditions	with	strong	bases	like	LDA	led	to	competitive	
deprotonation	 of	 the	 terminal	 alkyne	 (Scheme	 2-13,	 conditions	 2).	 Stoichiometric	
amounts	of	sodium	iodide	were	used	as	an	additive	to	form	the	stronger	enolating	
reagent	TBSI	in	situ.	Without	further	purification,	the	TBS-enolether	2.94	was	treated	
with	10	mol%	of	Au	catalyst	Ph3PAuCl/AgBF4	in	a	mixture	of	CH2Cl2/H2O	and	resulted	
in	 cycloisomerization	 to	 2.73	 in	 76%	 overall	 yield	 with	 the	 quaternary	 center	
installed.[117]	 The	 structure	 of	 compound	2.73	was	 unambiguously	 confirmed	by	 X-
ray	crystallography	(Scheme	2-13).		
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Scheme	2-13.	Cycloisomerization	strategies		
Due	to	its	weak	nucleophilicity,	the	ketone	2.74	usually	requires	pre-activation	as	
a	silyl-enolether	in	cycloisomerization	chemistry.	However,	if	the	activated	enolate	is	
formed	 in	 situ,	 the	 additional	 synthesis	 of	 silyl-enol	 ether	 2.94	 can	 be	 omitted.	
Indeed,	 with	 Dixon’s	 recently	 reported	 Cu(OTf)2-pyrrolidine	 co-catalyzed	
cycloisomerization	conditions,	a	direct	conversion	of	2.74	to	2.73	without	labile	silyl-
enol	ether	2.94	synthesis	was	possible	though	 in	a	 lower	overall	yield	compared	to	
the	two-step	Au-catalyzed	sequence	(Scheme	2-13).[118]	Initially,	the	condensation	of	
the	pyrrolidine	with	ketone	2.74	 affords	 the	 iminium	 ion	2.95,	which	 tautomerizes	
into	the	enamine	species	2.96	as	a	well-activated	nucleophilic	reagent.	Activation	of	
the	alkyne	in	2.96	by	the	copper	catalyst	leads	to	simultaneous	cycloisomerization	to	
afford	 the	 product	 2.73,	 concomitant	 with	 catalyst	 regeneration.	 Considering	 the	
availability	of	the	copper	catalyst,	this	provided	an	alternative	for	an	intramolecular	
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cycloisomerization	 approach	 for	 natural	 products	 synthesis.	 At	 this	 stage,	 the	
enantiomeric	 excess	 of	2.73	was	 improved	 after	 recrystallization	 to	 99%	with	 86%	
yield.		
	
Scheme	2-14.	Direct	anti-Markovnikov	hydroamination	attempts	
With	 the	optically	 pure	olefin	2.73	 being	efficiently	 synthesized,	 introduction	of	
the	 nitrogen	 atom	 was	 first	 investigated	 with	 the	 envisioned	 regio-	 and	
diastereoselective	 direct	 anti-Markovnikov	 hydroamination	 strategy.	 In	 2013,	
Hartwig’s	 group	 reported	 a	 one-pot	 hydrozirconation/amination	 sequence	 to	
introduce	 the	C-N	bond	 in	an	 anti-Markovnikov	 fashion,[119]	 and	Stoltz’s	 group	 first	
utilized	 this	 protocol	 in	 the	 total	 synthesis	 of	 (-)-goniomitine	 in	 2016	by	 late-stage	
functionalization	 of	 a	 terminal	 mono-substituted	 olefin.[120]	 However,	 in	 our	 case	
only	starting	material	was	recovered	with	olefin	2.73	(Scheme	2-14a).	We	reasoned	
that	the	direct	hydroamination	might	be	troublesome	due	to	the	steric	hindrance	of	
the	1,1’-disubstituted	exocyclic	olefin	and	the	adjacent	vicinal	all-carbon	quaternary	
center.	 The	hypothesis	was	 further	 confirmed	by	 the	 fact	 that	 the	olefin	2.73	was	
inactive	under	CuH-catalyzed	hydroamination	conditions	(Scheme	2-14b)[121]	as	well	
as	 palladium-catalyzed	 Wacker	 oxidation	 conditions	 (Scheme	 2-14c)[122].	 Based	 on	
these	 results,	we	envisioned	 that	 less	 sterically-demanding	 free-radical	 approaches	
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might	 be	 more	 feasible.	 However,	 Studer’s	 free	 radical	 hydroamination	
conditions[123]	 were	 still	 unfruitful	 and	 resulted	 in	 starting	 material	 recovery	 only	
(Scheme	2-14d).	
	
Scheme	2-15.	Investigations	of	hydrogen	auto-transfer	catalysis	
We	 then	 turned	 to	 the	 catalytic	 hydrogen	 auto-transfer	 strategy	 for	 the	 amine	
synthesis	from	the	corresponding	alcohol	with	water	as	the	only	by-product.	To	the	
best	of	our	knowledge,	this	strategy	has	never	been	used	in	total	synthesis.[124]	In	the	
model	 case	 studies,	 olefin	2.98	was	 treated	with	 borane-dimethyl	 sulfide	 complex	
followed	 by	 an	 oxidative	 work-up	 to	 give	 the	 diols	 2.99	 and	 2.100	 as	 a	 pair	 of	
diastereomers	 (Scheme	 2-15a).	 The	 minor	 cis-diol	 2.99	 was	 first	 tested	 in	 the	
ruthenium-catalyzed	 hydrogen	 auto-transfer	 catalysis	 with	 benzylamine	 as	 the	
amine	 source.	 Surprisingly,	 the	 lactone	 compound	2.101	was	 isolated	 in	 46%	 yield	
(Scheme	2-15b),	which	 represented	 a	 pathway	 that	 analogous	 to	 the	 Ru-catalyzed	
lactone	 synthesis	 shown	 in	 Scheme	 2-12.	 It	 was	 reasoned	 that	 the	 intramolecular	
hemiacetal	 formation	was	 faster	 than	 the	desired,	 intermolecular	 imine	 formation.	
Nevertheless,	we	assumed	 that	 this	might	not	be	an	 issue	 for	 the	major	 trans-diol	
2.100	 as	 the	 corresponding	 trans-hemiacetal	 formation	 is	 really	 difficult.	However,	
applying	the	same	conditions	to	trans-diol	2.100	only	 led	to	decomposition	 instead	
of	formation	of	the	desired	amine	2.102	(Scheme	2-15c).	This	is	due	to	the	instability	
of	 the	 aldehyde	 intermediate	 at	 high	 temperatures.	 Same	 results	 were	 obtained	
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when	 the	 less	 basic	 tert-butanesulfinamides	 (R,	 S	 or	 racemic)	 or	 other	 catalytic	
systems	were	used.		
On	the	other	hand,	the	isolation	of	lactone	2.101	offered	us	a	novel,	biomimetic	
total	 synthesis	 of	 picrotoxane	 sesquiterpenoids	2.6	 –	2.9	 by	 carefully	 investigating	
the	 selective	oxidation	conditions.	Therefore	we	 turned	our	attention	 to	 the	olefin	
2.73	 to	 test	 the	 feasibility	of	 additional	 lactone	 formation.	 To	our	disappointment,	
the	 hydroboration-oxidation	 sequence	 led	 to	 trans-diol	 2.103	 diastereoselectively	
(Scheme	 2-15d)	which	 then	 decomposed	 under	 the	 catalytic	 conditions	 instead	 of	
giving	 the	 desired	 intermediate	 2.16	 or	 amine	 2.104	 (Scheme	 2-15e).	 Further	
investigation	 into	 cis-diol	 synthesis	 from	 olefin	 2.73	 with	more	 sterically	 hindered	
borane	complexes	such	as	9-BBN	or	catecholborane	were	fruitless.	
	
Scheme	2-16.	Hydroboration-azidation	strategy	for	C-N	bond	formation	
However,	the	fact	that	the	olefin	could	be	hydroborated	inspired	us	to	trigger	C-B	bond	
disconnection	 in	 the	 boron-intermediate	 with	 a	 free	 radical	 initiator	 to	 give	 the	
corresponding	 carbon-radical,	which	might	 collapse	with	 another	 nitrogen-radical	 species	
to	implement	the	C-N	bond	(Scheme	2-16).	After	careful	evaluation	of	available	strategies,	
a	 sequence	 of	 hydroboration	with	 catecholborane	 to	2.105	 followed	 by	 subsequent	 free	
radical-initiated	azidation	of	the	C-B	bond	under	Renaud’s	conditions[125]	was	successful	and	
constructed	 the	 desired	 C-N	 bond	 in	 2.106	 in	 exclusively	 diastereo-	 and	 regioselective	
fashion,	 and	 azide	 2.106	 was	 isolated	 in	 47%	 overall	 yield.	 The	 uncommon	 free	 radical	
initiator	 di-tert-butyl	 hyponitrite	 was	 used	 because	 the	 oxygen	 radical	 has	 a	 stronger	
affinity	to	boron	compounds	according	to	Renaud’s	investigations.[125a]		
Gratifyingly,	 azide	 2.106	 underwent	 an	 intramolecular	 aza-Wittig	 reaction	 smoothly	
affording	the	dehydropyrrolidine	2.71	as	a	common	intermediate,	which	was	used	directly	
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in	the	following	steps	due	to	the	lability	of	the	imine	moiety	towards	moisture	(Scheme	2-
17).	Starting	from	the	common	intermediate	2.71,	(-)-dendrobine	2.1	and	(-)-mubironine	B	
2.2	were	synthesized	under	reductive	work-up	with	74%	and	62%	yield,	respectively.		
	
Scheme	2-17.	Collective	synthesis	of	three	picrotoxane	alkaloids		
(-)-Dendroxine	 2.3	 was	 obtained	 upon	 treatment	 of	 dehydropyrrolidine	 intermediate	
2.71	 with	 2-iodoethanol	 under	 thermal	 conditions,	 through	 an	 iminium	 ion	 formation	
followed	 by	 a	 very	 fast	 intramolecular	 nucleophilic	 O-addition.[126]	 In	 summary,	 the	
asymmetric	total	synthesis	of	2.1,	2.2	and	2.3	was	accomplished	in	12	or	11	steps	in	6.7%,	
7.8%	and	7.4%	yield,	respectively	(Scheme	2-17).	The	spectroscopic	data	of	the	synthesized	
alkaloids	are	identical	to	the	data	reported	in	the	literature	(a	comparison	of	spectroscopic	
data	can	be	seen	in	experimental	part).	As	can	be	seen	from	the	flowchart	(Figure	2-2),	this	
synthesis	 represents	 optimized	 synthetic	 efficiency	 which	 minimized	 non-strategic	
manipulations	and	the	highest	overall	yield	so	far.		
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Figure	2-2.	Step-efficiency	analysis	according	to	Christmann’s	method[110]	
In	the	meantime,	the	enantioselectivity	 in	our	approach	is	a	direct	consequence	of	the	
stereoselective	 intermolecular	Diels-Alder	cycloaddition	between	Danishefsky’s	diene	2.77	
and	 dienophile	 2.81.	 As	 far	 as	 we	 know,	 all	 the	 other	 available	 enantioselective	 total	
syntheses	started	from	chiral	pool	material.	To	underline	the	strength	of	our	approach,	we	
turned	 to	 synthesize	 the	 corresponding	 enantiomeric	 alkaloids	 and	 to	 characterize	 these	
non-natural	 antipodes.	 As	 illustrated	 in	 Scheme	 2-18,	 starting	 with	 the	 (R)-catalyst,	 the	
corresponding	 cyclohexenone	 (+)-2.87	was	 accessible	 in	 71%	yield	 and	91%	enantiomeric	
excess.	With	this	cyclohexenone	(+)-2.87	in	hand,	(+)-dendrobine	2.1,	(+)-mubironine	B	2.2	
and	 (+)-dendroxine	 2.3	 could	 be	 synthesized	 within	 10	 or	 11	 steps	 respectively.	 The	
absolute	configuration	of	the	natural	products	and	their	optical	antipodes	were	confirmed	
by	 X-ray	 crystallography	 of	 the	 intermediate	 2.73	 and	 ent-2.73.	 Combined	 with	 the	
possibility	of	 the	natural	 products’	 analogues	 can	be	 synthesized	by	 introducing	different	
substitution	patterns	in	oxazolidinone	moiety,	this	approach	is	highly	useful	for	expanding	
the	library	pool	of	picrotoxane	alkaloids	for	further	investigation	into	their	structure-activity	
relationships.			
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Scheme	2-18.	Enantiomeric	natural	products	synthesis	
2.5. Conclusion	and	Outlook	
In	this	part,	a	concise	enantiodivergent	total	synthesis	of	(-)-dendrobine,	(-)-mubironine	
B,	 (-)-dendroxine	 and	 their	 enantiomers	 was	 described	 using	 sophisticated	 catalytic	
methods	with	an	overall	yield	of	6.7%,	7.8%	and	7.4%,	respectively.	As	far	as	we	know,	this	
represents	a	notably	improved	yield	as	compared	to	synthetic	approaches	reported	in	the	
past.	 Furthermore,	 it	 is	 the	 first	 total	 synthesis	 of	 (-)-dendroxine	 being	 reported.	
Importantly,	the	asymmetric	Yb-catalyzed	Diels-Alder	cycloaddition	between	Danishefsky’s	
diene	 and	 an	 oxazolidinone	 allows	 for	 the	 synthesis	 of	 optically	 pure	 natural	 products,	
antipodes	 and	 the	 analogues	 in	 enantiodivergent	 and	 collective	 fashion,	 while	 the	 iron-
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catalyzed	 aerobic	 oxidation,	 the	 copper-catalyzed	 cycloisomerization	 and	 the	
hydroazidation	 underline	 the	 strength	 of	 modern	 synthetic	 sequences	 compared	 to	 the	
conventional	counterparts.	Further	work	will	concentrate	on	the	construction	of	additional	
picrotoxane	 alkaloids	 and	 sesquiterpenoids	 in	 order	 to	 explore	 their	 biological	 activities.	
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3. Catalytic	Enantioselective	Total	Synthesis	of	Englerins	A	and	B	
3.1. Introduction	to	the	Guaiane	Sesquiterpene	Englerins	A	and	B	
Renal	 cancer	 is	 the	 eighth	 most	 common	 adult	 cancer	 in	 the	 world,	 and	 the	 newest	
epidemiological	research	indicates	that	there	are	around	65,340	new	renal	cancer	cases	in	
the	United	States	and	73,400	cases	in	Europe	every	year,	which	account	for	more	than	50%	
of	 yearly	 new	 cases	 all	 around	 the	 world.[127-129]	 Surgery	 serves	 as	 the	 most	 common	
treatment	 as	 renal	 cancer	 cells	 often	 do	 not	 respond	 to	 radiotherapy	 or	 chemotherapy.	
However	 when	 surgery	 is	 not	 possible,	 chemotherapy	 is	 necessary	 to	 prolong	 the	
progression-free	survival.[130]	Nevertheless,	 the	current	 standard	of	 care	does	not	prolong	
the	PFS	 significantly.	 For	 example,	 sorafenib	 and	 sunitinib	 are	 currently	 used	 as	 the	 anti-
renal	 cancer	 drugs	 in	 markt,	 however	 the	 median	 PFS	 was	 5.5	 months	 in	 the	 sorafenib	
group[131]	 and	 11	 months	 in	 the	 sunitinib	 group[132].	 Pharmacologically	 speaking,	
sorafenib[131]	and	sunitinib[132]	are	 inhibitors	 to	 the	renal	cancer	cellular	signaling	pathway	
that	 inhibit	 multiple	 receptor	 tyrosine	 kinases.	 In	 other	 words,	 identification	 of	 small	
molecules	targeting	on	novel	renal	cancer	receptors	might	be	significantly	helpful	 in	renal	
cancer	chemotherapy	investigations.		
	
Scheme	3-1.	Guaiane	sesquiterpene	englerins	A	and	B	
(-)-Englerins	 A	 and	 B	 (3.1	 and	3.2	 Scheme	 3-1)	 are	 guaiane	 sesquiterpenes	 that	were	
isolated	from	the	East	Africa	shrub	tree	Phyllanthus	engleri’s	extracts	by	Beutler’s	group	in	
2009.[133]	 Biological	 evaluation	 revealed	 that	 (-)-englerin	 A	 3.1	 inhibits	 renal	 cancer	 cell	
line’s	 growth	with	GI50	 ranges	between	1-87	nM,	which	 is	 2-3	 fold	more	potent	 than	 the	
current	standard	of	care	sunitinib	and	sorafenib.[134]	Consequently,	(-)-englerin	A	3.1	might	
be	 a	 promising	 new	 lead	 compound	 to	 the	 treatment	 of	 renal	 cancer.	 Pharmacologically	
speaking,	(-)-englerin	A	3.1	 targets	an	unprecedented	anti-tumor	target	TRPC4/5,	which	is	
known	 as	 the	 transit	 receptor	 potential	 cation	 channels	 that	 regulate	 the	 Ca2+	
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concentration	 within	 cells,	 further	 more	 control	 endothelial	 permeability,	 and	 finally	
influence	 the	 cell’s	 proliferation	 (Scheme	 3-2).[135]	 This	 unusual	 working	 targets	 renders	
englerin	A	 to	be	 a	potent	 anti-cancer	drug	 candidate	 and	an	 interesting	 part	 in	potential	
novel	antitumor	target	research.		
	
Scheme	3-2.	Englerin	A’s	inhibition	of	renal	cancer	cells	
	
Scheme	3-3.	Biosynthesis	of	guaiane	sesquiterpene	engerins	
Structurally	 speaking,	 the	englerins	belong	 to	guaiane	 sesquiterpene	natural	products,	
featuring	 a	 challenging	 trans-fused	 bicyclo[5.3.0]	 core	 structure,	 an	 oxygen	 bridge	 and	 a	
seven-membered	ring	that	in	an	oxabicyclo[3.2.1]	heptane	system.	The	central	framework	
is	 highly	 oxidized	 and	 bears	 seven	 contiguous	 stereocenters.	 Similar	 to	 the	 picrotoxane	
sesquiterpenoids,	englerins	biogenetically	arise	from	the	mevalonate	pathway	(Scheme	3-
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3).	 The	 guaiane	 core	 structure	 3.4	 is	 synthesized	 via	 FPP	 polyene	 cyclization,	 and	 a	
subsequent	 late-stage	 selective	 oxidation-rearrangement	 gives	 the	 central	 structure	 3.6	
bearing	an	oxygen	bridge,	which	is	eventually	esterificated	to	give	the	englerins	A	and	B.[136]		
3.2. Prior	Synthetic	Approaches	towards	Englerins	A	and	B	
The	 interesting	 molecular	 structure	 of	 the	 englerins	 plus	 its	 bio-potential	 reactivities	
have	 spurred	 interest	 in	 synthetic	 chemists	 to	 develop	 efficient	 synthetic	 protocols.	
However,	the	complex	tricyclic	core	represents	a	severe	synthetic	challenge	that	needs	to	
be	addressed.		
	
Scheme	3-4.	Christmann’s	first	total	synthesis	of	(+)-englerin	A	via	RCM	strategy	
Ring-closing	 olefin	 metathesis	 was	 proven	 to	 be	 a	 powerful	 strategy	 and	 was	 widely	
used	towards	the	construction	of	macro	ring	system.	In	2009,	Christmann’s	group	reported	
the	first	total	synthesis	of	(+)-englerin	A	3.1	starting	from	bicyclic	nepetalactone	3.7,	which	
bears	 the	 desired	 cyclopentane	 moiety	 and	 the	 chiral	 stereocenters.	 As	 illustrated	 in	
Scheme	 3-4,	 a	 ring	 closing	 metathesis	 approach	 followed	 by	 a	 biomimetic	 oxidation-
transannular	 epoxide-opening	 strategy	 afforded	 the	 central	 scaffold.	 After	 additional	
esterification,	 ent-englerin	 A	 3.1	 was	 synthesized	 for	 the	 first	 time	 together	 with	 its	
absolute	configuration	determination.[137]	Meanwhile,	a	similar	RCM-biomimetic	oxidation-
transannular	epoxide	opening	sequence	was	utilized	by	Metz’s	group	in	their	synthesis	of	(-
)-englerin	A.[138]	
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Scheme	3-5.	Chain’s	efficient	total	synthesis	of	(-)-englerin	A	
Meanwhile,	Chain’s	group	developed	a	conjugate	addition-reductive	coupling	sequence	
to	 access	 the	 tricyclic	 core	 efficiently(Scheme	 3-5).[139]	 Starting	 from	 the	 3-furanone	3.16	
and	 the	 enantiomerically	 pure	 α,β-unsaturated	 aldehyde	 3.17,	 the	 conjugate	 addition	
occurred	 smoothly	 to	 give	 the	 adduct	 3.18	 in	 75%	 yield	 with	 moderate	
diastereoselectivity.Subsequent	 umpolung	 coupling	 was	 problematic	 due	 to	 the	 low	
reactivity	 of	 the	 bulky	 furanone	 3.18,	 and	 only	 a	 combination	 of	 samarium	 iodide	 and	
HMPA	afforded	the	reductive	coupling	product	3.19	with	moderate	yield.	With	the	central	
scaffold	being	constructed,	the	total	synthesis	of	 (-)-englerin	A	2.1	was	finished	 in	6	steps	
very	concisely.		
Aside	from	the	elegant	RCM-epoxide-opening	and	conjugate	addition-reductive	coupling	
strategies,	 the	majority	of	available	 strategies	are	based	on	 the	cycloadditions	as	 the	key	
steps,	such	as	Ma’s[140]	and	Echavarren’s[141]	independent	syntheses	of	(-)-englerin	A	2.1	via	
Au(I)-catalyzed	 enyne-carbonyl	 [2+2+2]	 cycloaddition	 (Scheme	 3-6).	 The	 enantioselective	
synthesis	of	enyne-carbonyl	compound	3.18	in	Ma’s	work	was	achieved	from	ex-chiral-pool	
(R)-citronellal	3.16,	while	 the	 corresponding	 cycloaddition	 precursor	3.26	 in	 Echavarren’s	
work	 was	 synthesized	 via	 Sharpless’	 catalytic	 asymmetric	 epoxidation.	 Ma	 used	 the	
relatively	 simpler	 and	 commercially	 available	 AuCl	 (10	 mol%)	 as	 catalyst	 to	 afford	 the	
cyclized	product	3.19	with	48%	yield,	while	Echavarren	reported	the	use	of	only	3	mol%	of	
[IPrAuNCPh]SbF6	that	delivered	the	product	in	58%	yield.		
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Scheme	3-6.	Ma’s	and	Echavarren’s	indepent	total	syntheses	of	(-)-englerin	A	
Contemporaneously,	Nicolaou’s	group	reported	a	total	synthesis	of	(-)-englerin	A	based	
on	 a	 [5+2]	 cycloaddition	 between	 oxidopyrylium	 species	 3.36	 and	 the	
camphorsulfonamide-derived	 acrylate	 3.41	 (Scheme	 3-7).[142]	 The	 enantioselectivity	 was	
induced	by	the	use	of	camphorsulfonamide	moiety	in	3.41	as	chiral	auxiliary.	Though	trivial	
functional	group	transformations	were	necessary	 in	this	work,	the	use	of	an	Achmatowicz	
rearrangement-	 [5+2]	 cycloaddition	 provided	 a	 novel	 strategy	 towards	 oxabicyclo[3.2.1]	
heptane	core	which	is	still	vivid	today.[143]	
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Scheme	3-7.	Nicolaou’s	total	synthesis	of	(-)-englerin	A	via	[5+2]	cycloaddition	
Lin’s	 group	 finished	 the	 total	 synthesis	 of	 (+)-englerin	 A	 3.1	 by	 approaching	 Ma’s	
intermediate	3.47	with	an	organocatalyzed	[4+3]	cycloaddition	(Scheme	3-8).[144]	However,	
the	 moderate	 regioselectivity	 and	 enantioselectivity	 in	 the	 organocatalysis	 limited	 its	
further	application	compared	to	the	other	cycloaddition	strategies.		
	
Scheme	3-8.	Lin’s	total	synthesis	of	(+)-englerin	A	via	[4+3]	cycloaddition	
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Very	 recently,	Mascareñas’	group	 reported	a	 total	 synthesis	of	 (-)-englerin	A	based	on	
platinum	catalyzed	[4+3]	cycloaddition	(Scheme	3-9).[145]	Similar	to	the	englerin	biogenesis	
pathway,	the	synthesis	can	be	divided	into	a	polycyclization	process	affording	the	guaiane	
moiety	 and	 a	 selective	 oxidation	 process.	 	 As	 shown	 in	 Scheme	 3-9,	 enantioselective	
catalytic	hydrogenation	of	 the	ynone	3.50	with	Noyori’s	 ruthenium	catalyst	3.56	afforded	
the	 enantiomerically	 pure	 propargylic	 alcohol,	 which	 was	 cyclized	 into	 the	 guaiane	 core	
3.52	 with	 platinum	 catalysis	 in	 71%	 yield.	 Late-stage	 sequential	 selective	 oxidation	 was	
achieved	with	potassium	osmate	and	L-Shi-catalyst	to	afford	the	englerin	scaffold	3.54	in	46%	
overall	yield.	With	the	central	skeleton	being	effectively	constructed,	total	synthesis	of	(-)-
englerin	A	was	completed	after	conventional	transformations.	
	
Scheme	3-9.	Mascareñas’	total	synthesis	of	(-)-englerin	A	via	[4+3]	cycloaddition	
Flowcharts	 of	 a	 selected	 examples	 of	 the	 syntheses	 are	 listed	 below,	 and	 Chain’s	
synthesis	represents	the	optimal	that	the	majority	of	the	transformations	are	the	strategic	
C-C	 bonds	 or	 C-Hetero	 bonds	 formation,	with	 the	 shortest	 LLS	 (8	 steps)	 and	 the	 highest	
overall	yield	so	far.	 	Biomimetic	approaches	usually	allow	relatively	shorter	syntheses	and	
higher	 efficiency	 due	 to	 nature	 itself	 adopt	 the	most	 optimized	 strategy	 in	 biosynthesis.	
Inspired	by	nature’s	high	efficiency,	Christmann’s	and	Mascarenas’	syntheses	were	finished	
with	more	than	10%	overall	yields.			
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				Figure	3-1.	Step-efficiency	analysis	according	to	Christmann’s	method[110]	
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3.3. Project	Design	and	Retrosynthetic	Analysis		
	
Scheme	3-10.	A	bio-inspired	retrosynthetic	analysis	of	englerins	A	and	B	
Primary	chemicals	and	simple	but	classical	organic	transformations	still	offer	significant	
inspiration	 for	modern	 chemistry.	 For	 example,	 Robinson’s	 synthesis	 of	 tropinone	3.61	 is	
considered	 a	 classic	 since	 the	 1920s	 due	 to	 its	 simplicity,	 biomimetic	 fashion	 as	 well	 as	
demonstrating	 a	 tandem	 reaction	 in	 “one-pot”	 synthesis.[146]	 Succinaldehyde	 3.58,	
methylamine	and	acetonedicarboxylic	acid	3.59	are	among	the	most	basic	building	blocks	in	
organic	 synthesis	 and	 are	 the	 same	 starting	 materials	 in	 tropinone	 3.61’s	 biosynthesis.	
Acetonedicarboxylic	 acid	 3.59	 is	 known	 as	 the	 synthetic	 equivalent	 of	 acetone,	 which	
facilitates	 the	 cyclization	 in	 Robinson’s	 case.	 Actually,	 in	 modern	 organic	 chemistry,	
acetonediacarboxylic	acid	3.59,	β-ketone	acid	3.66	or	their	derivatives	3.64	are	widely	used	
as	 biological	 enol-surrogates	 in	 aldol	 type	 C-C	 bond	 formations	 or	 as	 1,3-dianion	 in	
cycloaddition	 chemistry.	 Inspired	 by	 this	 chemistry,	 we	 hypothesized	 that	 these	 primary	
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compounds	would	allow	for	a	short,	straightforward	modular	total	synthesis	of	englerins	A	
and	B.[147]		
The	 corresponding	 retrosynthetic	 analysis	 is	 illustrated	 in	 Scheme	 3-10.	 Accordingly,	
simple	 later-stage	 transformations	 of	3.71	would	 provide	 the	 englerins,	 and	 alcohol	3.71	
might	be	synthesized	through	a	diastereoselective	oxidation	of	3.70,	which	was	envisaged	
to	derive	 from	a	diastereoselective	 reductive	Heck	coupling	 reaction.	 	Coupling	precursor	
3.69	 could	 be	 prepared	 in	 a	 straightforward	 way	 from	 the	 β-ketone	 ester	 3.62.	 The	
oxabicyclo[3.2.1]	 heptane	 core-containing	 3.62	 might	 be	 furnished	 by	 an	 annulation	
between	 the	 1,4-diketone	 3.63	 and	 methyl	 acetoacetate	 3.64	 (surrogate	 to	 1,3-dianion	
3.65),	which	was	inspired	by	tropinone’s	biogenesis.	Obviously	the	α-hydroxyl-1,4-diketone	
3.63	could	be	synthesized	from	methylglyoxal	3.68	and	the	enolate	3.67	via	aldol	reaction.	
Meanwhile,	according	to	the	biomimetic	decarboxylative	aldol	chemistry	utilizing	MAHTs	as	
enolate	equivalents	for	stereoselective	transformations,	enantioselective	synthesis	of	3.63	
should	be	possible	between	enolate	3.67’s	surrogate	β-ketone	acid	3.66	and	methylglyoxal	
3.68	if	a	polyketide	synthase-type	catalyst	is	applied.[86a,	87]		
3.4. Bio-inspired	Synthesis	of	Englerins	A	and	B	
	
Scheme	3-11.	Racemic	decarboxylative	aldol	reaction	
As	discussed	in	the	previous	part,	the	project	started	with	an	aldol	reaction	between	the	
β-ketone	acid	3.66	and	methylglyoxal	3.68,	and	 it	was	 found	that	 the	reaction	proceeded	
smoothly	non-enantioselectively	in	water	without	any	catalysts	(base,	acid,	metal	etc.)	in	93%	
yield.[148]	 For	 the	 enantioselective	 counterpart,	 a	 biomimetic,	 PKS-type	 catalyst	 is	 highly	
desired.	 However,	 as	 far	 as	 we	 know	 the	 substrate	 scope	 of	 this	 chemistry	 is	 rather	
limited[149],	and	no	protocol	for	stereoselective	decarboxylative	aldol	reactions	between	the	
two	 desired	 substrates	 were	 reported.	 Therefore,	 we	 initiated	 to	 investigate	 the	
enantioselective	 transformation	 with	 chiral	 organocatalysts	 since	 methylglyoxal	 is	 only	
available	in	aqueous	solution.		
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The	 catalysis	 was	 performed	 initially	 at	 -20	 oC	 according	 to	 the	 control	 experiments	
(Table	3-1,	entries	1-2),	a	primary	catalysts	screening	(Table	3-1,	Scheme	3-12)	showed	that	
the	cinchona-type	catalysts	promoted	this	reaction	at	low	temperature	in	organic	solvents	
while	 other	 types	 of	 organocatalysts	 were	 inactive	 (Table	 3-1,	 entries	 3-10).	 Cinchona	
dimers,	used	for	ligands	as	Os-catalyzed	asymmetric	dihydroxylations,	were	more	effective	
than	their	corresponding	monomers	in	improving	the	enantioselectivity	(Table	3-1,	entries	
11-16).	 Cinchona	 monomers	 that	 provide	 additional	 hydrogen-bond	 interactions	 did	 not	
improve	the	enantioselectivity	(Table	3-1,	entries	15	and	17-19).	Hence,	 it	was	postulated	
that	the	Brønsted-basic	tertiary	amines	are	the	main	catalytic	reactive	sites.	Nevertheless,	
the	 linkers	 of	 cinchona	 dimers	 had	 a	 strong	 effect.	 A	 phthalazine	 linker	was	 found	 to	 be	
superior	to	both	anthraquinone	and	pyrimidine	linkers	(Table	3-1,	entries	11,	12,	14	and	16),	
and	yielded	the	aldol	product	in	79%	yield	and	51%	ee.	Considering	the	enolizable	β-ketone	
acid	 and	 methylglyoxal	 hydrate	 are	 decent	 multiple	 hydrogen-bond	 donors,	 the	 two	
concurrent	nitrogen	atoms	on	the	phthalazine	linker	might	provide	as	additional	hydrogen-
bond	 acceptors.	 Therefore,	 a	 six-membered	 transition	 state	 was	 proposed	 with	multiple	
hydrogen-bond	 interactions.	 When	 the	 phthalazine	 linker	 was	 combined	 with	 different	
cinchona	alkaloids,	a	 reversal	 in	enantioselectivity	was	observed	 (Table	3-1,	entries	3	and	
11),	 which	 suggested	 the	 enantioselectivity	 was	 determined	 by	 the	 benzyl	 stereocenter.	
Similar	to	phthalazine,	catalysts	with	“concurrent	nitrogen	atoms”	linkers	were	tested	and	
were	found	to	have	minor	effects	on	the	enantioselectivity	(Table	3-1,	entries	20	and	21).	
Furthermore,	the	reactivity	of	the	catalyst	was	inhibited	at	lower	temperatures	and	longer	
reaction	times	were	required	to	reach	a	full	conversion	of	β-ketone	acid	3.66.	However,	no	
significant	 improvement	 of	 enantioselectivity	 was	 possible	 (Table	 3-1,	 entries	 22-24).	
Nevertheless,	 a	 strong	 solvent	 effect	 was	 observed	 (Table	 3-1,	 entries	 28-32)	 after	
extensive	solvent	screening,	and	trifluoroethanol	as	co-solvent	was	found	to	increase	of	the	
enantiomeric	 excess	 slightly	 to	 60%	 in	 81%	 yield.	 Further	 attempts	 to	 increase	 the	ee	 by	
increasing	 the	 catalyst	 loading	 did	 not	 provide	 encouraging	 results	 (Table	 3-1,	 entries	 34	
and	35).		
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Scheme	3-12.	Organocatalysts	investigation	for	the	aldol	reaction	
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Table	3-1.	Condition	optimization	and	postulated	transition	state		
	
Entry	 Catalyst	
(10	mol%)	
Temperature	
(oC)	
Solvent	
(0.1	M)	
Yield	
(%)a	
ee	
(%)b	
1	 ---	 0	 THF	 92	 n.d.	
2	 ---	 -20	 THF	 0	 n.d.	
3	 C3.1	 -20	 THF	 79	 51	
4	 C3.2	 -20	 THF	 62	 2	
5	 C3.3	 -20	 THF	 18	 0	
6	 C3.4	 -20	 THF	 0	 n.d.	
8	 C3.5	 -20	 THF	 0	 n.d.	
9	 C3.6	 -20	 THF	 0	 n.d.	
10	 C3.7	 -20	 THF	 0	 n.d.	
11	 C3.8	 -20	 THF	 76	 -52	
12	 C3.9	 -20	 THF	 83	 -24	
13	 C3.10	 -20	 THF	 76	 -20	
14	 C3.11	 -20	 THF	 81	 -19	
15	 C3.12	 -20	 THF	 76	 -27	
16	 C3.13	 -20	 THF	 67	 -28	
17	 C3.14	 -20	 THF	 71	 -18	
18	 C3.15	 -20	 THF	 76	 -27	
19	 C3.16	 -20	 THF	 83	 0	
20	 C3.17	 -20	 THF	 68	 -50	
21	 C3.18	 -20	 THF	 72	 -51	
22c	 C3.8	 -40	 THF	 76	 -52	
23	c	 C3.8	 -60	 THF	 66	 -52	
24	c	 C3.8	 -80	 THF	 71	 -52	
25	 C3.8	 -20	 CH2Cl2	 56	 -40	
26	 C3.8	 -20	 MeCN	 56	 -43	
27	 C3.8	 -20	 Toluene	 0	 n.d.	
28	 C3.8	 -20	 DME/MTBE	=	3:1	 71	 -52	
29	 C3.8	 -20	 THF/TFE	=	3:1	 75	 -60	
30	 C3.8	 -20	 THF/TFE	=	10:1	 81	 -60	
31	 C3.8	 -20	 THF/TFE	=	1:1	 19	 -60	
32	 C3.8	 -20	 THF/HFIP	=	10:1	 66	 -47	
33	c	 C3.8	 -40	 THF/TFE	=	10:1	 82	 -60	
34d	 C3.8	 -20	 THF/TFE	=	10:1	 83	 -60	
35e	 C3.8	 -20	 THF/TFE	=	10:1	 85	 -60	
a	Isolated	yield;	b	Enantiomeric	excess	was	analyzed	by	chiral	GC;	c	The	reaction	was	stirred	at	the	
indicated	temperature	for	72	h.		d	Catalyst	loading	20	mol%.	e	Catalyst	loading	50	mol%.	
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Scheme	3-13.	Control	experiments	to	investigate	the	basic	stability	of	product	
It	 is	 known	 that	 chiral	 α-hydroxyl	 ketones	 tend	 to	 racemize	 under	 basic	 conditions.	
Therefore	 control	 experiments	 were	 performed	 to	 test	 the	 enantiomeric	 stability	 of	 the	
product	in	the	presence	of	catalytic	amount	of	base	(Scheme	3-13),	and	the	results	showed	
the	 aldol	 product	 is	 enantiomerically	 stable	 towards	 Brønsted	 base.	 Considering	 the	 fact	
that	the	facial	discrimination	imposed	by	the	non-substituted	β-ketone	acid	is	not	sufficient	
to	achieve	high	enantiomeric	excess	and	the	asymmetric	aldol	chemistry	of	sterically	non-
demanding	substrates	is	still	an	on	going	difficulty,	we	decided	at	this	point	to	continue	the	
synthesis	with	 the	 enantiomerically	 enriched	 aldol	 product	3.63	 (81%	 yield,	 -60%	ee,	 2.0	
mmol	scale)	and	to	increase	the	enantiomeric	purity	in	a	late-stage	transformation.		
The	 bio-inspired	 annulation	 was	 then	 investigated	 to	 approach	 the	 oxabicyclo[3.2.1]	
heptane	core.	 In	Robinson’s	example,	methylamine	was	used	as	an	 internal	base	while	 in	
our	 case	an	additional	base	was	 required	 for	 the	dianion	 formation.	 Initial	 tests	between	
3.63	 and	methyl	 acetoacetate	 3.64	 with	 LDA	 or	 sodium	methoxide	 as	 bases	 led	 to	 non-
identified	messy	mixtures	 (Scheme	3-14,	a	and	b),	which	 implied	the	necessity	to	simplify	
the	 reaction	 system.	 However,	 same	 results	 were	 obtained	 when	 the	 free	 alcohol	 was	
protected	with	a	TBS	group	3.76	 (Scheme	3-14,	 c	 and	d).	 It	was	 reasoned	 that	 the	 regio-	
and	 chemoselectivity	 could	 not	 be	 effectively	 controlled	 in	 the	 presence	 of	multi-ketone	
components	 and	 the	 flexibility	 of	 both	 substrates	 led	 to	 a	 poor	 diastereoselectivity.	 The	
symmetric	 dianion-surrogate	 acetonedicarboxylic	 acid	 3.59	 was	 then	 considered	 as	 the	
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optimal	substrate	to	avoid	the	non-productive	regio-	and	chemoisomers.	Actually,	a	similar	
transformation	 has	 been	 done	 in	 our	 lab	 for	 the	 syntheses	 of	 polyprenylated	 polycyclic	
acylphloroglucines.[147,	150]	The	in	situ	formed	magnesium	might	be	utilized	as	a	coordinating	
Lewis	acid	and	to	enable	the	diastereoselectivity	control.	Nevertheless,	only	decomposition	
occurred	 as	 the	 alcohol	 is	 sensitive	 towards	 acidic	magnesium	 salts	 (Scheme	3-14,	 e	 and	
f).[151]		
	
Scheme	3-14.	Bio-inspired	annulation	under	basic	conditions	
The	 unproductive	 results	 above	 suggested	 that	 Lewis	 acid	 catalysis	with	 pre-activated	
acetoacetate	might	be	superior	 to	base	promoted	dianion	chemistry,	as	Lewis	acid	 forces	
the	1,4-diketone	to	form	a	more	rigid	hemiketal	intermediate	3.79	due	to	the	neighboring	
group	 effect	 (Scheme	 3-15).	 Hemiketal	 intermediate	3.79	may	 undergo	 highly	 regio-	 and	
diastereoselective	cycloaddition	with	the	pre-activated	acetoacetate.	 Indeed,	by	 following	
Molander’s	 TMSOTf	 catalyzed	 [4+3]	 cycloaddition	 with	 1,4-diketone	 3.76	 as	 electrophile	
towards	 bis-silylenolether	 3.80,	 the	 oxabicyclo[3.2.1]	 heptane	 core	 was	 obtained	 in	 an	
exclusively	regioselective	and	diastereoselective	fashion	of	the	C-O	bonds	at	C-3	and	C-4	in	
85%	 yield.[152]	 Accordingly,	 the	 sterically	 less	 hindered	 ketone	was	 silylated,	which	 led	 to	
oxonium	 3.81.	 This	 oxonium	 species	 3.81	 was	 stabilized	 by	 the	 neighboring	 group	
stabilization	of	the	adjacent	ketone	to	afford	hemiketal	3.82.	The	bulky	TBS	silyl-ether	thus	
shielded	 the	 top	 face	 of	 3.82,	 forcing	 the	 diene	 3.80	 to	 nucleophilic	 attack	 from	 the	
opposite	side	of	the	TBS	silyl-ether	to	give	the	first	C-C	bond	 in	3.83	with	desired	relative	
configuration.	 Intramolecular	 Mukaiyama	 aldol	 reaction	 afforded	 3.84	 and	 its	
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diastereomers	 at	 the	 β-ketoester	 position	 with	 10:1:1	 ratio.	 The	 structure	 of	 the	 major	
product	3.84	was	fully	characterized	by	NMR	analyses.	
	
Scheme	3-15.	Lewis	acid	catalyzed	cyclization	under	neighboring	group	effect	control	
With	regards	to	efficiency	in	total	synthesis,	the	free	alcohol	3.89,	acetate	and	glycolate	
protected	 oxabicyclo[3.2.1]	 heptane	 compounds	 3.88	 and	 3.90	 are	 better	 intermediates	
compared	 to	 the	 TBS-ether	 3.84,	 which	 needs	 trivial	 protecting	 group	 manipulations	 to	
afford	 the	 natural	 products.	 Therefore,	 acetate	 and	 glycolate	 compounds	 3.85	 and	 3.86	
were	 synthesized	 via	 esterification	 affording	 the	 product	 with	 82%	 and	 78%	 yield,	
respectively	(Scheme	3-16).	When	the	three	available	1,4-diketones	were	subjected	to	the	
optimized	[4+3]	cycloaddition	with	bis-silylenolether	3.80,	the	free	alcohol	3.63	underwent	
decomposition	due	to	 its	 lability	towards	Lewis	acids.	Acetate	3.85	 led	to	a	non-identified	
messy	mixture.	Crude	NMR	analysis	showed	the	acetate	carbonyl	group	was	involved	in	the	
reaction,	as	 the	singlet	around	2.0	ppm	was	missing.	Additionally,	we	postulated	that	 the	
acetate	group	might	not	be	bulky	enough	to	shield	the	top	face	of	the	hemiketal,	which	led	
to	poor	diastereoselective	control.	Gratifyingly,	glycolate	3.86	led	to	a	clean	reaction	to	the	
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desired	products	 in	83%	yield,	which	contains	3	diastereomers	at	the	β-ketoester	position	
with	10:2:1	ratio.	The	structure	of	3.90	was	fully	characterized	by	NMR	analysis.	Additional	
transition	state	analysis	 indicated	 that	except	 for	 the	shielding	effect	of	bulky	TBDPS,	 the	
adjacent	 carbonyl	 group	 of	 glycolate	 further	 stabilizes	 the	 cyclic	 oxonium	 species	 to	
improve	diastereoselective	control	(Scheme	3-16).	
	
Scheme	3-16.	Protecting	group	screening	in	TMSOTf	catalyzed	[4+3]	cycloaddition	
With	 the	 fully	 characterized	 bicyclic	 heptane	 3.90	 in	 hand,	 we	 turned	 to	 explore	 the	
feasibility	 of	 the	 cyclopentane	 structure	 construction.	Metal	 bases	 and	 the	 additive	were	
found	 to	 influence	 the	 C-	 or	 O-alkylation	 of	 β-ketoester	 3.90	 dramatically	 (Table	 3-2).	
Among	 different	 metal	 bases,	 sodium	 or	 potassium	 carbonate	 led	 to	 O-alkylation	
exclusively	(Table	3-2,	entry	1-2),	while	cesium	carbonate	was	found	to	give	a	mixture	of	C-	
and	O-alkylated	products	in	1:1	ratio	(Table	3-2,	entry	3).	Even	though	lithium-HMDS	gave	
O-alkylated	product	initially	(Table	3-2,	entry	4),	the	addition	of	2	equivalents	of	DMPU	was	
found	to	reverse	the	selectivity	towards	the	C-alkylated	product	3.91	in	86%	yield,	with	O-
alkylated	product	3.92	obtained	as	a	minor	product	in	5%	yield	(Table	3-2,	entry	5).	
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Table	3-2.	Alkylation	investigations	
	
Entry	 Base	 Additive	 Solventa	 C-yieldb	/%	 O-yieldb/%	
1c	 NaH	 ---	 THF	 n.d.	 74	
2d	 K2CO3	 ---	 CH3CN	 n.d.	 96	
3d	 Cs2CO3	 ---	 CH3CN	 42	 46	
4e	 LiHMDS	 ---	 THF	 10	 81	
5e	 LiHMDS	 DMPU	(2.0	eq.)	 THF	 86	 5	
a	c	=	0.3	M;	b	Isolated	yield;	c	temperature:	25	oC;	d	refluxing	in	CH3CN;	
e	temperature:	-78	oC.	
The	following	decarboxylation	was	attempted	by	ester	hydrolysis	with	lithium	hydroxide	
in	 refluxing	 THF/H2O,	 however	 the	 hydrolysis	 was	 fruitless	 with	 100%	 starting	 material	
recovered.	 The	3D	 structure	of	3.91	 indicated	 that	 the	methyl	ester	was	pushed	 into	 the	
“concave	face”	of	the	bicyclic	system	after	alkylation,	and	the	approach	of	this	methyl	ester	
was	 difficult	 in	 gentle	 hydrolysis	 conditions	 (Scheme	 3-17).	 Consequently,	 Krapcho	
decarboxylation	was	performed	at	150	oC	and	trace	amounts	of	decarboxylated	3.93	were	
detected.	 As	 the	 starting	 material	 or	 product	 might	 not	 be	 thermally	 stable,	 microwave	
irradiation	was	thought	to	accelerate	the	decarboxylation.[153]	To	our	delight	 irradiation	of	
the	reaction	mixture	 in	the	microwave	for	1	h	 led	to	the	formation	of	the	decarboxylated	
product	3.93	with	reversed	C-2	configuration	during	the	quenching	process.		
	
Scheme	3-17.	Decarboxylation	investigations	
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Scheme	3-18.	Cyclopentane	moiety	construction	
The	 formation	 of	 compound	 3.93	 set	 the	 stage	 for	 the	 synthesis	 of	 the	 coupling	
precursor,	which	was	 performed	 via	 regioselective	 deprotonation	 at	 -78	 oC	with	 KHMDS,	
followed	 by	 quenching	 of	 the	 resulting	 enolate	with	 trifluoromethanesulfonimide	 to	 give	
the	enol-triflate	3.94	in	93%	yield	(Scheme	3-18a).		The	temperature	had	to	be	strictly	held	
at	 -78	 oC	 for	 one	 hour	 and	 then	 warmed	 up	 to	 0	 oC	 over	 three	 hours	 to	 avoid	 enolate	
exchange	to	 its	 thermally	stable	regioisomer.	The	subsequently	desired	diastereoselective	
reductive	 Heck	 reaction	 was	 performed	 under	 standard	 conditions	 with	 formic	 acid	 as	
hydride	 donor,	 but	 a	 clean	 formation	 of	 Heck	 product	 3.95	 in	 quantitative	 yield	 was	
observed	 (Scheme	 3-18b).	 Attempts	 to	 hydrogenate	 the	 1,3-diene	 chemo-	 and	
diastereoselectively	 at	 the	 1,2-position	 resulted	 in	 a	 1,4-reduced	 tetra-substituted	 olefin	
3.96	 due	 to	 its	 thermal	 stability	 (Scheme	 3-18c).	 Finally,	 Cook’s	 gentle	 reductive	 Heck	
condition	 at	 room	 temperature	 (to	 inhibit	 the	 competitive	 intramolecular	 β-hydride	
elimination)	 afforded	 the	 reductive	 Heck	 product	 3.97	 in	 64%	 yield	 (3-18d),[154]	 and	 the	
configuration	of	the	newly	formed	stereocenter	was	confirmed	as	the	desired	one	since	the	
structurally	similar	aocohol	3.98	is	literature-known.[140]		
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Scheme	3-19.	Attempts	on	olefin	diastereoselective	oxidation	
The	 reductive	 Heck	 product	 3.97	 was	 then	 subjected	 to	 a	 diastereoselective	 olefin	
oxidation	 to	 construct	 the	 trans-fused	 core.	 Wacker	 oxidation	 led	 to	 starting	 material	
recovery	 only,	 while	 hydroboration-oxidation	 sequence	 was	 exclusively	 convex	 face	
selective	(Scheme	3-19a).	When	a	bulky,	soft	Lewis	acid	(TBSOTf)	was	used	to	coordinate	to	
the	 oxygen	 bridge	 to	 shield	 the	 convex	 face	 in	 the	 hydroboration,	 only	 decomposition	
occurred	 due	 to	 oxygen	 bridge	 disconnection.	 The	 hydroboration-oxidation	 product	 was	
further	 oxidized	 via	 Ley	 oxidation	 (Scheme	 3-19b)	 and	 the	 cis-fused	 compound	3.99	 was	
isolated	as	 the	only	product	 in	 28%	 combined	 yield.	 Attempts	 to	 epimerize	 the	α-ketone	
proton	with	bases	(DBU,	LDA	TMSOTf+Et3N)	did	not	afford	any	promising	results	due	to	the	
thermal	 stability	 of	 the	 cis-fused	 scaffold.	 Further	 epoxidation	 of	 3.97	 was	 convex	 face	
selective	 to	 give	 the	 epoxide	 3.101	 in	 moderate	 yield	 (Scheme	 3-19c).	 The	 following	
epoxide	opening	with	hydride	(Scheme	3-19d)	was	temperature	sensitive,	reduction	at	-78	
oC	 led	 to	 epoxide	 opening	 and	 simultaneous	 trans-elimination	 to	 the	 tetra-substituted	
olefin	3.96	in	81%	yield.	Epoxide	opening	with	cis-elimination	to	3.102	was	observed	when	
DIBAl-H	was	added	at	0	oC,	which	indicated	the	existence	of	a	carbon	cation	intermediate	
during	the	latter	elimination	process.		
Inspired	by	 the	 tendency	of	 tetra-substituted	olefin	 formation	 (Scheme	3-18c,	Scheme	
3-19d),	 we	 envisioned	 a	 similar	 1,4-functionalization	 of	 diene	 3.95	 might	 introduce	 the	
hydroxyl	 group	 in	 3.104,	 and	 the	 tetra-substituted	 double	 bond	 could	 be	 reduced	 by	
diastereoselective	 hydrogenation	 (Scheme	 3-20).	 Selective	 1,4-hydroboration-oxidation	
sequence	 with	 simple	 borane	 BH3	 or	 9-BBN	 led	 to	 messy	 mixtures	 due	 to	 their	 high	
reactivity,	 while	 palladium	 catalyzed	 hydrosilylation	with	 dichloromethylsilane	 as	 hydride	
Total	Synthesis	of	Englerins	A	and	B	
	
85	
donor	provided	the	desired	allylsilane	3.103,	which	was	converted	to	the	alcohol	3.104	 in	
64%	 yield	 after	 oxidative	 work-up	 (Scheme	 3-20).[155]	 The	 highly	 regio-	 and	
diastereoselective	 control	 can	be	explained	 through	 the	palladium	sepecies	approach	 the	
diene	3.95	 from	the	less	hindered	convex	face,	while	the	hydride	being	transferred	to	the	
least	 hindered	 exocyclic	 olefin	 (Scheme	 3-20).	 Oxidative	 work-up	 via	 Tamao-Fleming	
oxidation	 resulted	 in	 clean	 oxidation	 of	 the	 allylic	 silane	3.103	 to	 give	 the	 corresponding	
allyilc	alcohol	3.104	with	retention	of	the	configuration.	Additionally,	it	was	found	that	the	
two	 palladium	 catalyzed	 transformations	 could	 be	 done	 one-pot	 with	 Pd(PPh3)2Cl2	 as	
catalyst	 by	 adding	 the	 reagents	 sequentially.	 After	 oxidative	 work-up	 the	 allylic	 alcohol	
3.104	could	be	isolated	with	58%	overall	yield	from	enol-triflate	3.94.	
	
Scheme	3-20.	Palladium-catalyzed	Heck-1,4-hydrosilylation	sequence	
In	order	 to	obtain	alcohol	3.105	with	 the	correct	 relative	configuration,	 the	oxidation-
reduction	sequence	was	envisioned	as	a	suitable	strategy	(Scheme	3-21).	Considering	that	
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unitl	 this	 point	 the	 synthesis	was	done	using	material	with	 60%	enantiomeric	 excess,	we	
were	 hoping	 to	 increase	 the	 enantiopurity	 through	 the	 use	 of	 enantioselective	
transformation.	Allylic	alcohol	3.104	was	inactive	with	freshly	made	MnO2	or	DMP	as	well	
as	iron-catalyzed	aerobic	oxidation.	Following	to	Ma’s	report[140],	Ley	oxidation	was	used	to	
give	 the	 enone	 3.106	 with	 86%	 yield.	 Corey-Bakshi-Shibata	 reduction	 with	 catalytic	
amounts	 of	 chiral	 oxazaborolidine	 3.108	 is	 widely	 known	 for	 its	 enantioselective	 ketone	
reduction	 and	 could	 be	 used	 for	 kinetic	 resolution	 in	 our	 case.[156]	 Indeed,	 we	 were	
delighted	to	find	that	when	(S)-CBS	catalyst	3.108	was	used	under	the	optimized	conditions,	
the	reaction	proceeded	very	fast	at	 -10	oC	 in	69%	yield	and	96%	enantiomeric	excess	 (ee)	
with	 the	 desired	 concave	 face	 alcohol	 installed.	 Detailed	 conditions	 optimization	 can	 be	
found	 in	 Table	 3-3.	 The	 unfavorable	 steric	 repulsions	 between	 the	 catalyst	 and	 the	
undesired	 enantiomer’s	 oxygen	 bridge	 and	 isopropyl	 group	 might	 lead	 to	 the	 kinetic	
resolution.	 The	 enantiomeric	 excess	 was	 analyzed	 on	 3.107	 (Scheme	 3-21c),	 and	 its	
absolute	 confirguration	 was	 unambiguously	 confirmed	 by	 X-ray	 analysis.	 Interestingly,	 6	
independent	 conformers	 were	 detected	 in	 each	 unit	 cell	 (see	 experimental	 section).	
Meanwhile,	the	enantiomeric	excess	of	3.107	directly	derived	from	3.106	was	analyzed	as	
60%,	which	indicated	that	no	enantiomeric	excess	erosion	occurred	before	this	step.	
	
Scheme	3-21.	Alcohol	configuration	inversion	and	enantiomeric	purity	improvement		
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Table	3-3.	Optimization	of	enantioselective	CBS	reduction		
	
Entry	 Catalyst	
(mol%)	
Temperature	
(oC)	
Time	
(h)	
Yield	
(%)a	
ee	
(%)b	
1	 (R)-CBS	(20)	 0	 3		 66	 43	
2	 (S)-CBS	(20)	 0	 3	 83	 76	
3	 (S)-CBS	(20)	 0	 1	 81	 84	
4	 (S)-CBS	(20)	 -10	 1	 69	 91	
5	 (S)-CBS	(30)	 -10	 1	 69	 96	
6	 (S)-CBS	(30)	 -20	 1	 29	 96	
7	 (S)-CBS	(40)	 -10	 1	 70	 96	
a	Isolated	yield;	b	Enantiomeric	excess	was	analyzed	on	compound	3.107	via	chiral	GC.	
By	 effective	 discrimination	 of	 two	 enantiomers’	 reactivity	 as	 well	 as	 by	 installing	 the	
desired	 stereocenter	 with	 excellent	 diastereoselectivity,	 we	 set	 out	 for	 the	
diastereoselective	hydrogenation	of	the	tetra-substituted	double	bond	under	high	pressure	
(Scheme	3-22).	Allylic	 alcohols	 are	 known	as	 good	directing	 groups	 for	 diastereoselective	
hydrogenation	from	the	sterically	less	favored	face,	therefore	homogeneous	catalysts	were	
chosen	 for	 this	 selective	 hydrogenation.	 However,	 neither	 Wilkinson’s	 catalyst	 nor	
Crabtree’s	catalyst	led	to	the	detectable	amounts	of	reduced	product	under	high	pressure.	
The	 heterogeneous	 catalysts	 PtO2,	 Pd/C	 were	 tested	 and	 Pd/C	 was	 found	 to	 give	 the	
hydrogenated	product	3.108	with	the	desired	diastereoselectivity	 in	86%	yield.	This	result	
further	proved	that	alcohols	can	be	used	as	directing	group	for	heterogeneous	catalysts	as	
well.	 Esterification	 and	deprotection	 sequence	 eventually	 provided	 englerin	A	3.1	 in	 79%	
yield	over	two	steps.	Optical	rotation	analysis	as	well	as	X-ray	crystallographic	structure	of	
3.107	confirmed	our	sample	to	be	identical	to	natural	(-)-englerin	A.	Selective	hydrolysis	of	
the	more	reactive	glycolic	ester	moiety	gave	(-)-englerin	B	3.2	in	71%	yield.		
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Scheme	3-22.	Synthesis	of	(-)-englerins	A	and	B	
In	 summary,	 a	 novel	 synthesis	 of	 the	 anti-tumor	 active	 compound	 (-)-englerins	 was	
developed.	 This	 protocol	 featuring	 an	 organocatalyzed	 enantioselective	 decarboxylative	
aldol	 reaction,	 a	 bio-inspired,	 Lewis	 acid	 catalyzed	 [4+3]	 cycloaddition	 of	 β-ketoester-
derived	 bis-silylenolether	 to	 a	 1,4-diketone	 and	 a	 sequential	 Pd-catalyzed	 Heck-reaction-
1,4-hydrosilylation-Tamao-Fleming-oxidation.	 The	 state-of-the-art	 catalytic	methodologies	
allowed	 a	 highly	 efficient	 and	 enantioselective	 synthesis,	 which	 can	 also	 be	 used	 as	 the	
starting	point	 for	 the	synthesis	of	various	englerin	analogues	 for	 further	structure-activity	
relationship	research.		
	
Figure	3-2.	Step-efficiency	analysis	according	to	Christmann’s	method[110]	
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3.5. Conclusion	and	Outlook	
In	 this	 part,	 we	 highlighted	 the	 state-of-the-art	 chemical	 transformations	 that	 are	
inspired	 from	 classical	 chemistry,	 which	 allowed	 the	 conceptually	 novel	 12-step	 total	
synthesis	 of	 the	 anti-tumor	 active	 natural	 products	 (-)-englerin	 A	 and	 (-)-englerin	 B.	 The	
synthesis	 featured	 an	 organocatalyzed	 enantioselective	 decarboxylative	 aldol	 reaction	
which	 was	 inspired	 by	 the	 polyketide	 biogenesis.	 A	 [4+3]	 cycloaddition	 of	 β-ketoester-
derived	 bis-silylenolether	 to	 a	 1,4-diketone	 was	 employed	 for	 the	 construction	 of	 the	
bicyclic[3.2.1]	 heptane	 core.	 A	 sequential	 Pd-catalyzed	 Heck-reaction-1,4-hydrosilylation-
Tamao-Fleming-oxidation	afforded	the	cyclopentane	moiety,	while	kinetic	resolution	with	a	
CBS	reduction	step	allowed	us	to	obtain	the	desired	product	with	96%	enantiomeric	excess.	
The	synthesis	based	on	the	initial	catalytic	aldol	reaction	sets	the	stage	to	enrich	englerin	A	
library	and	to	study	the	structure-activity	relationships,	which	is	significantly	important	for	
further	 anti-tumor	 entities	 as	 well	 as	 potential	 target	 investigation.
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1. General	Remarks	
All	 the	 reactions,	 which	 were	 sensitive	 to	 air	 or	 moisture	 were	 performed	 under	 dry	
nitrogen	 using	 standard	 Schlenk	 techniques.	 All	 solvents	 were	 purified	 prior	 to	 use.	 All	
chemicals	 were	 purchased	 from	 Acros	 Organics,	 Sigma	 Aldrich,	 TCI	 or	 Alfa	 Aesar.	 NMR	
spectra	were	 recorded	on	 a	 Bruker	AV	300	 spectrometer	 at	 300	MHz	 (1H-NMR),	 75	MHz	
(13C-NMR),	 a	 Bruker	 AV	 400	 spectrometer	 at	 400	MHz	 (1H	 NMR),	 100	MHz	 (13C-NMR),	 a	
Bruker	AV	500	spectrometer	at	500	MHz	(1H	NMR),	125	MHz	(13C-NMR),	or	a	Bruker	AV	700	
spectrometer	at	700	MHz	(1H	NMR),	175	MHz	(13C	NMR).	Chemical	shifts	were	reported	in	
ppm	down	field	using	tetramethylsilane	as	internal	standards.	IR	spectra	were	measured	on	
a	Bruker	Vector	22	FT-IR	spectrometer	in	an	ART	mode.	Mass	spectra	were	measured	using	
electrospray	ionization	on	a	Bruker	Micro-TOF-Q.	High	performance	liquid	chromatography	
(HPLC)	 was	 performed	 using	 a	 Knauer	 K-501	 pump,	 Knauer	 RI-detector	 K	 2400	 and	 a	
Macherey-Nagel	VP250/21	Nucleodur	100-5	column.	Analytical	chiral	HPLC	was	performed	
using	a	HP	series	1050	HPLC	module	and	a	Daciel	Chiralpak	AD-H	250*4.6	mm	column.	ECD	
measurements	were	performed	using	a	JASCO	J-815	Circular	Dichroism	Spectrometer.	
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2. Experimental	Details	in	Picrotoxane	Alkaloids	Synthesis	
Enantioselective	Diels-Alder	reaction	
	
To	a	flame	dried	schlenk	flask	with	a	stirring	bar,	Yb(OTf)3	(55.8	mg,	0.09	mmol,	0.1	equiv)	
and	 (R)-BINUERA	 L2-4	 (52.2	 mg,	 0.09	 mmol,	 0.1	 equiv)	 ligand	 were	 charged,	 then	 the	
schlenk	 flask	was	heated	at	120	oC	under	reduced	pressure	 (<0.1	mbar)	 for	2	h,	and	then	
cooled	 down	 to	 room	 temperature	 under	 nitrogen.	 3	mL	DCM	was	 added	 followed	with	
DBU	 (0.027	 mL,	 0.18	 mmol,	 0.2	 equiv),	 and	 the	 resulting	 solution	 was	 stirred	 at	 room	
temperature	 for	 2	 h.	 At	 this	 time,	 the	 clear	 colorless	 solution	 turned	 to	 a	 faint	 yellow	
solution,	and	 the	mixture	was	cooled	down	 to	0	 oC	and	a	 solution	of	 the	dienophile	2.81	
(164.7	mg,	0.9	mmol,	1.0	equiv)	in	1.5	mL	DCM	was	added	followed	with	freshly	prepared	
diene	2.77	(385.2	mg,	1.8	mmol,	2.0	equiv)	drop	wise.	The	schlenk	flask	was	sealed,	stirred	
for	3	h	at	0	 oC.	After	 the	starting	dienophile	2.81	was	consumed	completely,	 the	mixture	
was	 quenched	 with	 TFA	 (0.5	 mL)	 at	 0	 oC.	 After	 stirring	 for	 additional	 30	 min	 at	 room	
temperature,	 the	reaction	was	diluted	by	10	mL	saturated	NaHCO3	aqueous	solution.	The	
aqueous	layer	was	extracted	three	times	with	DCM	(3*20	mL).	The	combined	organic	layers	
were	 washed	 with	 brine	 (3*10	 mL),	 dried	 over	 Na2SO4,	 concentrated	 under	 reduced	
pressure	 gave	 the	 crude	 product	 as	 faint	 yellow	 oil.	 The	 crude	 product	 was	 purified	 by	
column	chromatography	(PE/EtOAc	=	2:1)	gave	the	oxazolidinone	2.82	as	faint	yellow	solid	
(176	mg,	0.69	mmol,	78%	yield).	
								Compound	(-)-2.82:	1H	NMR	(400	MHz,	CDCl3):	δ	6.70	(dd,	J	=	10.12,	2.99	Hz,	1	H),	6.10	
(dd,	J	=	10.12,	2.62	Hz,	1	H),	4.83	–	4.86	(m,	1	H),	4.48	(t,	J	=	7.97	Hz,	2	H),	4.01	(t,	J	=	8.08	Hz,	
2	H),	2.60	(dd,	J	=	15.61,	4.20	Hz,	1	H),	2.52	–	2.57	(m,	1	H),	2.26	-	2.33	(m,	1	H),	1.67	–	1.73	
(m,	1	H),	0.95	(d,	J	=	6.85	Hz,	3	H),	0.88	(d,	J	=	6.85	Hz,	3	H)	ppm;	13C	NMR	(100	MHz,	CDCl3):	
δ	 198.9,	 172.1,	 153.2,	 145.0,	 130.6,	 62.1,	 44.5,	 42.9,	 42.5,	 37.1,	 29.7,	 20.7,	 17.7	 ppm;	 IR	
(film):	v	2960	(s),	2929	(w),	1770	(s),	1674	(s),	1385	(s),	1370	(s),	1219	(s),	1112	(s),	1039	(s),	
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758	(s),	705	(s)	cm-1;	MS	(ESI)	calculated	for	C13H17NO4Na+:	274.1050,	found:	274.1031;	M.p.	
92	oC;	[α]D25	-29.0	(c	1.3,	CHCl3,	91%	ee).	
	
The	Diels-Alder	 reaction	was	 performed	 according	 to	 the	 same	 procedure	 above.	 The	
reaction	 was	 quenched	 with	 5	 mL	 water	 when	 the	 dienophile	 2.81	 was	 consumed	
completely.	 	 The	 aqueous	 layer	 was	 extracted	 three	 times	 with	 DCM	 (3*20	 mL).	 The	
combined	 organic	 layers	 were	 washed	 with	 brine	 (3*10	 mL),	 dried	 over	 Na2SO4,	
concentrated	under	reduced	pressure	gave	the	crude	product	2.86	as	faint	yellow	oil.	The	
crude	product	2.86	was	labile	and	used	directly	without	further	purification.		
				To	 a	 solution	 of	 the	 crude	 product	 2.86	 in	 THF	 (9	mL)	 was	 added	MeOH	 (0.1	mL,	 2.7	
mmol,	3.0	equiv)	and	LiBH4	solution	(2.0	M,	1.35	mL,	2.7	mmol,	3.0	equiv)	drop	wise	at	0	oC.	
The	mixture	was	stirred	for	1	h	at	room	temperature,	then	the	reaction	was	cooled	down	to	
0	 oC,	 quenched	 by	 addition	 of	 10	 mL	 1N	 HCl	 drop	 wise.	 The	 mixture	 was	 stirred	 for	
additional	 30	min	 at	 this	 temperature,	 and	 the	 aqueous	 layer	was	 extracted	 three	 times	
with	 DCM	 (3*20	 mL).	 The	 combined	 organic	 layers	 were	 washed	 with	 brine	 (3*10	 mL),	
dried	over	Na2SO4,	 concentrated	under	 reduced	pressure	gave	 the	crude	product	as	 faint	
yellow	 oil.	 The	 crude	 product	 was	 purified	 by	 column	 chromatography	 (PE/EtOAc	 =	 3:1)	
gave	the	alcohol	2.87	as	faint	yellow	oil	(112	mg,	0.67	mmol,	74%	yield).	The	enantio	excess	
was	determined	by	chiral	HPLC	as	91%	ee.	
				Compound	(-)-28.6:	 1H	NMR	 (400	MHz,	CDCl3):	δ	6.99	(dd,	J	=	10.17,	2.87	Hz,	1	H),	6.05	
(dd,	J	=	10.13,	1.87	Hz,	1	H),	3.89	(dd,	J	=	10.64,	4.52	Hz,	1	H),	3.71	(dd,	J	=	10.62,	6.13	Hz,	1	
H),	2.54	–	2.49	(m,	1	H),	2.47	(dd,	J	=	16.28,	4.05	Hz,	1	H),	2.23	(dd,	J	=	16.20,	11.23	Hz,	1	H),	
2.04	–	1.91	(m,	3	H),	0.93	(d,	J	=	6.80	Hz,	3	H),	0.86	(d,	J	=	6.76	Hz,	3	H)	ppm;	13C	NMR	(100	
MHz,	CDCl3):	δ	200.5,	152.3,	130.0,	63.0,	41.6,	41.4,	36.8,	27.8,	20.8,	16.9	ppm;	IR	(film):	v	
3422	(w),	2959	(s),	1666	(s),	1391	(s),	1261	(s),	1081	(s),	840	(s)	cm-1;	MS	(ESI)	calculated	for	
C10H16O2Na+:	191.1043,	found:	191.1041;	[α]D25	-76.8	(c	1.6,	CHCl3,	91%	ee);	Daicel	Chiralcel	
AD-H,	hexane/i-PrOH	=	95/5,	 f	=	1.0	mL/min,	230.4	nm,	 retention	 time:	19.1	min	 (minor)	
and	20.6	min	(major).	
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HPLC	Spectrums:	
																			(±)-compound	28.6																																																(-)-compound	28.6	
	
	
	
	
	
	
Lactone	core	synthesis	
	
				To	a	 flame	dried	 flask	with	a	 stirring	bar,	 a	 solution	of	 the	 substrate	2.87	 (168	mg,	1.0	
mmol,	1.0	equiv)	in	THF	(2	ml)	was	charged	under	nitrogen.	The	flask	was	cooled	down	to	-
78	oC,	then	a	solution	of	LDA	in	THF	[freshly	prepared	by	treating	a	solution	of	iPr2NH	(0.32	
mL,	2.3	mmol,	2.3	equiv)	in	THF	(8	mL)	with	nBuLi	(1.6M	in	THF,	1.4	mL,	2.2	mmol,	2.2	equiv)	
under	-78	oC	and	then	stirred	at	0	oC	for	15	min)]	was	added	drop	wise	at	this	temperature.	
The	faint	yellow	mixture	was	stirred	at	-78	oC	for	30	min	followed	by	addition	of	TMSCl	(0.3	
mL,	2.4	mmol,	2.4	equiv)	drop	wise.	This	mixture	was	warmed	 to	 room	temperature	and	
stirred	for	2	h,	and	then	quenched	with	saturated	NaHCO3	aqueous	solution.	The	aqueous	
layer	was	extracted	with	diethyl	ether	(3*20	mL),	the	combined	organic	layers	were	washed	
with	 brine	 (3*10	mL),	 dried	 over	Na2SO4,	 concentrated	 under	 reduced	pressure	 gave	 the	
crude	enolate	product	as	faint	yellow	oil.	The	crude	enolate	product	was	dissolved	in	5	mL	
DCM,	and	then	NaHCO3	(117.6	mg,	1.4	mmol,	1.4	equiv)	was	added	at	0	oC	followed	by	m-
CPBA	(75%,	276	mg,	1.2	mmol,	1.2	equiv)	in	one	portion.	The	mixture	was	stirred	for	30	min	
at	 room	 temperature,	 and	 then	 quenched	with	 saturated	Na2S2O3	 solution.	 The	 aqueous	
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layer	was	extracted	with	DCM	(3*20	mL),	 the	combined	organic	 layers	were	washed	with	
HCl	 (2N,	 3*20	mL)	 and	 brine	 (3*10	mL),	 dried	 over	Na2SO4,	 concentrated	 under	 reduced	
pressure	 gave	 the	 crude	 product	 as	 faint	 yellow	 oil.	 The	 crude	 product	 was	 purified	 by	
column	 chromatography	 (PE/EtOAc	 =	 2:1)	 gave	 the	 diol	 product	 2.88	 as	 faint	 yellow	 oil	
(150.9	mg,	0.82	mmol,	82%	yield).	
				Compound	(+)-2.88:	1H	NMR	(400	MHz,	CDCl3):	δ	7.03	(dd,	J	=	10.12,	2.41	Hz,	1	H),	6.18	
(dd,	J	=	10.12,	2.76	Hz,	1	H),	4.15	(d,	J	=	12.14	Hz,	1	H),	3.95	(dd,	J	=	10.73,	3.49	Hz,	1	H),	
3.72	 (dd,	 J	=	10.66,	6.23	Hz,	1	H),	2.59	–	2.54	 (m,	1	H),	2.17	–	2.10	 (m,	1	H),	1.93	 (ddd,	 J	
=11.97,	9.88,	1.55,	1	H),	1.55	(br	s,	2	H),	1.14	(d,	J	=	7.13	Hz,	3	H),	1.10	(d,	J	=	7.04	Hz,	3	H)	
ppm;	 13C	NMR	 (100	MHz,	CDCl3):	δ	200.8,	153.4,	126.5,	73.7,	63.8,	48.3,	42.2,	27.9,	21.5,	
18.2	ppm;	IR	(film):	v	3422	(w),	2957	(s),	2875	(s),	1680	(s),	1247	(s),	1031	(s),	786	(s)	cm-1;	
MS	 (ESI)	calculated	for	C10H16O3Na+:	207.0992,	found:	207.0987;	[α]D25	+11.6	(c	2.3,	CHCl3,	
91%	ee).	
				Lactonization	method	I	with	Fe-catalysis:	to	a	flask	charged	with	stirring	bar	were	added	
Fe(NO3)3`9H2O	 (20.2	mg,	0.05	mmol,	 5	mol%	equiv),	 TEMPO	 (7.8	mg,	0.05	mmol,	 5	mol%	
equiv),	KCl	(7.5	mg,	0.1	mmol,	10	mol%	equiv),	the	diol	substrate	2.88	(184	mg,	1.0	mmol,	
1.0	equiv)	and	10	mL	1,2-dichloroethane	successively,	then	the	mixture	was	bubbled	with	a	
balloon	of	oxygen	for	5	min.	The	mixture	was	stirred	under	this	balloon	of	oxygen	at	room	
temperature	overnight,	and	with	TLC	monitored	the	reaction	progress.	After	the	substrate	
was	consumed	completely,	the	mixture	was	loaded	to	a	pad	of	Celite	to	remove	insoluble	
materials	 (eluted	 with	 EtOAc).	 The	 organic	 layer	 was	 concentrated	 gave	 a	 brown	 yellow	
residue,	which	was	purified	by	column	chromatography	(PE/EtOAc	=	15:1)	gave	the	lactone	
product	2.75	as	faint	yellow	oil	(160.2	mg,	0.89	mmol,	89%	yield).					
				Lactonization	 method	 II	 with	 Ru-catalysis:	 to	 a	 flask	 charged	 with	 stirring	 bar	 were	
added	Macho-Ru	complex	(60.7	mg,	0.1	mmol,	10	mol%	equiv),	NaOH	(8.0	mg,	0.2	mmol,	
20	mol%	equiv),	the	diol	substrate	2.88	(184	mg,	1.0	mmol,	1.0	equiv)	and	10	mL	anhydrous	
toluene	successively.	The	mixture	was	stirred	under	 reflux	 for	6	h	until	 the	substrate	was	
consumed	 completely.	 The	 mixture	 was	 loaded	 to	 a	 pad	 of	 Celite	 to	 remove	 insoluble	
materials	 (eluted	 with	 EtOAc).	 The	 organic	 layer	 was	 concentrated	 gave	 a	 brown	 yellow	
residue,	which	was	purified	by	column	chromatography	(PE/EtOAc	=	15:1)	gave	the	lactone	
product	2.75	as	faint	yellow	oil	(93.6	mg,	0.52	mmol,	52%	yield).					
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				Compound	(-)-2.75:	1H	NMR	(400	MHz,	CDCl3):	δ	7.10	(ddd,	J	=	9.19,	7.15,	1.81	Hz,	1	H),	
6.20	(dd,	J	=	9.66,	1.54	Hz,	1	H),	4.67	(d,	J	=	5.16	Hz,	1	H),	3.31	(dd,	J	=	7.02,	4.03	Hz,	1	H),	
2.74	–	2.69	(m,	1	H),	1.88	–	1.79	(m,	1	H),	0.97	(d,	J	=	6.62	Hz,	3	H),	0.93	(d,	J	=	6.58	Hz,	3	H)	
ppm;	13C	NMR	 (100	MHz,	CDCl3):	δ	190.3,	173.2,	142.7,	130.2,	84.4,	60.0,	43.9,	23.9,	21.3,	
19.6	ppm;	IR	(film):	v	2962(s),	2875	(w),	1790	(s),	1699	(s),	1124	(s),	989	(s),	953	(s),	881	(d)	
cm-1;	MS	 (ESI)	 calculated	 for	 C10H12O3+:	 180.0786,	 found:	 180.0783;	 [α]D25	 -248.6	 (c	 2.6,	
CHCl3,	91%	ee).	
Cyclopentane	moiety	construction	
	
To	a	flame-dried	flask	charged	with	stirring	bar	and	reflux	condenser,	magnesium	(48	mg,	
2.0	 mmol,	 2.0	 equiv)	 was	 added	 followed	 by	 2	 mL	 THF	 under	 nitrogen,	 then	 catalytic	
amount	of	 I2	was	 added	 in	one	portion.	A	 solution	of	 4-bromo-1-(trimethylsilyl)-1-butyne	
2.91	(304.5	mg,	1.5	mmol,	1.5	equiv)	in	5	mL	THF	was	added	via	syringe	pump	over	a	period	
of	1	h	under	 refluxing	condition.	The	 reaction	mixture	was	 refluxed	 for	additional	30	min	
and	then	cooled	down	to	-78	oC.	CuBr-DMS	(154.2	mg,	0.75	mmol,	0.75	equiv)	was	added	in	
one	portion	followed	by	Me2S	(0.073	mL,	1.0	mmol,	1.0	equiv).	The	resulting	mixture	was	
stirred	at	this	temperature	for	30	min	for	the	cuprate	complex	formation.	After	30	min,	a	
solution	of	the	lactone	2.75	(180	mg,	1.0	mmol,	1.0	equiv)	in	2	mL	THF	was	added	drop	wise,	
and	 the	 reaction	 progress	 was	 detected	 with	 TLC	 until	 the	 substrate	 was	 consumed	
completely	 (less	 than	5	min),	 then	CH3I	 (0.18	mL,	3.0	mmol,	3.0	equiv)	was	added	 in	one	
portion.	 The	 reaction	 was	 allowed	 to	 warm	 to	 room	 temperature	 and	 stirred	 overnight,	
after	 which	 TBAF	 trihydrate	 was	 added	 in	 one	 portion.	 The	 mixture	 was	 stirred	 for	
additional	 1	 h,	 quenched	 with	 5	 mL	 saturated	 NH4Cl	 solution.	 The	mixture	 was	 filtrated	
through	a	pad	of	Celite	to	remove	the	black	solid	(eluted	with	diethyl	ether),	the	aqueous	
layer	was	extracted	with	diethyl	ether	(3*20	mL),	the	combined	organic	layers	were	washed	
with	 aqueous	 NH4Cl	 (3*20	 mL)	 solution	 and	 brine	 (3*10	 mL),	 dried	 over	 Na2SO4,	
concentrated	under	reduced	pressure	gave	a	residue.	The	residue	was	purified	by	column	
chromatography	(PE/EtOAc	=	30:1)	gave	the	product	2.74	as	faint	yellow	liquid	(158.7	mg,	
0.64	mmol,	64%	overall	yield).	
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				Compound	(-)-2.74:	 1H	NMR	 (400	MHz,	CDCl3):	δ	4.57	(d,	J	=	5.77	Hz,	1	H),	2.82	(dd,	J	=	
4.43,	2.83	Hz,	1	H),	2.49	–	2.45	(m,	1	H),	2.44	–	2.36	(m,	3	H),	2.05	(tt,	J	=	10.52,	2.95,	1	H),	
1.97	(t,	J	=	2.68	Hz,	1	H),	1.88	–	1.80	(m,	1	H),	1.78	–	1.69	(m,	1	H),	1.45	–	1.35	(m,	1	H),	1.15	
(d,	J	=	6.57	Hz,	3	H),	0.97	(d,	J	=	6.52	Hz,	3	H),	0.92	(d,	J	=	6.41	Hz,	3	H)	ppm;	13C	NMR	(100	
MHz,	CDCl3):	δ	205.8,	175.6,	83.7,	82.5,	69.9,	53.2,	45.1,	41.7,	37.6,	28.6,	24.2,	20.3,	19.5,	
16.1,	11.2	ppm;	IR	(film):	v	3285	(w),	2964	(w),	1785	(s),	1725	(s),	1320	(s),	1062	(s),	1009	(s),	
925	 (s),	 757	 (s),	 660	 (w)	 cm-1;	 MS	 (ESI)	 calculated	 for	 C15H20O3Na+:	 271.1305,	 found:	
271.1308;	[α]D25	-163.6	(c	1.9,	CHCl3,	91%	ee).	
Cycloisomerization	 method	 I	 with	 Au-catalysis:	 to	 a	 flame-dried	 flask	 charged	 with	
stirring	bar,	a	solution	of	 the	substrate	2.74	 (248	mg,	1.0	mmol,	1.0	equiv)	 in	acetonitrile	
(10	mL)	was	 added	 via	 syringe	 followed	by	 triethylamine	 (0.21	mL,	 1.5	mmol,	 1.5	 equiv),	
tert-butyldimethylsilyl	chloride	(225.8	mg,	1.5	mmol,	1.5	equiv)	and	NaI	(225	mg,	1.5	mmol,	
1.5	equiv)	 in	 this	order	 subsequently.	 The	 reaction	mixture	was	warmed	 to	60	 oC,	 stirred	
overnight,	 and	 with	 TLC	 monitored	 the	 reaction	 progress.	 After	 the	 substrate	 was	
consumed	 completely,	 the	 reaction	was	 cooled	 down	 to	 room	 temperature,	 then	 10	mL	
petrolum	 ether	 and	 5	mL	 saturated	NaHCO3	 aqueous	 solution	were	 added.	 The	 aqueous	
layer	 was	 extracted	 with	 petrolum	 ether	 (3*20	 mL),	 the	 combined	 organic	 layers	 were	
washed	 with	 brine,	 dried	 over	 Na2SO4,	 concentrated	 under	 reduced	 pressure	 gave	 the	
crude	product	2.94,	which	was	labile	and	was	used	directly	in	the	catalytic	reaction	without	
further	 purification.	 To	 a	 nitrogen	 protected	 schlenk	 flask	 charged	 with	 stirring	 bar,	 a	
solution	of	the	crude	silyl	enolate	ether	2.94	in	10	mL	DCM	was	added	via	syringe	followed	
by	1	mL	distilled	H2O	under	nitrogen.	Then	chloro(triphenylphosphine)gold(I)	(49.5	mg,	0.1	
mmol,	10	mol%	equiv)	and	silver	tetrafluoroborate	(19.5	mg,	0.1	mol,	10	mol%	equiv)	were	
added	 subsequently.	 The	 flask	was	 sealed,	 heated	at	 40	 oC	 for	 30	min.	 Then	 the	mixture	
was	 diluted	 with	 50	 mL	 DCM,	 dried	 over	 Na2SO4,	 concentrated	 under	 reduced	 pressure	
gave	a	residue,	which	was	purified	by	column	chromatography	(PE/EtOAc	=	20:1)	gave	the	
product	 2.73	 as	 white	 solid	 (188.5	mg,	 0.76	mmol,	 76%	 yield	 over	 two	 steps).	 Then	 the	
product	2.73	was	 recrystallized	 in	 a	mixture	of	 PE/EtOAc	=	 5:1	 gave	white	 crystals;	 upon	
recrystallization	the	ee	was	improved	from	91%	to	99%.			
Cycloisomerization	method	II	with	Cu-catalysis:	To	a	flame	dried	schlenk	flask	charged	
with	stirring	bar,	a	solution	of	the	substrate	2.74	(124	mg,	0.5	mmol,	1.0	equiv)	in	5	mL	THF	
was	 added	 via	 syringe	 followed	 by	 catalytic	 amount	 of	 copper(II)	 triflate	 (18.1	 mg,	 0.05	
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mmol,	 10	 mol%	 equiv),	 triphenylphosphine	 (52.5	 mg,	 0.2	 mmol,	 40	 mol%	 equiv)	 and	
pyrrolidine	 (0.016	mL,	 0.2	mmol,	 40	mol%	 equiv)	 under	 nitrogen.	 The	 schlenk	 flask	 was	
sealed,	warmed	to	90	oC	and	stirred	for	72	h,	and	with	TLC	monitored	the	progress	of	the	
reaction.	After	72	h,	the	solution	was	allowed	to	cool	down	to	room	temperature,	diluted	
with	 5	 mL	 EtOAc	 and	 then	 filtered	 through	 Celite	 (eluted	 with	 EtOAc).	 The	 filtrate	 was	
concentrated	 in	 vacuum	 and	 loaded	 to	 silica	 gel,	 purified	 by	 column	 chromatography	
(PE/EtOAc	=	20:1)	gave	the	product	2.73	as	white	solid	(53.3	mg,	0.22	mmol,	43%	yield	with	
26%	of	starting	material	recovered).	
				Compound	(+)-2.73:	1H	NMR	(400	MHz,	CDCl3):	δ	4.93	(t,	J	=	2.07	Hz,	1	H),	4.76	(t,	J	=	2.54	
Hz,	1	H),	4.57	(d,	J	=	5.53	Hz,	1	H),	2.73	–	2.54	(m,	3	H),	2.45	–	2.40	(m,	2	H),	2.23	–	2.15	(m,	
1	H),	2.13	–	2.04	(m,	1	H),	1.53	–	1.44	(m,	1	H),	1.30	(s,	3	H),	0.99	(d,	J	=	6.48	Hz,	3	H),	0.95	(d,	
J	=	6.44	Hz,	3	H)	ppm;	13C	NMR	 (100	MHz,	CDCl3):	δ	204.7,	177.5,	152.8,	108.3,	83.9,	58.2,	
54.4,	46.4,	44.8,	30.6,	26.6,	25.7,	24.7,	20.7,	19.5	ppm;	IR	 (film):	v	2966	(s),	1796	(s),	1713	
(s),	1124	(s),	1006	(s),	911	(s)	cm-1;	MS	 (ESI)	calculated	for	C15H20O3Na+:	271.1305,	found	:	
271.1318;	M.p.	163	oC;	[α]D25	+60.3	(c	1.8,	CHCl3,	99%	ee).	Daicel	Chiralcel	AD-H,	hexane/i-
PrOH	=	98/2,	f	=	1.0	mL/min,	230.4	nm,	retention	time:	7.6	min	(major)	and	8.7	min	(minor).	
HPLC	Spectrums	
																	(±)-compound	2.73																									(+)-compound	2.73	(after	recrystallization)	
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Free	radical-mediated	hydroazidation	
	
				To	a	flame	dried	flask	charged	with	stirring	bar,	catecholborane	(1.0	M	in	THF,	0.6	mL,	0.6	
mmol,	3.0	equiv)	was	added	drop	wise	at	0oC	to	a	solution	of	the	olefin	2.73	(49.6	mg,	0.2	
mmol,	1.0	equiv)	 and	N,N-dimethylamide	 (0.002	mL,	0.02	mmol,	0.1	equiv)	 in	2	mL	DCM	
under	 nitrogen.	 The	 mixture	 was	 heated	 under	 reflux	 for	 5	 h,	 after	 the	 substrate	 was	
consumed	completely	(monitored	by	TLC),	the	reaction	mixture	was	cooled	down	to	0	 oC,	
0.2	 mL	 t-BuOH	 was	 added	 drop	 wise	 to	 consume	 the	 rest	 of	 catecholborane.	 After	
evaporation	of	the	solvent	under	reduced	pressure,	2	mL	N,N-dimethylformamide,	PhSO2N3	
(109.8	mg,	0.6	mmol,	3.0	equiv)	and	DTBHN	(di-tert-butylhyponitrite)	(3.5	mg,	0.02	mol,	0.1	
equiv)	were	added	and	the	solution	was	stirred	at	80	oC.	After	3	h,	the	reaction	mixture	was	
cooled	down	 to	 room	 temperature,	 diluted	with	 Et2O,	 filtered	 through	a	pad	of	 Celite	 to	
remove	 insoluble	 solid	 (eluted	with	Et2O).	 The	 filtrate	was	washed	with	brine,	dried	over	
Na2SO4,	 concentrated	 under	 reduced	 pressure.	 The	 residue	 was	 purified	 by	 column	
chromatography	(PE/EtOAc	=	10:1)	gave	the	azide	2.106	as	white	solid	(27.4	mg,	0.09	mmol,	
47%	yield).		
				Compound	(+)-2.106:	1H	NMR	(400	MHz,	CDCl3):	δ	4.47	(d,	J	=	5.47	Hz,	1	H),	3.33	(dd,	J	=	
11.95,	4.69	Hz,	1	H),	3.02	(dd,	J	=	11.78,	10.16	Hz,	1	H),	2.63	(t,	J	=	4.67	Hz,	1	H),	2.43	–	2.38	
(m,	1	H),	2.36	–	2.32	(m,	1	H),	2.10	–	2.02	(m,	4	H),	1.72	–	1.62	(m,	1	H),	1.60	–	1.53	(m,	1	H),	
1.38	(s,	3	H),	0.99	(d,	J	=	6.48	Hz,	3	H),	0.92	(d,	J	=	6.46	Hz,	3	H)	ppm;	13C	NMR	(100	MHz,	
CDCl3):	δ	207.7,	177.2,	83.3,	55.6,	53.9,	53.3,	53.1,	45.8,	44.8,	30.9,	29.6,	28.7,	24.5,	20.9,	
19.5	ppm;	IR	 (film):	v	2965	(s),	2096	(s),	1789	(s),	1741	(s),	1461	(s),	1115	(s),	998	(s)	cm-1;	
MS	 (ESI)	 calculated	 for	 C15H21N3O3Na+:	 314.1475,	 found	 :	 314.1478;	M.p.	 106	 oC;	 [α]D25	
+46.7	(c	1.7,	CHCl3,	99%	ee).	
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Synthesis	of	(-)-mubironine	B	2.2	
	
				To	a	 flame	dried	 flask	charged	with	stirring	bar,	a	 solution	of	 the	azide	substrate	2.106	
(14.6	mg,	0.05	mmol,	1.0	equiv)	 in	2	mL	THF	was	added	 followed	by	PPh3	 (15.7	mg,	0.06	
mmol,	1.2	equiv)	in	one	portion.	The	reaction	mixture	was	stirred	at	room	temperature	for	
12	 h,	 and	 the	 reaction	 progress	 was	 detected	 by	 TCL	 until	 the	 substrate	 was	 consumed	
completely.	To	this	mixture,	3	mL	MeOH,	HOAc	(0.029	mL,	0.5	mmol,	10	equiv)	and	HCOOH	
(0.019	mL,	 0.5	mmol,	 10	 equiv)	were	 added	 subsequently,	 and	 then	NaBH3CN	 (63	mg,	 1	
mmol,	20	equiv)	was	added	in	one	portion.	The	mixture	was	stirred	at	room	temperature	
for	additional	12	h,	after	which	10	mL	1N	HCl	was	added	drop	wise.	The	mixture	was	stirred	
for	1	h,	and	then	washed	with	5	mL	Et2O.	The	aqueous	 layer	was	basified	with	10	mL	3N	
NaOH	solution,	then	extracted	with	DCM	(4*30	mL),	and	the	combined	organic	layers	were	
dried	over	Na2SO4,	concentrated	under	reduced	pressure	gave	a	residue.	The	residue	was	
purified	 by	 column	 chromatography	 (EtOAc/MeOH/TEA	 =	 100:4:1)	 gave	 (-)-mubironine	 B	
2.2	as	colorless	oil	(9.7	mg,	0.038	mmol,	78%	yield).	
				(-)-Mubironine	B	2.1:	1H	NMR	(400	MHz,	CDCl3):	δ	4.68	(dd,	J	=	5.24,	3.48	Hz,	1	H),	3.95	
(br	s,	1	H),	3.24	(dd,	J	=	11.33,	8.61	Hz,	1	H),	2.95	(d,	J	=	3.36	Hz,	1	H),	2.88	(dd,	J	=	11.37,	
7.12	Hz,	1	H),	2.46	(dd,	J	=	5.45,	4.64	Hz,	1	H),	2.37	–	2.28	(m,	1	H),	2.21	–	2.02	(m,	4	H),	1.85	
–	1.75	(m,	2	H),	1.53	–	1.44	(m,	1	H),	1.37	(s,	3	H),	0.98	(d,	J	=	4.68	Hz,	3	H),	0.96	(d,	J	=	4.68	
Hz,	3	H)	ppm;	13C	NMR	 (100	MHz,	CDCl3):	δ	178.9,	82.4,	63.2,	56.6,	53.7,	53.3,	51.6,	43.8,	
42.4,	33.3,	32.2,	30.2,	24.5,	21.1,	20.4	ppm;	IR	(film):	v	2957	(s),	2924	(s),	1775	(s),	1465	(w),	
1119(s),	969	(s)	cm-1;	MS	(ESI)	calculated	for	C15H24NO2+:	250.1802,	found:	250.1804;	[α]D25	-
16.5	(c	1.4,	CHCl3,	99%	ee).	
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NMR	data	for	reported	and	our	synthetic	(-)-mubironine	B:	
δH	(m,	J	(Hz),	xH)	
Reported	(CDCl3,	300	MHz)	 Ours’	(CDCl3,	400	MHz)	
4.61	(dd,	J	=	5.3,	3.5	Hz,	1	H)	 4.68	(dd,	J	=	5.24,	3.48	Hz,	1	H)	
3.18	(dd,	J	=	11.4,	8.5	Hz,	1	H)	 3.24	(dd,	J	=	11.33,	8.61	Hz,	1	H)	
2.86	(d,	J	=	3.5	Hz,	1	H)	 2.95	(d,	J	=	3.36	Hz,	1	H)	
2.83	(dd,	J	=	11.4,	6.9	Hz,	1	H)	 2.88	(dd,	J	=	11.37,	7.12	Hz,	1	H)	
2.47	–	2.43	(m,	1	H)	 2.46	(dd,	J	=	5.45,	4.64	Hz,	1	H)	
2.35	–	2.20	(m,	1	H)	 2.37	–	2.28	(m,	1	H)	
2.20	–	2.00	(m,	5	H),	 2.21	–	2.02	(m,	4	H),	3.95	(br	s,	1	H)	
1.89	–	1.71	(m,	1	H)	 1.85	–	1.75	(m,	1	H)	
1.55	–	1.39	(m,	1	H)	 1.53	–	1.44	(m,	1	H)	
1.34	(s,	3	H)	 1.37	(s,	3	H)	
0.96	(d,	J	=	6.4	Hz,	3	H)	 0.98	(d,	J	=	4.68	Hz,	3	H)	
0.95	(d,	J	=	6.4	Hz,	3	H)	 0.96	(d,	J	=	4.68	Hz,	3	H)	
	
Synthesis	of	(-)-dendrobine	2.1	
	
					To	 a	 flask	 charged	with	 stirring	 bar	 and	 (-)-mubironine	 B	2.2	 (7.5	mg,	 0.03	mmol,	 1.0	
equiv)	 was	 added	 5	 mL	 water	 followed	 with	 HCOOH	 (0.11	 mL,	 3	 mmol,	 100	 equiv)	 and	
paraformaldehyde	 (22.5	 mg,	 0.75	 mmol,	 25	 equiv).	 The	 suspension	 mixture	 was	 heated	
under	 reflux	 and	 stirred	 for	 12	h.	After	 cooling	 down	 to	 room	 temperature,	 the	 reaction	
mixture	was	basified	with	10	mL	3N	NaOH	solution.	The	aqueous	layer	was	extracted	with	
DCM	 (4*30	mL),	 and	 the	 combined	 organic	 layers	were	 dried	 over	Na2SO4,	 concentrated	
under	 reduced	 pressure	 gave	 a	 residue.	 The	 residue	 was	 purified	 by	 column	
chromatography	 (PE/EtOAc/MeOH/TEA	 =	 250:250:10:1)	 gave	 (-)-dendrobine	2.1	 as	white	
crystals	(6.6	mg,	0.025	mmol,	84%	yield).	
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(-)-Dendrobine	(-)-2.1:	1H	NMR	(400	MHz,	CDCl3):	δ	4.84	(dd,	J	=	5.53,	2.99	Hz,	1	H),	3.16	
(t,	J	=	8.70	Hz,	1	H),	2.71	–	2.67	(m,	2	H),	2.50	(s,	3	H),	2.45	(dd,	J	=	5.32,	4.56	Hz,	1	H),	2.41	–	
2.32	(m,	1	H),	2.16	–	2.04	(m,	3	H),	2.02	–	1.99	(m,	1	H),	1.89	–	1.75	(m,	2	H),	1.60	–	1.49	(m,	
1	H),	1.38	(s,	3	H),	0.97	(d,	J	=	6.44	Hz,	3	H),	0.96	(d,	J	=	6.44	Hz,	3	H)	ppm;	13C	NMR	 (100	
MHz,	CDCl3):	 δ	179.0,	 79.3,	 66.8,	 62.0,	 53.7,	 52.5,	 51.6,	 44.0,	 43.1,	 36.5,	 32.8,	 32.7,	 30.8,	
24.5,	21.1,	20.4	ppm;	IR	(film):	v	2956	(s),	2921	(s),	1774	(s),	1464	(s),	1118	(s),	794	(s)	cm-1;	
MS	(ESI)	calculated	for	C16H26NO2+:	264.1958,	found:	264.1961;	M.p.	132	oC;	[α]D25	-52.6	(c	
1.6,	CHCl3).	
NMR	data	for	Carreira’s	and	our	synthetic	(-)-dendrobine:	
δH	(m,	J	(Hz),	xH)	 	 δc	(xC)	
Carreira’s	
	(CDCl3,	600	MHz)	
Our’s		
(CDCl3,	400	MHz)	
Carreira’s		
(CDCl3,		
150	MHz)	
Our’s		
(CDCl3,		
100	MHz)	
4.87	(dd,	J	=	5.3,	3.0	Hz,	1	H)	 4.84	(dd,	J	=	5.53,	2.99	Hz,	1	H)	 179.1	 179.0	
3.18	(app.	t,	J	=	8.7	Hz,	1	H)	 3.16	(t,	J	=	8.70	Hz,	1	H)	 79.3	 79.3	
2.74	–	2.69	(m,	2	H)	 2.71	–	2.67	(m,	2	H)	 66.9	 66.8	
2.53	(s,	3	H)	 2.50	(s,	3	H)	 62.0	 62.0	
2.48	(dd,	J	=	5.7,	4.4	Hz,	1	H)	 2.45	(dd,	J	=	5.32,	4.56	Hz,	1	H)	 53.8	 53.7	
2.39	(app.	pentet,	J	=	8.8	Hz,	1	H)	 2.45	(dd,	J	=	5.32,	4.56	Hz,	1	H)	 52.5	 52.5	
2.18	–	2.06	(m,	3	H),	 2.16	–	2.04	(m,	3	H),	 51.6	 51.6	
2.4	(dd,	J	=	7.9,	5.9	Hz,	1	H)	 2.02	–	1.99	(m,	1	H)	 44.0	 44.0	
1.91	–	1.79	(m,	2	H)	 1.89	–	1.75	(m,	2	H)	 43.1	 43.1	
1.62	–	1.54	(m,	1	H)	 1.60	–	1.49	(m,	1	H)	 36.6	 36.5	
1.41	(s,	3	H)	 1.38	(s,	3	H)	 32.8	 32.8	
1.00	(app.	dd,	J	=	6.5,	4.0	Hz,	6	H)	 0.97	(d,	J	=	6.44	Hz,	3	H),		
0.96	(d,	J	=	6.44	Hz,	3	H)	
32.8	 32.7	
	 	 30.8	 30.8	
	 	 24.5	 24.5	
	 	 21.1	 21.1	
	 	 20.5	 20.4	
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Late	stage	redox-neutral	elaboration	to	dendroxine	
	
To	a	flame	dried	flask	charged	with	stirring	bar,	a	solution	of	the	azide	substrate	2.106	
(7.3	mg,	 0.025	mmol,	 1.0	 equiv)	 in	 1	mL	 THF	was	 added	 followed	 by	 PPh3	 (6.6	mg,	 0.03	
mmol,	1.2	equiv)	in	one	portion.	The	reaction	mixture	was	stirred	at	room	temperature	for	
12	h	until	the	substrate	was	consumed	completely.	Then	the	solvent	was	evaporated	under	
vacuum,	and	the	residue	was	dissolved	in	1	mL	CH3CN.	2-iodoethanol	(0.01	mL,	0.13	mmol,	
5.0	equiv)	was	added	in	one	portion	to	this	solution,	and	the	solution	was	warmed	to	reflux	
under	 nitrogen	 and	 stirred	 at	 this	 temperature	 for	 24	 h.	 Meanwhile	 the	 system	 was	
covered	 with	 aluminum	 foil	 due	 to	 the	 light-sensitivity	 of	 2-iodoethanol.	 After	 24	 h	 the	
mixture	was	cooled	down	to	room	temperature,	 the	reaction	mixture	was	basified	with	5	
mL	3N	NaOH	solution	and	stirring	was	continued	for	additional	15	min.	Then	the	aqueous	
layer	 was	 extracted	 with	 EtOAc	 (3*10	mL),	 and	 the	 combined	 organic	 layers	 were	 dried	
over	 Na2SO4,	 concentrated	 under	 reduced	 pressure	 gave	 a	 residue.	 The	 residue	 was	
purified	by	column	chromatography	(PE/EtOAc/TEA	=	100:200:3)	gave	(-)-dendroxine	2.3	as	
colorless	oil	(4.9	mg,	0.017	mmol,	68%	yield).	
(-)-Dendroxine	(-)-2.3:	1H	NMR	(400	MHz,	CDCl3):	δ	4.35	(d,	J	=	4.67	Hz,	1	H),	3.93	–	3.98	
(m,	1	H),	3.85	(dd,	J	=	14.07,	7.81	Hz,	1	H),	3.25	–	3.31	(m,	1	H),	3.00	–	3.08	(m,	2	H),	2.86	
(dd,	J	=	10.07,	7.48	Hz,	1	H),	2.48	(dd,	J	=	6.57,	4.11	Hz,	1	H),	2.24	–	2.32	(m,	1	H),	2.07	–	
2.15	(m,	2	H),	1.98	–	2.04	(m,	2	H),	1.89	–	1.96	(m,	1	H),	1.73	–	1.80	(m,	1	H),	1.50	–	1.62	(m,	
1	H),	1.26	(s,	3	H),	1.02	(d,	J	=	6.14	Hz,	3	H),	0.93	(d,	J	=	6.	54	Hz,	3	H)	ppm;	13C	NMR	 (100	
MHz,	CDCl3):	δ	178.0,	103.5,	80.5,	65.2,	55.7,	54.0,	53.6,	51.8,	51.6,	43.3,	42.4,	31.7,	30.8,	
27.9,	24.3,	21.2,	21.0	ppm;	IR	(film):	v	2958	(s),	2925	(s)	2868	(s)	1774	(s),	1469	(s),	1351	(s),	
1111	 (s),	 1005	 (s),	 928	 (s),	 773(s)	 cm-1;	MS	 (ESI)	 calculated	 for	 C17H25NO3Na+:	 314.1727,	
found:	314.1723;	[α]D25		-17.3	(c	0.97,	EtOH).	
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A	selected	1H	NMR	data	for	natural19	and	synthetic	(-)-dendroxine:	
δH	(m,	J	(Hz),	x	H)	
Natural	 Synthetic	(CDCl3,	400	MHz)	
0.95	(q,	6	H)	 1.02	(d,	J	=	6.14	Hz,	3	H),	
0.93	(d,	J	=	6.	54	Hz,	3	H)	
1.20	(s,	3	H)	 1.26	(s,	3	H)	
2.7	–	3.2	(m,	4	H)	 3.25	–	3.31	(m,	1	H),	3.00	–	3.08	(m,	2	H),	2.86	
(dd,	J	=	10.07,	7.48	Hz,	1	H)	
3.8	(t,	2	H)	 3.93	–	3.98	(m,	1	H),	3.85	(dd,	J	=	14.07,	7.81	Hz,	
1	H)	
4.10	(d,	1	H)	 4.35	(d,	J	=	4.67	Hz,	1	H)	
		
Note:	A	detailed	1H	NMR	data	for	natural	(-)-dendroxine	cannot	be	extracted	due	to	
the	low	resolution	of	original	spectra.		
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3. Experimental	Details	in	Guaiane	Sesquiterpene	Englerins	Synthesis	
I. Racemic	decarboxylative	aldol	reaction	
	
To	a	solution	of	the	β-ketone	carboxylic	acid	3.66	(1.3	g,	10	mmol,	1.0	equiv)	in	H2O	(50	
mL,	0.2	M)	was	added	methyl	glyoxal	3.68	solution	(2.2	mL,	12	mmol,	1.2	equiv)	 in	water	
(commercially	 available,	 ~40%)	 at	 room	 temperature.	 The	 reaction	 was	 stirred	 at	 room	
temperature	for	12	h	until	the	β-ketone	carboxylic	acid	3.66	was	consumed	completely.	The	
mixture	was	diluted	with	additional	50	mL	H2O,	extracted	with	CH2Cl2	(50	ml*3),	dried	over	
anhydrous	Na2SO4,	concentrated	under	reduced	pressure	to	give	the	crude	aldol	product.	
The	product	was	slightly	sensitive	to	acid	and	has	to	be	purified	by	column	chromatography	
fast	on	silica	(PE/EA	=	3:1)	to	give	the	pure	product	3.63	(1.47	mg,	9.3	mmol,	93%	yield)	as	
light	yellow	liquid.		
Compound	(±)-3.63:	1H	NMR	 (300	MHz,	CDCl3),	δ	4.32	(dd,	J	=	6.08,	3.88	Hz,	1	H),	3.67	
(br	s,	1	H),	2.99	(dd,	J	=	17.37,	3.91	Hz,	1	H),	2.87	(dd,	J	=	17.37,	6.12	Hz,	1	H),	2.65	–	2.56	(m,	
1	H),	2.25	(s,	3	H),	1.11	(d,	J	=	1.0	Hz,	3	H),	1.08	(d,	J	=	1.0	Hz,	3	H)	ppm;	13C	NMR	(75	MHz,	
CDCl3),	δ	213.1,	209.5,	73.8,	43.0,	41.4,	25.4,	17.7,	17.6	ppm;	IR	(film):	v	3465	(br	s),	2971	(s),	
1706	(s),	1356	(s),	1103	(s),	1081	(s)	cm-1;	MS	(ESI)	calculated	for	C8H15O3+:	159.0977,	found:	
159.0979.			
Organocatalyzed	asymmetric	decarboxylative	aldol	reaction	under	optimized	
condition	
	
In	a	flask	charged	with	stirring	bar,	1.8	mL	trifluoroethanol	was	added	to	a	solution	of	β-
ketone	carboxylic	acid	9	 (260	mg,	2.0	mmol,	1.0	equiv)	 in	18.2	mL	THF	under	stirring.	The	
solution	was	cooled	to	-20	oC,	and	then	methyl	glyoxal	10	solution	(0.43	mL,	2.4	mmol,	1.2	
equiv)	 in	 water	 (commercially	 available,	 ~40%)	 was	 added	 in	 once	 followed	 by	
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organocatalyst	(DHQD)2PHAL	(155.8	mg,	0.2	mmol,	0.1	equiv).	The	mixture	was	stirred	at	-
20	 oC	 for	 16	 h	 until	 the	 β-ketone	 carboxylic	 acid	 9	 was	 consumed	 completely.	 Then	 the	
reaction	was	quenched	by	addiiton	of	5	mL	water,	allowed	to	warm	to	room	temperature,	
extracted	with	CH2Cl2	(20	ml*3),	dried	over	anhydrous	Na2SO4,	concentrated	under	reduced	
pressure	to	give	the	crude	enantioselective	aldol	product.	The	product	was	slightly	sensitive	
to	acid	and	has	to	be	purified	by	column	chromatography	fast	on	silica	(PE/EA	=	3:1)	to	give	
the	pure	product	8	(262	mg,	1.66	mmol,	83%	yield)	as	light	yellow	liquid.	
Compound	 (-)-3.63:	 1H	NMR,	 13C	NMR,	 IR,	MS	 spectrums	are	 identical	as	 the	racemic	
product.	[α]D25	-8.8	(c	0.54,	CHCl3,	-60%	ee);	Enantiomeric	excess	was	analyzed	by	chiral	GC	
analysis:	Colum:	Amidex_C,	Temperature	program:	initial	temperature	at	40	oC,	hold	for	1	
min,	then	ramping	in	a	rate	of	2	oC/min	to	200	oC;	Retention	Time:	33.6	min	(minor),	34.0	
min	(major).		
Chiral	GC	spectrums	
																														Racemic																																																							Enantioselective	
	
Free	alcohol	protection	
TBS-protection:	
	
In	an	oven-dried	flask,	a	solution	of	enantioselective	aldol	product	3.63	 (158.0	mg,	1.0	
mmol,	1.0	equiv)	in	anhydrous	CH2Cl2	(10	mL,	0.1	M)	was	charged	under	nitrogen	followed	
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by	TBSCl	(158.3	mg,	1.05	mmol,	1.05	equiv)	at	room	temperature.	Then	imidazole	(81.6	mg,	
1.2	mmol,	1.2	equiv)	was	added	in	one	portion.	The	mixture	turned	cloudy	and	was	stirred	
at	room	temperature	for	overnight	until	the	substrate	3.63	was	consumed	completely.	The	
reaction	was	quenched	by	addition	of	5	mL	water,	extracted	with	CH2Cl2	 (20	ml*3),	dried	
over	 anhydrous	Na2SO4,	 concentrated	 under	 reduced	pressure	 to	 the	 crude	 liquid,	which	
was	purified	by	column	chromatography	on	silica	 (PE/EA	=	30:1)	 to	give	the	pure	product	
3.76	(234	mg,	0.86	mmol,	86%	yield)	as	light	yellow	liquid.	
Compound	(-)-3.76:	1H	NMR	(400	MHz,	CDCl3),	δ	4.44	(dd,	J	=	5.61,	5.615	Hz,	1	H),	2.84	
(dd,	J	=	16.66,	5.78	Hz,	1	H),	2.77	(dd,	J	=	16.53,	4.84	Hz,	1	H),	2.61	–	2.54	(m,	1	H),	2.25	(s,	3	
H),	1.10	(d,	J	=	3.43	Hz,	3	H),	1.08	(d,	J	=	3.43	Hz,	3	H)	0.89	(s,	9	H),	0.10	(s,	3	H),	0.05	(s,	3	H)	
ppm;	13C	NMR	(100	MHz,	CDCl3),	δ	211.3	210.7,	74.7,	45.0,	41.4,	26.1,	25.7,	17.9,	17.8,	17.7,	
-4.9,	 -5.1;	 IR	 (film):	 v	 3481	 (br	 s),	 2956	 (s),	 1716	 (s),	 1362	 (s),	 1122	 (s)	 cm-1;	MS	 (ESI)	
calculated	for	C14H29O3Si+:	273.1880,	found:	273.1874;	[α]D25	-5.9	(c	0.82,	CHCl3,	-60%	ee).	
Glycolate-protection	(Yamaguchi’s	esterification):	
	
In	an	oven-dried	flask,	a	solution	of	enantioselective	aldol	product	3.63	 (158.0	mg,	1.0	
mmol,	1.0	equiv)	in	anhydrous	toluene	(10	mL,	0.1	M)	was	charged	under	nitrogen	followed	
by	 TBDPS	 protected	 glycolic	 acid	 3.87	 (330	 mg,	 1.05	 mmol,	 1.05	 equiv)	 at	 room	
temperature.	 Then	 Et3N	 (166	 μL,	 1.2	 mmol,	 1.2	 equiv),	 DMAP	 (12.2	 mg,	 0.1	 mmol,	 0.1	
equiv),	 2,4,6-trichlorobenzoyl	 chloride	 (164	 μL,	 1.05	 mmol,	 1.05	 equiv)	 were	 added	 in	
sequence.	The	mixture	turned	cloudy	and	was	stirred	at	room	temperature	for	1	h	until	the	
substrate	3.63	was	consumed	completely.	The	reaction	was	quenched	by	addition	of	5	mL	
water,	 extracted	with	 Et2O	 (20	ml*3),	 dried	 over	 anhydrous	 Na2SO4,	 concentrated	 under	
reduced	 pressure	 to	 the	 crude	 liquid,	which	was	 purified	 by	 column	 chromatography	 on	
silica	(PE/EA	=	20:1)	to	give	the	pure	product	3.86	(354	mg,	0.78	mmol,	78%	yield)	as	light	
yellow	liquid.	
Compound	(-)-3.86:	1H	NMR	(300	MHz,	CDCl3),	δ	7.70	–	7.66	(m,	4	H),	7.44	–	7.36	(m,	6	
H),	5.39	(dd,	J	=	5.64,	4.93	Hz,	1	H),	4.30	(d,	J	=	1.02	Hz,	2	H),	3.00	(dd,	J	=	17.77,	5.76	Hz,	1	
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H),	2.92	(dd,	J	=	17.77,	4.86	Hz,	1	H),	2.58	–	2.49	(m,	1	H),	2.15	(s,	3	H),	1.08	(s,	9	H),	1.07	(s,	
3	H),	1.05	(s,	3	H)	ppm;	13C	NMR	(75	MHz,	CDCl3),	δ	209.6,	205.4,	170.5,	135.5,	132.6,	130.0,	
127.8,	74.3,	62.0,	41.2,	40.8,	26.6,	26.5,	19.2,	17.8,	17.7	ppm;	IR	(film):	v	2931	(s),	1768	(s),	
1717	 (s),	 1140	 (s),	 1113	 (s),	 704	 (s),	 505	 (s)	 cm-1;	MS	 (ESI)	 calculated	 for	 C26H34O5SiNa+:	
477.2608,	found	:	477.2608;	[α]D25	-4.3	(c	0.82,	CHCl3,	-60%	ee).	
TMSOTf	catalyzed,	regio-	and	diastereoselective	[4+3]	cycloaddition	
With	TBS	protected	substrate	3.76	
	
In	an	oven-dried	flask,	a	solution	of	the	substrate	3.76	(272	mg,	1.0	mmol,	1.0	equiv)	in	
anhydrous	 CH2Cl2	 (10	mL,	 0.1	M)	was	 charged	under	 nitrogen	 at	 room	 temperature.	 The	
flask	was	then	cooled	to	-78	oC,	followed	by	addition	of	the	bis-silylenolether	3.80	(390	mg,	
1.5	mmol,	1.5	equiv)	at	 this	 temperature.	Then	a	catalytic	amount	of	TMSOTf	 (36	μL,	0.2	
mmol,	 0.2	 equiv)	was	 added,	 and	 the	mixture	was	 stirred	 at	 -78	 oC	 for	 30	min	 until	 the	
substrate	3.76	was	consumed	completely.	The	reaction	was	quenched	by	addition	of	5	mL	
saturated	NaHCO3	aqueous	solution,	allowed	to	warm	to	room	temperature,	extracted	with	
CH2Cl2	 (20	ml*3),	 dried	 over	 anhydrous	Na2SO4,	 concentrated	 under	 reduced	pressure	 to	
the	crude	liquid,	which	was	purified	by	column	chromatography	on	silica	(PE/EA	=	40:1)	to	
give	 the	 product	 (314	 mg,	 0.85	 mmol,	 85%	 overall	 yield)	 as	 light	 yellow	 liquid,	 which	
contained	the	three	isomers	(8:1:2)	at	the	β-ketone	ester	position.	
Compound	(+)-3.84:	1H	NMR	(400	MHz,	CDCl3),	δ		3.88	(dd,	J	=	7.26,	3.19	Hz,	1	H),	3.71	
(s,	3	H),	3.12	(s,	1	H),	2.86	(dd,	J	=	14.64,	1.93	Hz,	1	H),	2.30	(dd,	J	=	14.50,	0.81	Hz,	1	H),	
2.09	–	1.99	(m,	2	H),	1.68	–	1.62	(m,	1	H),	1.31	(s,	3	H),	0.97	(d,	J	=	6.95,	1	H),	0.93	(d,	J	=	
6.85	Hz,	3	H),	0.86	(s,	9	H),	0.01	(s,	6	H)	ppm;	13C	NMR	 (100	MHz,	CDCl3),	δ	204.7,	167.3,	
86.0,	85.8,	77.2,	65.7,	55.2,	47.6,	44.7,	35.9,	25.7,	18.1,	18.0,	17.5,	17.0,	-4.5,	-5.1;	IR	(film):	
v	2971	(s),	1763	(s),	1121	(s)cm-1;	MS	 (ESI)	calculated	for	C19H34O5SiNa+:	393.2068,	found	:	
393.2071;	[α]D25	+35.0	(c	0.91,	CHCl3,	-60%	ee).	
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Compound	(+)-epi-3.84:	 1H	NMR	 (400	MHz,	CDCl3),	δ		4.72	(dd,	J	=	7.30,	2.74	Hz,	1	H),	
3.75	(s,	3	H),	3.48	(s,	1	H),	2.34	(s,	2	H),	2.15	–	2.10	(m,	1	H),	2.02	–	1.95	(m,	1	H),	1.72	–	1.68	
(m,	1	H),	1.34	(s,	3	H),	0.96	(d,	J	=	6.92,	1	H),	0.93	(d,	J	=	6.92	Hz,	3	H),	0.88	(s,	9	H),	0.05	(s,	6	
H)	ppm;	13C	NMR	(100	MHz,	CDCl3),	δ	203.3,	168.4,	87.1,	85.8,	73.6,	66.9,	52.0,	48.1,	45.4,	
35.9,	25.8,	25.7,	19.7,	19.1,	17.5,	17.1,	-4.8,	-5.0;	IR	(film):	v	2983	(s),	1773	(s),	1121	(s)cm-1;	
MS	 (ESI)	 calculated	 for	 C19H34O5SiNa+:	 393.2068,	 found	 :	 393.2064;	 [α]D25	 +47.1	 (c	 0.53,	
CHCl3,	-60%	ee).	
With	glycolate	protected	substrate	3.86	
	
In	an	oven-dried	flask,	a	solution	of	the	substrate	3.86	(454	mg,	1.0	mmol,	1.0	equiv)	in	
anhydrous	 CH2Cl2	 (10	mL,	 0.1	M)	was	 charged	under	 nitrogen	 at	 room	 temperature.	 The	
flask	was	then	cooled	to	-78	oC,	followed	by	addition	of	the	bis-silylenolether	3.80	(390	mg,	
1.5	mmol,	1.5	equiv)	at	 this	 temperature.	Then	a	catalytic	amount	of	TMSOTf	 (36	μL,	0.2	
mmol,	 0.2	 equiv)	was	 added,	 and	 the	mixture	was	 stirred	 at	 -78	 oC	 for	 30	min	 until	 the	
substrate	3.86	was	consumed	completely.	The	reaction	was	quenched	by	addition	of	5	mL	
saturated	NaHCO3	aqueous	solution,	allowed	to	warm	to	room	temperature,	extracted	with	
CH2Cl2	 (20	ml*3),	 dried	 over	 anhydrous	Na2SO4,	 concentrated	 under	 reduced	pressure	 to	
the	crude	liquid,	which	was	purified	by	column	chromatography	on	silica	(PE/EA	=	40:1)	to	
give	 the	 product	 (458	 mg,	 0.83	 mmol,	 83%	 overall	 yield)	 as	 light	 yellow	 liquid,	 which	
contained	the	three	isomers	(8:1:2)	at	the	β-ketone	ester	position.	
Compound	(+)-3.90:	1H	NMR	(400	MHz,	CDCl3),	δ	7.68	–	7.66	(m,	4	H),	7.46	–	7.38	(m,	6	
H),	4.83	(dd,	 J	=	10.60,	4.33	Hz,	1	H),	4.22	(s,	2	H),	3.71	(s,	3	H),	3.38	(s,	1	H),	2.83	(d,	 J	=	
15.80	Hz,	1	H),	2.42	–	2.35	(m,	2	H),	1.97	–	1.90	(m,	1	H),	1.37	(s,	3	H),	1.32	(dd,	J	=	14.30,	
4.50,	1	H),	1.10	(s,	9	H),	0.96	(d,	J	=	6.84	Hz,	3	H),	0.91	(d,	J	=	6.84	Hz,	3	H)	ppm;	13C	NMR	
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(100	MHz,	CDCl3),	δ	202.7,	170.5,	167.8,	135.6,	132.6,	130.0,	127.8,	85.0,	82.1,	79.6,	62.0,	
60.4,	52.3,	47.6,	39.5,	35.8,	26.7,	22.8,	19.2,	17.0,	16.8	ppm;	 IR	 (film):	v	2959	(s),	2933	(s),	
1767	 (s),	 1738	 (s),	 1720	 (s),	 1138	 (s),	 703	 (s)	 cm-1;	MS	 (ESI)	 calculated	 for	 C31H40O7SiNa+:	
575.2436,	found	:	575.2444;	[α]D25	+35.0	(c	0.62,	CHCl3,	-60%	ee).	
	
Compounds	(+)-epi-3.90:	1H	NMR	(400	MHz,	CDCl3),	δ	12.28	(s,	0.6	H),	7.71	–	7.67	(m,	4	
H),	7.44	–	7.37	(m,	6	H),	5.79	(dd,	J	=	7.55,	2.55	Hz,	0.33	H),	5.18	(d,	J	=	6.26	Hz,	0.6	H),	4.30	
–	4.19	(m,	2	H),	3.80	–	3.78	(m,	3	H),	3.46	(s,	0.33	H),	2.56	(d,	J	=	17.67	Hz,	0.6	H),	2.39	(s,	
0.6	H),	2.78	(dd,	J	=	14.73,	7.66	Hz,	0.33	H),	2.15	–	2.04	(m,	1.33	H),	1.96	–	1.83	(m,	1.33	H),	
1.74	–	1.67	(m,	1	H),	1.44	(s,	2	H),	1.33	(s,	1.2	H),	1.28	–	1.24	(m,	0.6	H),	1.10	(s,	9	H),	0.96	–	
0.84	 (m,	6	H)	ppm;	13C	NMR	 (100	MHz,	CDCl3),	δ	201.9,	172.6,	171.2,	170.7,	170.0,	167.8,	
135.7,	135.6,	132.8,	129.9,	127.8,	103.9,	86.0,	85.4,	82.5,	81.0,	80.1,	68.0,	66.7,	62.3,	62.2,	
52.3,	 51.6,	 47.8,	 42.3,	 40.8,	 39.0,	 35.9,	 35.8,	 26.7,	 19.6,	 19.2,	 19.7,	 17.4,	 17.3,	 17.0,	 16.5	
ppm;	 IR	(film):	v	2933	(s),	2954	(s),	1767	(s),	1745	(s),	1738	(s),	1720	(s),	1701	(s),	1144	(s),	
711	(s)	cm-1;	MS	(ESI)	calculated	for	C31H40O7SiNa+:	575.2436,	found	:	575.2439;	[α]D25	+28.5	
(c	0.82,	CHCl3,	-60%	ee).	
Alkylation	reaction	
	
In	 an	 oven-dried	 flask,	 a	 solution	 of	 the	 cycloaddition	 product	 3.90	 (552	 mg,	 1.0	
mmol,	 1.0	 equiv)	 in	 anhydrous	 THF	 (10	mL,	 0.1	M)	was	 charged	 under	 nitrogen	 at	 room	
temperature.	The	flask	was	then	cooled	to	-78	oC,	followed	by	dropwise	addition	of	LiHMDS	
(1.0	M,	1.1	ml,	1.1	equiv)	over	10	min	at	this	temperature.	The	solution	was	stirred	at	-78	oC	
for	30	min,	 followed	by	addition	of	DMPU	 (240	μL,	2.0	mmol,	2.0	equiv)	 and	4-bromo-1-
butene	(152	μL,	1.5	mmol,	1.5	equiv).	The	mixture	was	warmed	to	room	temperature	over	
2	 h,	 and	 stirred	 at	 room	 temperature	until	 the	 substrate	was	 consumed	 completely.	 The	
Experimental	Section	–	Guaiane	Sesquiterpene	Englerins	Synthesis	
	
111	
reaction	was	quenched	by	addition	of	5	mL	saturated	NaHCO3	aqueous	solution,	extracted	
with	Et2O	(20	ml*3),	dried	over	anhydrous	Na2SO4,	concentrated	under	reduced	pressure	to	
give	the	crude	liquid,	which	was	purified	by	column	chromatography	on	silica	(PE/EA	=	40:1)	
to	yield	the	product	3.91	(521	mg,	0.83	mmol,	86%	yield)	as	light	yellow	liquid.	
Compound	(+)-3.91:	1H	NMR	(400	MHz,	CDCl3),	δ	7.68	–	7.66	(m,	4	H),	7.45	–	7.36	(m,	6	
H),	5.98	(dd,	J	=7.77,	3.21	Hz,	1	H),	5.82	–	5.72	(m,	1	H),	5.01	(d,	J	=	17.14	Hz,	1	H),	4.96	(d,	J	
=	10.18	Hz,	1	H),	4.23	(s,	2	H),	3.80	(s,	3	H),	2.37	–	2.24	(m,	4	H),	2.11	–	2.02	(m,	2	H),	1.97	–	
1.90	(m,	1	H),	1.58	–	1.68	(m,	2	H),	1.13	(s,	3	H),	1.08	(s,	9	H),	0.95	(d,	J	=	6.74	Hz,	3	H),	0.89	
(d,	J	=	6.99	Hz,	3	H)	ppm;	13C	NMR	 (100	MHz,	CDCl3),	δ	204.4,	170.0,	169.6,	137.6,	135.6,	
132.7,	 130.0,	 127.8,	 115.1,	 87.5,	 85.7,	 76.5,	 68.6,	 62.2,	 52.5,	 46.0,	 41.9,	 35.8,	 29.6,	 28.9,	
26.6,	19.2,	17.4,	16.9,	15.2	ppm;	 IR	 (film):	v	2958	(s),	2857(s),	1764	(s),	1731	(s),	1136	(s),	
1113	 (s),	 703	 (s),	 505	 (s)	 cm-1;	MS	 (ESI)	 calculated	 for	 C35H46O7SiNa+:	 629.2905,	 found	 :	
629.2918;	[α]D25	+82.3	(c	0.31,	CHCl3,	-60%	ee).	
Microwave-assisted	Krapcho	decarboxylation		
	
A	solution	of	the	alkylated	product	3.91	(181.8	mg,	0.3	mmol,	1.0	equiv)	in	wet	DMSO	(6	
mL,	 0.05	 M)	 was	 charged	 to	 a	 microwave	 vial	 under	 nitrogen	 at	 room	 temperature,	
followed	by	addition	of	 LiCl	 (19.1	mg,	0.45	mmol,	1.5	equiv)	 in	one	portion.	The	vial	was	
loaded	onto	the	microwave	reactor,	irradiated	at	150	oC	for	1	h.		It	was	then	cooled	down	
to	room	temperature,	and	the	decarboxylation	reaction	was	quenched	by	addition	of	20	mL	
water,	 extracted	with	 Et2O	 (20	ml*3),	 dried	 over	 anhydrous	 Na2SO4,	 concentrated	 under	
reduced	pressure	to	give	the	crude	 liquid,	which	was	purified	by	column	chromatography	
on	silica	(PE/EA	=	40:1)	to	yield	the	product	3.93	(129.9	mg,	0.22	mmol,	74%	yield)	as	light	
yellow	liquid.	
Compound	(+)-3.93:	1H	NMR	(400	MHz,	CDCl3),	δ	7.68	–	7.66	(m,	4	H),	7.43	–	7.36	(m,	6	
H),	5.81	–	5.71	(m,	1	H),	5.03	–	4.98	(m,	3	H),	4.23	(s,	1	H),	2.42	(d,	J	=	13.91	Hz,	1	H),	2.31	(d,	
J	=	14.13	Hz,	1	H),	2.28	–	2.25	(m,	2	H),	2.15	–	2.10	(m,	1	H),	2.08	–	2.00	(m,	2	H),	1.94	–	1.88	
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(m,	1	H),	1.67	(d,	J	=	14.6	Hz,	1	H),	1.29	–	1.25	(m,	1	H),	1.24	(s,	3	H),	1.09	(s,	9	H),	0.94	(d,	J	=	
6.73	Hz,	 3	H),	 0.87	 (d,	 J	=	6.82	Hz,	 3	H)	 ppm;	13C	 NMR	 (100	MHz,	CDCl3),	 δ	 208.3,	 170.4,	
138.0,	135.6,	132.7,	129.9,	127.8,	115.5,	87.5,	85.5,	75.9,	62.1,	59.5,	48.7,	41.9,	36.0,	33.4,	
26.6,	23.2,	19.4,	19.2,	17.5,	17.0	ppm;	IR	(film):	v	2960	(s),	2932	(s),	1763	(s),	1735	(s),	1711	
(s),	1137	(s),	1112	(s),	702	(s),	505	(s)	cm-1;	MS	(ESI)	calculated	for	C33H44O5SiNa+:	571.2850,	
found	:	571.2827;	[α]D25	+77.8	(c	0.27,	CHCl3,	-60%	ee).	
Enol-triflate	synthesis	
	
In	 an	 oven-dried	 flask,	 a	 solution	 of	 the	 decarboxylated	 product	 3.93	 (164.4	 mg,	 0.3	
mmol,	 1.0	 equiv)	 in	 anhydrous	 THF	 (3	 mL,	 0.1	M)	 was	 charged	 under	 nitrogen	 at	 room	
temperature,	 followed	 by	 N-phenyl-bis(trifluoromethanesulfonimide)	 (128.5	 mg,	 0.36	
mmol,	 1.2	 equiv).	 The	 flask	was	 then	 cooled	 to	 -78	 oC,	 followed	by	 dropwise	 addition	 of	
KHMDS	(0.5	M,	0.72	ml,	1.2	equiv)	at	this	temperature.	The	solution	was	stirred	at	-78	oC	
for	30	min,	warmed	to	0	oC	over	3	h	(the	reaction	has	to	be	warmed	to	0	oC	slowly	to	avoid	
side	products)	until	 the	 substrate	was	 consumed	completely.	 The	 reaction	was	quenched	
by	 addition	 of	 5	mL	 saturated	NaHCO3	 aqueous	 solution,	warmed	 to	 room	 temperature,	
extracted	with	Et2O	(10	ml*3),	dried	over	anhydrous	Na2SO4,	concentrated	under	reduced	
pressure	to	give	the	crude	 liquid,	which	was	purified	by	column	chromatography	on	silica	
(PE/EA	=	80:1)	 to	yield	the	product	3.94	 (189.7	mg,	0.28	mmol,	93%	yield)	as	 light	yellow	
liquid.	
Compound	(+)-3.94:	1H	NMR	(700	MHz,	CDCl3),	δ	7.69	–	7.67	(m,	4	H),	7.45	–	7.43	(m,	2	
H),	7.40	–	7.38	(m,	4	H),	5.89	(s,	1	H),	5.79	–	5.73	(m,	1	H),	5.33	(dd,	J	=	7.70,	5.13	Hz,	1	H),	
5.09	(d,	J	=	17.14	Hz,	1	H),	5.05	(d,	J	=	10.09	Hz,	1	H),	4.26	(d,	J	=	3.64	Hz,	2	H),	2.65	(d,	J	=	
7.26	Hz,	1	H),	2.54	(dd,	J	=	12.86,	7.91	Hz,	1	H),	2.37	–	2.32	(m,	1	H),	2.17	–	2.11	(m,	1	H),	
1.91	–	1.87	(m,	1	H),	1.72	–	1.66	(m,	2	H),	1.63	(dd,	J	=	12.92,	5.16	Hz,	1	H),	1.19	(s,	3	H),	
1.10	(s,	9	H),	0.93	(d,	J	=	5.91	Hz,	3	H),	0.92	(d,	J	=	6.51	Hz,	3	H)	ppm;	13C	NMR	(175	MHz,	
CDCl3),	δ	170.5,	150.4,	137.1,	135.6,	135.5,	132.7,	132.6,	130.0,	129.9,	127.8,	127.7,	120.1,	
118.4	(q,	JC-F	=	320.8	Hz),	116.3,	85.9,	82.8,	75.9,	62.1,	48.1,	46.3,	34.2,	33.8,	26.7,	25.9,	19.5,	
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19.2,	17.2,	17.1	ppm;	R	(film):	v	2961	(s),	2934	(s),	1763	(s),	1736	(s),	1420	(s),	1139	(s),	702	
(s),	 608	 (s),	 504	 (s)	 cm-1;	 MS	 (ESI)	 calculated	 for	 C34H43F3O7SiSNa+:	 703.2343,	 found	 :	
703.2308;	[α]D25	+61.3	(c	0.47,	CHCl3,	-60%	ee).	
Heck-coupling-hydrosiylation-Tamao-Fleming-oxidation	sequence	
Step-wise	Heck	reaction:	
	
In	an	oven-dried	flask,	a	solution	of	the	enol-triflate	compound	3.94	(136	mg,	0.2	mmol,	
1.0	 equiv)	 in	 anhydrous	 toluene	 (10	 mL,	 0.02	 M)	 was	 charged	 under	 nitrogen	 at	 room	
temperature,	 followed	by	 Et3N	 (41.5	μL,	 0.3	mmol,	 1.5	 equiv)	and	Pd(PPh3)2Cl2	 (14.0	mg,	
0.02	mmol,	0.1	equiv)	 in	one	portion.	The	flask	was	then	heated	at	80	oC	for	30	min	until	
the	substrate	was	consumed	completely.	The	reaction	was	quenched	by	addition	of	5	mL	
H2O,	 cooled	 down	 to	 room	 temperature,	 extracted	 with	 Et2O	 (10	 ml*3),	 dried	 over	
anhydrous	 Na2SO4,	 concentrated	 under	 reduced	 pressure	 to	 give	 the	 crude	 liquid,	which	
was	purified	by	column	chromatography	on	silica	(PE/EA	=	80:1)	to	yield	the	product	3.95	
(189.7	mg,	0.28	mmol,	quantitative	yield)	as	light	yellow	liquid.	
Compound	(-)-3.95:	1H	NMR	(400	MHz,	CDCl3),	δ	7.69	–	7.67	(m,	4	H),	7.45	–	7.36	(m,	6	
H),	5.94	(d,	J	=	2.72	Hz,	1	H),	5.28	(s,	1	H),	5.22	(dd,	J	=	6.90,	6.74	Hz,	1	H),	4.90	(s,	1	H),	4.24	
(s,	2	H),	2.79	–	2.74	(m,	1	H),	2.49	(dd,	J	=	16.12,	7.98	Hz,	1	H),	2.41	(dd,	J	=	12.05,	7.82	Hz,	1	
H),	2.38	–	2.31	(m,	1	H),	1.95	–	1.90	(m,	1	H),	1.88	–	1.80	(m,	1	H),	1.64	(dd,	J	=	11.94,	5.97	
Hz,	1	H),	1.54	–	1.43	(m,	1	H),	1.17	(s,	3	H),	1.09	(s,	9	H),	0.98	(d,	J	=	7.23	Hz,	3	H),	0.96	(d,	J	=	
6.96	Hz,	3	H)	ppm;	13C	NMR	 (100	MHz,	CDCl3),	δ	170.7,	146.6,	139.9,	135.6,	132.8,	129.9,	
127.8,	119.1,	103.9,	84.0,	83.8,	75.6,	62.2,	52.5,	47.1,	33.8,	32.1,	26.7,	25.2,	20.1,	19.2,	17.7,	
17.6	ppm;	R	(film):	v	2959	(s),	2932	(s),	1760	(s),	1733	(s),	1140	(s),	702	(s),	504	(s)	cm-1;	MS	
(ESI)	calculated	for	C33H46NO4Si+:	548.3191,	found	:	548.3181;	 [α]D25	-2.5	(c	0.12,	CHCl3,	-60%	
ee).	
	
Experimental	Section	–	Guaiane	Sesquiterpene	Englerins	Synthesis	
	
114	
One-pot	transformation:	
	
In	an	oven-dried	 flask,	a	 solution	of	 the	 triflate	compound	3.94	 (68	mg,	0.1	mmol,	1.0	
equiv)	 in	 anhydrous	 toluene	 (5	 mL,	 0.02	 M)	 was	 charged	 under	 nitrogen	 at	 room	
temperature,	followed	by	Et3N	(41.5	μL,	0.3	mmol,	3.0	equiv)	and	Pd(PPh3)2Cl2	(7.0	mg,	0.01	
mmol,	0.1	equiv)	 in	one	portion.	The	 flask	was	 then	heated	at	80	 oC	 for	30	min	until	 the	
substrate	was	 consumed	 completely.	 Then	dichloromethylsilane	 (28.5	μL,	 0.25	mmol,	 2.5	
equiv)	was	added	via	syringe	in	one	portion.	The	reaction	was	stirred	at	80	oC	for	additional	
5	h	until	the	Heck	coupling	intermediate	was	consumed	completely.	The	reaction	was	then	
cooled	down	 to	 room	temperature,	quenched	by	addition	of	ethanol	 (5	mL),	 followed	by	
H2O2	 (0.5	 mL)	 in	 one	 portion.	 The	 resulting	 suspension	 was	 stirred	 vigorously	 at	 room	
temperature	 for	 2	 h,	 extracted	 with	 Et2O	 (10	 ml*3),	 dried	 over	 anhydrous	 Na2SO4,	
concentrated	 under	 reduced	 pressure	 to	 give	 the	 crude	 liquid,	 which	 was	 purified	 by	
column	chromatography	on	silica	(PE/EA	=	20:1)	to	yield	the	product	3.104	(31.8	mg,	0.06	
mmol,	58%)	as	light	yellow	liquid.	
Compound	(-)-3.104:	1H	NMR	(400	MHz,	CDCl3),	δ	7.69	–	7.67	(m,	4	H),	7.45	–	7.36	(m,	6	
H),	5.02	(dd,	J	=	7.11,	2.75	Hz,	1	H),	4.24	(s,	2	H),	4.07	(s,	1	H),	2.95	(m,	1	H),	2.44	–	2.28	(m,	
3	H),	1.99	–	1.95	(m,	1	H),	1.73	(s,	3	H),	1.64	–	1.61	(m,	2	H),	1.58	–	1.52	(m,	2	H),	1.09	(s,	12	
H),	0.89	(d,	J	=	6.29	Hz,	3	H),	0.88	(d,	J	=	6.33	Hz,	3	H)	ppm;	13C	NMR	 (100	MHz,	CDCl3),	δ	
171.0,	137.5,	135.6,	132.8,	132.0,	129.9,	127.8,	87.5,	75.0,	66.7,	62.2,	52.3,	37.5,	36.1,	28.2,	
26.6,	23.0,	19.2,	18.7,	17.7,	15.9,	13.5	ppm;	R	(film):	v	2957	(s),	2932	(s),	1758	(s),	1731	(s),	
1138	 (s),	 1113	 (s),	 702	 (s),	 504	 (s)	 cm-1;	MS	 (ESI)	 calculated	 for	 C33H44O5SiNa+:	 571.2850,	
found	:	571.2843;	[α]D25	-17.9	(c	0.14,	CHCl3,	-60%	ee).	
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Ley	oxidation	
	
In	an	oven-dried	flask,	a	solution	of	the	alcohol	3.104	(27.4	mg,	0.05	mmol,	1.0	equiv)	in	
anhydrous	 CH2Cl2	 (2	mL)	was	 charged	 under	 nitrogen	 at	 room	 temperature,	 followed	 by	
anhydrous	MeCN	 (0.2	mL),	N-methylmorpholine-N-oxide	 (7.0	mg,	 0.06	mmol,	 1.2	 equiv),	
and	 TPAP	 (1.8	mg,	 0.005	mmol,	 0.1	 equiv)	 in	 one	 portion.	 The	 flask	 was	 then	 stirred	 at	
room	temperature	for	2	h	until	the	substrate	was	consumed	completely.	The	reaction	was	
quenched	by	addition	of	5	mL	H2O,	extracted	with	CH2Cl2	(10	ml*3),	dried	over	anhydrous	
Na2SO4,	concentrated	under	reduced	pressure	to	give	the	crude	liquid,	which	was	purified	
by	 column	 chromatography	 on	 silica	 (PE/EA	 =	 40:1)	 to	 yield	 the	 oxidation	 product	3.106	
(23.5	mg,	0.043	mmol,	86%)	as	light	yellow	liquid,	which	has	to	stored	under	0	oC.	
Compound	(-)-3.106:	1H	NMR	(400	MHz,	CDCl3),	δ	7.70	–	7.66	(m,	4	H),	7.44	–	7.37	(m,	6	
H),	5.36	(dd,	J	=	4.41,	8.13	Hz,	1	H),	4.27	(s,	2	H),	3.27	–	3.22	(m,	1	H),	2.57	–	2.45	(m,	1	H),	
2.37	(dd,	J	=	17.78,	9.57	Hz,	1	H),	2.24	–	2.14	(m,	2	H),	2.07	(s,	3	H),	1.98	–	1.88	(m,	2	H),	
1.77	–	1.66	(m,	1	H),	1.14	(s,	3	H),	1.09	(s,	9	H),	1.01	(d,	J	=	1.46	Hz,	3	H),	0.99	(d,	J	=	1.32	Hz,	
3	H)	 ppm;	 13C	 NMR	 (100	MHz,	 CDCl3),	 δ	 198.6,	 170.9,	 155.8,	 135.6,	 135.3,	 132.7,	 129.9,	
127.8,	89.7,	86.1,	74.6,	62.2,	56.7,	41.5,	38.7,	30.0,	26.7,	25.2,	19.2,	18.9,	18.0,	17.2,	15.9	
ppm;		R	 (film):	v	2932	(s),	1759	(s),	1734	(s),	1691	(s),	1625	(s),	1428	(s),	1139	(s),	702	(s),	
504	(s)	cm-1;	MS	(ESI)	calculated	for	C33H42O5SiNa+:	569.2694,	found	:	569.2666;	[α]D25	-58.3	
(c	0.24,	CHCl3,	-60%	ee).	
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Kinetic	CBS	reduction	under	optimized	condition	
	
In	an	oven-dried	flask,	a	solution	of	the	enone	3.106	(27.3	mg,	0.05	mmol,	1.0	equiv)	in	
anhydrous	 THF	 (2	mL)	 was	 charged	 under	 nitrogen	 at	 room	 temperature.	 The	 flask	 was	
cooled	 to	 -10	 oC,	 and	 then	 (S)-CBS	 catalyst	 (4.2	mg,	 0.015,	 0.3	mmol)	was	 added	 in	 one	
portion	 followed	 by	 borane	 tetrahydrofuran	 complex	 solution	 (1.0	M	 in	 THF,	 45	 μL,	 0.9	
equiv)	 dropwise.	 The	 flask	 was	 then	 stirred	 at	 -10	 oC	 for	 2	 h,	 it	 was	 then	 quenched	 by	
addition	 of	 1.0	 mL	 methanol	 (the	 reaction	 has	 to	 be	 quenched	 before	 the	 enone	 was	
consumed	completely	to	ensure	higher	ee).	After	it	was	brought	to	room	temperature,	the	
mixture	was	diluted	with	10	mL	saturated	NH4Cl	aqueous	solution,	extracted	with	Et2O	(10	
ml*3),	 dried	 over	 anhydrous	 Na2SO4,	 concentrated	 under	 reduced	 pressure	 to	 give	 the	
crude	liquid,	which	was	purified	by	column	chromatography	on	silica	(PE/EA	=	20:1)	to	yield	
the	reduced	product	3.105	(18.9	mg,	0.035	mmol,	69%)	as	light	yellow	liquid.	
Compound	(-)-3.105:	1H	NMR	(400	MHz,	CDCl3),	δ	7.70	–	7.68	(m,	4	H),	7.43	–	7.36	(m,	6	
H),	5.09	(dd,	J	=	7.91,	1.95	Hz,	1	H),	4.39	(s,	1	H),	4.24	(s,	2	H),	2.68	(m,	1	H),	2.33	(br	s,	1	H),	
2.27	(dd,	J	=	14.27,	8.27	Hz,	1	H),	1.98	–	1.91	(m,	1	H),	1.88	(s,	3	H),	1.86	–	1.82	(m,	1	H),	
1.58	–	1.49	(m,	3	H),	1.09	(s,	9	H),	1.04	(s,	3	H),	1.03	(d,	J	=	6.16,	3	H),	0.98	(d,	J	=	6.72	Hz,	3	
H)	ppm;	13C	NMR	(100	MHz,	CDCl3),	δ	170.9,	135.6,	134.4,	132.8,	131.5,	129.9,	127.8,	86.1,	
75.9,	73.3,	62.3,	56.4,	39.1,	37.5,	31.2,	26.7,	23.1,	19.2,	18.4,	17.9,	17.2,	14.6	ppm;	R	(film):	
v	3500	 (s),	2958	 (s),	2932	 (s),	1757	 (s),	11139	 (s),	1113	 (s),	702	 (s),	504	 (s)	 cm-1;	MS	 (ESI)	
calculated	 for	C33H44O5SiNa+:	571.2850,	 found	 :	571.2842;	 [α]D25	 -35.7	 (c	0.21,	CHCl3,	 96%	
ee).	
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Enantiomeric	excess	determination	
	
In	an	oven-dried	flask,	a	solution	of	the	reduced	product	3.106	(16.5	mg,	0.03	mmol,	1.0	
equiv)	 in	anhydrous	CH2Cl2	 (3	mL)	was	charged	under	nitrogen	at	 room	temperature.	The	
flask	was	cooled	to	0	oC,	and	then	DIBAl-H	solution	(1.0	M	in	hexanes,	0.15	mL,	5	equiv)	was	
added	 in	 one	 portion.	 The	 flask	 was	 stirred	 at	 0	 oC	 for	 30	 min	 until	 the	 substrate	 was	
consumed	 completely.	 Then	 the	 reaction	 was	 quenched	 by	 dropwise	 addition	 of	 1	 mL	
saturated	 sodium	 potassium	 tartrate	 aqueous	 solution.	 The	 resulting	 suspension	 was	
stirred	 vigorously	 until	 it	 became	 homogeneous,	 then	 it	 was	 diluted	 with	 10	 mL	 H2O,	
extracted	with	CH2Cl2	(10	ml*3),	dried	over	anhydrous	Na2SO4,	concentrated	under	reduced	
pressure	to	give	the	crude	 liquid,	which	was	purified	by	column	chromatography	on	silica	
(PE/EA	=	4:1)	to	yield	the	trans-diol	3.107	(6.9	mg,	0.028	mmol,	92%)	as	colorless	solid.	
Compound	(-)-3.107:	1H	NMR	(400	MHz,	CDCl3),	δ	4.39	(s,	1	H),	3.94	(dd,	J	=	7.31,	1.51	Hz,	1	
H),	2.75	–	2.68	(m,	1	H),	2.37	–	2.23	(m,	2	H),	2.27	(dd,	J	=	14.34,	7.44	Hz,	1	H),	2.03	–	1.94	
(m,	1	H),	1.89	–	1.82	(m,	1	H),	1.88	(s,	3	H),	1.56	(dt,	J	=	14.30,	1.73	Hz,	1	H),	1.53	(br	s,	2	H),	
1.36	–	1.25	(m,	2	H),	1.20	(s,	3	H),	1.07	(d,	J	=	3.43	Hz,	3	H),	1.05	(d,	J	=	3.26	Hz,	3	H)	ppm;	
13C	NMR	(100	MHz,	CDCl3),	δ	133.6,	132.2,	86.8,	85.7,	73.5,	56.1,	40.5,	38.9,	30.9,	23.6,	18.8,	
17.8,	17.2,	14.6	ppm;	R	 (film):	v	3445	(s),	3356	(s),	1455	(s),	1038	(s),	973	(s),	893	(s)	cm-1;	
MS	 (ESI)	 calculated	 for	 C15H24O3Na+:	 275.1618,	 found	 :	 275.1617;	 [α]D25	 -40.2	 (c	 0.13,	
CHCl3,96%	 ee);	 enantiomeric	 excess	 was	 measured	 by	 chiral	 GC:	 Colum:	 BetaDex_120,	
Temperature	program:	 initial	 temperature	at	40	oC,	hold	for	1	min,	 then	ramping	 in	the	
rate	of	2.5	oC/min	to	200	oC,	then	hold	at	200	oC;	Retention	Time:	81.29	min	(major),	82.03	
min	(minor).	
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Chiral	GC	spectrums	
												Racemic																																																																													Kinetic	(S)-CBS		
	
	
	
	
Non-chiral	reduction	
	
	
	
	
	
Hydrogenation	of	the	tetra-substituted	olefin	
	
To	 a	 solution	 of	 the	 substrate	 3.105	 (16.5	 mg,	 0.03	 mmol,	 1.0	 equiv)	 in	 anhydrous	
ethanol	(10	mL)	in	a	vial	was	added	palladium	on	charcoal	(Pd	10%,	16.5	mg,	10%	w/w)	in	
one	portion.	The	vial	was	loaded	into	autoclave,	pressurized	under	H2	atmosphere	at	90	bar	
for	 48	 h	 at	 room	 temperature.	 The	 suspension	 was	 then	 loaded	 onto	 a	 pad	 of	 Celite,	
flushed	with	EA.	 The	 filtrate	was	 concentrated	under	 reduced	pressure	 to	 give	 the	 crude	
liquid,	which	was	purified	by	column	chromatography	on	silica	(PE/EA	=	20:1)	to	yield	the	
product	3.108	(14.2	mg,	0.026	mmol,	86%)	as	colorless	liquid.		
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Compound	(-)-3.105:	1H	NMR	(75	MHz,	CDCl3),	δ	7.70	–	7.67	(m,	4	H),	7.46	–	7.34	(m,	6	
H),	5.07	(dd,	J	=	7.91,	2.89	Hz,	1	H),	4.25	(s,	2	H),	3.63	(d,	J	=	10.09	Hz,	1	H),	2.40	(dd,	J	=	
14.58,	8.00	Hz,	1	H),	2.33	–	2.29	(m,	1	H),	2.05	–	1.91	(m,	2	H),	1.69	–	1.62	(m,	2	H),	1.35	–	
1.17	(m,	5	H),	1.09	(s,	9	H),	1.07	(s,	3	H),	1.03	(d,	J	=	7.17	Hz,	3	H),	1.01	(d,	J	=	7.03,	3	H),	0.88	
(d,	 J	 =	 7.17	 Hz,	 3	H)	 ppm;	 13C	 NMR	 (75	MHz,	 CDCl3),	 δ	 170.90,	 135.59,	 132.79,	 129.90,	
127.79,	85.82,	84.40,	75.44,	70.69,	62.24,	47.91,	38.41,	31.97,	31.27,	30.51,	26.65,	25.52,	
19.23,	18.89,	18.22,	17.36,	16.84	ppm;	R	(film):	v	2956	(s),	2933	(s),	1758	(s),	1139	(s),	702	
(s),	504	(s)	cm-1;	MS	(ESI)	calculated	for	C33H46O5SiNa+:	573.3007,	found	:	573.3005;	[α]D25	-
16.1	(c	0.21,	CHCl3,	96%	ee).	
Esterification	with	cinnamoyl	chloride	and	synthesis	of	(-)-englerin	A	
	
In	an	oven-dried	flask,	a	solution	of	the	substrate	3.108	(11.0	mg,	0.02	mmol,	1.0	equiv)	
in	anhydrous	CH2Cl2	(2	mL)	was	charged	under	nitrogen	at	room	temperature.	Then	DMAP	
(0.5	mg,	0.004,	0.2	equiv),	Et3N	(0.2	mL),	cinnamoyl	chloride	(3.7	mg,	0.022	mmol,	1.1	equiv)	
was	 added	 in	 this	 order.	 The	 flask	was	warmed	 to	 40	 oC	 for	 2	 h	 until	 the	 substrate	was	
consumed	 completely.	 Then	 the	 reaction	was	 cooled	 to	 room	 temperature,	quenched	by	
addition	 of	 1	mL	 saturated	 NaHCO3	 aqueous	 solution.	 The	 resulting	mixture	 was	 diluted	
with	 10	 mL	 H2O,	 extracted	 with	 CH2Cl2	 (10	 ml*3),	 dried	 over	 anhydrous	 Na2SO4,	
concentrated	 under	 reduced	 pressure	 to	 give	 the	 crude	 liquid	 3.109,	 which	 was	 used	
directly	in	the	next	step	without	further	purification.		
Compound	(-)-3.109:	 1H	NMR	 (400	MHz,	CDCl3),	δ	7.72	–	7.68	(m,	4	H),	7.66	(d,	J	=	15.92,	1	H),	
7.55	–	7.51	(m,	2	H),	7.45	–	7.36	(m,	9	H),	6.39	(d,	J	=	15.92,	1	H),	5.16	–	5.09	(m,	2	H),	4.27	(s,	2	H),	
2.61	(dd,	J	=	14.50,	7.96	Hz,	1	H),	2.17	–	2.10	(m,	1	H),	1.99	–	1.90	(m,	1	H),	1.87	–	1.81	(m,	1	H),	1.78	
–	1.69	(m,	3	H),	1.53	–	1.49	(m,	1	H),	1.12	(s,	3	H),	1.10	(s,	9	H),	0.97	(d,	J	=	6.87	Hz,	3	H),	0.95	(d,	J	=	
2.99	Hz,	3	H),	0.93	(d,	J	=	2.93	Hz,	3	H)	ppm;	13C	NMR	(75	MHz,	CDCl3),	δ	171.0,	165.6,	145.1,	135.6,	
134.3,	132.7,	130.4,	129.9,	128.9,	128.1,	127.8,	128.1,	85.4,	84.5,	75.4,	71.3,	62.3,	47.5,	46.9,	39.8,	
32.9,	31.2,	30.9,	26.7,	24.6,	19.2,	18.9,	18.2,	17.5,	16.9	ppm;	R	 (film):	v	2948	(s),	1731	(s),	1345	(s),	
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1316	 (s),	 898	 (s),	 706	 (s),	 cm-1;	MS	 (ESI)	 calculated	 for	 C42H52O6Na
+:	 703.9334,	 found	 :	 703.9341;	
[α]D
25	-18.7	(c	0.14,	CHCl3,	96%	ee).	
To	a	solution	of	the	substrate	3.109	in	THF	was	added	a	solution	of	TBAF	(1.0	M	in	THF,	
0.1	mL,	5.0	equiv)	at	room	temperature.	The	mixture	was	stirred	at	room	temperature	for	6	
h	until	the	substrate	was	consumed	completely.	The	reaction	was	quenched	by	addition	of	
1	mL	saturated	NH4Cl	aqueous	solution,	extracted	with	EA	(10	ml*3),	dried	over	anhydrous	
Na2SO4,	concentrated	under	reduced	pressure	to	give	the	crude	liquid,	which	was	purified	
by	column	chromatography	on	silica	(PE/EA	=	3:1)	to	yield	(-)-englerin	A	3.1	(7.0	mg,	0.016	
mmol,	79%	over	2	steps)	as	colorless	solid.	
(-)-Englerin	A	3.1:	1H	NMR	(400	MHz,	CD3OD),	δ	7.69	(d,	J	=	16.0	Hz,	1	H),	7.60	–	7.62	(m,	
2	H),	7.40	–	7.42	(m,	3	H),	6.50	(d,	J	=	16.1	Hz,	1	H	),	5.27	(dd,	J	=	7.9,	2.8	Hz,	1	H),	5.12	(d,	J	=	
9.9	Hz,	1	H),	4.15	(s,	2	H),	2.70	(dd,	J	=	14.6,	8.0	Hz,	1	H),	2.11	–	2.16	(m,	1	H),	1.96	–	2.04	(m,	
1	H),	1.84	–	1.90	(m,	2	H),	1.73	–	1.81	(m,	2	H),	1.64	–	1.71	(m,	1	H),	1.26	–	1.36	(m,	2	H),	
1.19	(s,	3	H),	1.02	(d,	J	=	6.8	Hz,	3	H),	0.97	(d,	J	=	7.1	Hz,	3	H),	0.93	(d,	J	=	7.1	Hz,	3	H)	ppm;	
13C	NMR	(100	MHz,	CD3OD),	δ	174.0,	167.3,	146.8,	135.7,	131.6,	130.1,	129.3,	118.8,	86.7,	
86.1,	76.7,	72.5,	61.1,	48.9,	48.0,	40.7,	34.1,	32.5,	32.0,	25.5,	19.2,	18.6,	17.7,	17.2	ppm;	R	
(film):	v	3373	(br	s),	2957	(s),	2489	(br	s),	1709	(s),	1336	(s),	1118	(s),	971	(s),	cm-1;	MS	(ESI)	
calculated	for	C26H34O6Na+:	465.2248,	found	:	465.2248;	[α]D25	-27.9	(c	0.11,	MeOH,	96%	ee).	
δ	H	(synthetic)	
	
CD3OD,	400	MHz	
δ	H	(natural)	
	
CD3OD,	500	MHz	
δ	C	(synthetic)	
	
CD3OD	
	100	MHz	
δ	C	(natural)	
	
CD3OD	
	125	MHz	
7.69	(d,	J	=	16.0	Hz,	1	H)	 7.68	(d,	J	=	16.0	Hz,	1	H)	 174.0	 173.9	
7.60	–	7.62	(m,	2	H)	 7.61	(m,	2	H)	 167.3	 167.3	
7.40	–	7.42	(m,	3	H)	 7.40	(m,	3	H)	 146.8	 146.8	
6.50	(d,	J	=	16.1	Hz,	1	H	)	 6.50	(d,	J	=	16.0	Hz,	1	H	)	 135.7	 135.6	
5.27	(dd,	J	=	7.9,	2.8	Hz,	1	H)	 5.26	(dd,	J	=	8.1,	2.9	Hz,	1	H)	 131.6	 131.6	
5.12	(d,	J	=	9.9	Hz,	1	H)	 5.11	(d,	J	=	9.6	Hz,	1	H)	 130.1	 130.1	
4.15	(s,	2	H)	 4.15	(s,	2	H)	 129.3	 129.3	
2.70	(dd,	J	=	14.6,	8.0	Hz,	1	H)	 2.69	(dd,	J	=	14.5,	7.9	Hz,	1	
H)	
118.8	 118.8	
2.11	–	2.16	(m,	1	H)	 2.14	(m,	1	H)	 86.7	 86.4	
1.96	–	2.04	(m,	1	H)	 1.99	(m,	1	H)	 86.1	 86.0	
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1.84	–	1.90	(m,	2	H)	 1.86	(m,	2	H)	 76.7	 76.6	
1.73	–	1.81	(m,	2	H)	 1.71	(m,	1	H)	 72.5	 72.4	
1.75	(m,	1	H)	 61.1	 61.0	
1.64	–	1.71	(m,	1	H)	 1.67	(m,	1	H)	 48.9	 48.9	
1.26	–	1.36	(m,	2	H)	 1.30	(m,	2	H)	 48.0	 48.0	
1.19	(s,	3	H)	 1.18	(s,	3	H)	 40.7	 40.7	
1.02	(d,	J	=	6.8	Hz,	3	H)	 1.01	(d,	J	=	6.8	Hz,	3	H)	 34.1	 34.0	
0.97	(d,	J	=	7.1	Hz,	3	H)	 0.96	(d,	J	=	7.0	Hz,	3	H)	 32.5	 32.4	
0.93	(d,	J	=	7.1	Hz,	3	H)	 0.92	(d,	J	=	7.0	Hz,	3	H)	 32.0	 32.0	
	 	 25.5	 25.5	
	 	 19.2	 19.3	
	 	 18.6	 18.6	
	 	 17.7	 17.8	
	 	 17.2	 17.3	
	
Synthesis	of	(-)-englerin	B	3.1	
	
To	a	solution	of	(-)-englerin	A	(8.8	mg,	0.02	mmol,	1.0	equiv)	 in	a	mixture	of	methanol	
and	H2O	(3	mL,	2:1)	was	added	K2CO3	(8.3	mg,	0.06	mmol,	3.0	equiv)	at	0	oC.	The	mixture	
was	 stirred	 at	 this	 temperature	 for	 4	 h	 until	 englerin	 A	 was	 consumed	 completely.	 The	
reaction	was	 diluted	with	 5	mL	 H2O,	 extracted	with	 EA	 (10	ml*3),	 dried	 over	 anhydrous	
Na2SO4,	concentrated	under	reduced	pressure	to	give	the	crude	liquid,	which	was	purified	
by	 column	 chromatography	 on	 silica	 (PE/EA	 =	 1:1)	 to	 yield	 (-)-englerin	 B	 (5.5	 mg,	 0.014	
mmol,	71%)	as	colorless	liquid.	
	(-)-Englerin	B	3.2:	1H	NMR	(400	MHz,	CD3OD),	δ	7.69	(d,	J	=	16.1	Hz,	1	H),	7.60	(m,	2	H),	
7.39	–	7.41	(m,	3	H),	6.49	(d,	J	=	16.0	Hz,	1	H),	5.07	(d,	J	=	10.1	Hz,	1	H),	4.04	(dd,	J	=	7.8,	2.7	
Hz,	1	H),	2.63	(dd,	J	=	14.1,	7.8	Hz,	1	H),	2.06	–	2.11	(m,	1	H),	1.90	–	2.00	(m,	1	H),	1.83	–	
1.88	(m,	1	H),	1.68	–	1.75	(m,	3	H),	1.54	–	1.61	(m,	1	H),	1.26	–	1.31	(m,	1	H),	1.22	(s,	3	H),	
1.16	–	1.18	(m,	1	H),	1.02	(d,	J	=	6.8	Hz,	3	H),	0.95	(d,	J	=	7.1	Hz,	3	H),	0.91	(d,	J	=	7.1	Hz,	3	H)	
Experimental	Section	–	Guaiane	Sesquiterpene	Englerins	Synthesis	
	
122	
ppm;	13C	NMR	 (100	MHz,	CD3OD),	δ	167.5,	146.7,	135.7,	131.6,	130.1,	129.3,	119.0,	86.8,	
86.3,	 73.2,	 48.9,	 47.8,	 43.5,	 34.6,	 32.4,	 32.1,	 25.7,	 19.5,	 18.8,	 17.9,	 17.3	 ppm;	R	 (film):	 v	
3453	 (br	 s),	 2956	 (s),	 1708	 (s),	 1636	 (s),	 1171	 (s),	 766	 (s),	 cm-1;	MS	 (ESI)	 calculated	 for	
C24H32O4Na+:	407.2193,	found	:	407.2168;	[α]D25	-12.4	(c	0.1,	MeOH,	96%	ee).	
δ	H	(synthetic)	
CD3OD,	400	MHz	
δ	H	(natural)	
CD3OD,	500	MHz	
δ	C	(synthetic)	
CD3OD,	100	
MHz	
δ	C	(natural)	
CD3OD,	125	
MHz	
7.69	(d,	J	=	16.1	Hz,	1	H)	 7.67	(d,	J	=	16.0	Hz,	1	H)	 167.5	 168.4	
7.60	(m,	2	H)	 7.60	(m,	2	H)	 146.7	 146.6	
7.39	–	7.41	(m,	3	H)	 7.39	(m,	3	H)	 135.7	 135.7	
6.49	(d,	J	=	16.0	Hz,	1	H	)	 6.48	(d,	J	=	16.0	Hz,	1	H	)	 131.6	 131.6	
5.07	(d,	J	=	10.1	Hz,	1	H)	 5.06	(d,	J	=	10.0	Hz,	1	H)	 130.1	 130.0	
4.04	(dd,	J	=	7.8,	2.7	Hz,	1	H)	 4.02	(dd,	J	=	8.0,	2.5	Hz,	1	H)	 129.3	 129.3	
2.63	(dd,	J	=	14.1,	7.8	Hz,	1	H)	 2.60	(dd,	J	=	14.0,	8.0	Hz,	1	H)	 119.0	 118.9	
2.06	–	2.11	(m,	1	H)	 2.7	(m,	1	H)	 86.8	 86.7	
1.90	–	2.00	(m,	1	H)	 1.94	(m,	1	H)	 86.3	 86.2	
1.83	–	1.88	(m,	1	H)	 1.86	(m,	1	H)	 73.2	 73.2	
1.68	–	1.75	(m,	3	H)	 1.73	(dd,	J	=	14.0,	2.5	Hz,	2	H)	 48.9	 48.9	
1.70	(m,	2	H)	 47.8	 47.8	
1.54	–	1.61	(m,	1	H)	 1.57	(m,	1	H)	 43.5	 43.4	
1.26	–	1.31	(m,	1	H)	 1.24	(m,	1	H)	 34.6	 34.6	
1.22	(s,	3	H)	 1.22	(s,	3	H)	 32.4	 32.4	
1.16	–	1.18	(m,	1	H)	 1.18	(m,	1	H)	 32.1	 32.1	
1.02	(d,	J	=	6.8	Hz,	3	H)	 1.02	(d,	J	=	7.0	Hz,	3	H)	 25.7	 25.7	
0.95	(d,	J	=	7.1	Hz,	3	H)	 0.95	(d,	J	=	7.0	Hz,	3	H)	 19.5	 19.5	
0.91	(d,	J	=	7.1	Hz,	3	H)	 0.90	(d,	J	=	7.0	Hz,	3	H)	 18.8	 18.8	
	 	 17.9	 17.9	
	 	 17.3	 17.3	
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Attachment:	NMR	Spectrums	
Compound	2.82		
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Compound	2.87	
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Compound	2.88	
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Compound	2.75	
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Compound	2.74
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Compound	2.73	
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Compound	2.106	
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	(-)-Mubironine	B	2.2	
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(-)-Dendribine	2.1	
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(-)-Dndroxine	2.3
	
	
	
	
Notes	and	References		
	
133	
Compound	3.63	
	
	
	
Notes	and	References		
	
134	
Compound	3.76		
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Compound	3.86	
	
	
	
Notes	and	References		
	
136	
Compound	3.84		
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Compound	3.84		
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Compound	3.90	
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Compounds	epi-3.90	
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Compound	3.91	
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Compound	3.93	
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Compound	3.94	
	
	
	
	
Notes	and	References		
	
145	
Compound	3.95	
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Compound	3.104	
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Compound	3.106	
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Compound	3.105	
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Compound	3.107	
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Compound	3.108	
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Compound	3.109	
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(-)-Englerin	A	3.1	
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(-)-Englerin	B	3.2	
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Attachment:	X-ray	Crystal	Data	
X-Ray	crystal	data	of	(+)-compound	2.73:	
	
						Table	1.		Crystal	data	and	structure	refinement	for	s2433lc.		
						Identification	code															s2433lc				
						Empirical	formula																	C15	H20	O3		
						Formula	weight																				248.31		
						Temperature																							130(2)	K		
						Wavelength																								1.54178	A		
						Crystal	system,	space	group							Monoclinic,		P	21		
						Unit	cell	dimensions														a	=		8.8202(12)	A		alpha	=	90°	
																																								b	=		6.3966(8)	A				beta	=	92.240(10)°	
																																								c	=	11.3691(14)	A		gamma	=	90°	
						Volume																												640.95(14)	A^3		
						Z,	Calculated	density													2,		1.287	Mg/m^3		
						Absorption	coefficient												0.709	mm^-1		
						F(000)																												268		
						Crystal	size																						0.16	x	0.06	x	0.03	mm		
						Theta	range	for	data	collection			3.89	to	63.97	deg.		
						Limiting	indices																		-10<=h<=5,	-7<=k<=7,	-13<=l<=13		
						Reflections	collected	/	unique				6833	/	2066	[R(int)	=	0.0661]		
						Completeness	to	theta	=	63.97					98.4	%		
						Absorption	correction													Semi-empirical	from	equivalents		
						Max.	and	min.	transmission								0.7469	and	0.6243		
						Refinement	method																	Full-matrix	least-squares	on	F^2		
						Data	/	restraints	/	parameters				2066	/	1	/	167		
						Goodness-of-fit	on	F^2												1.032		
						Final	R	indices	[I>2sigma(I)]					R1	=	0.0388,	wR2	=	0.0870		
						R	indices	(all	data)														R1	=	0.0506,	wR2	=	0.0917		
						Absolute	structure	parameter						0.1(3)		
						Extinction	coefficient												0.0069(16)		
						Largest	diff.	peak	and	hole							0.185	and	-0.133	e.A^-3		
Table	2.		Atomic	coordinates	(	x	10^4)	and	equivalent	isotropic		
									displacement	parameters	(A^2	x	10^3)	for	s2433lc.		
									U(eq)	is	defined	as	one	third	of	the	trace	of	the	orthogonalized		
									Uij	tensor.		
________________________________________________________________		
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																									x													y													z											U(eq)		
________________________________________________________________		
										O(1)									8399(2)						-1428(3)							4154(1)							33(1)		
										C(1)									8950(3)							1963(4)							3563(2)							30(1)		
										O(2)									8345(2)								972(3)							5589(1)							38(1)		
										C(2)									7515(3)							2651(4)							2846(2)							30(1)		
										O(3)									7250(2)						-2426(3)							1319(2)							39(1)		
										C(3)									6599(2)								831(4)							2236(2)							29(1)		
										C(4)									7526(3)						-1169(4)							2093(2)							30(1)		
										C(5)									8877(3)						-1466(4)							2940(2)							31(1)		
										C(6)									9905(3)								438(4)							2865(2)							30(1)		
										C(7)									8545(3)								567(4)							4570(2)							32(1)		
										C(8)								10337(3)							1112(4)							1625(2)							30(1)		
										C(9)								11376(3)							3019(4)							1694(2)							38(1)		
										C(10)							11084(3)							-680(4)								968(2)							36(1)		
										C(11)								5910(3)							1533(4)							1040(2)							38(1)		
										C(12)								4391(3)						-1254(4)							2938(2)							36(1)		
										C(13)								5317(3)								360(4)							3076(2)							32(1)		
										C(14)								5261(3)							2057(4)							3986(2)							36(1)		
										C(15)								6341(3)							3761(4)							3595(2)							37(1)		
________________________________________________________________		
Table	3.		Bond	lengths	[A]	and	angles	[deg]	for	s2433lc.		
_____________________________________________________________		
												O(1)-C(7)																					1.364(3)		
												O(1)-C(5)																					1.460(3)		
												C(1)-C(7)																					1.505(3)		
												C(1)-C(6)																					1.531(3)		
												C(1)-C(2)																					1.543(3)		
												C(1)-H(1)																					1.0000		
												O(2)-C(7)																					1.208(3)		
												C(2)-C(15)																				1.540(3)		
												C(2)-C(3)																					1.563(4)		
												C(2)-H(2)																					1.0000		
												O(3)-C(4)																					1.210(3)		
												C(3)-C(4)																					1.530(4)		
												C(3)-C(11)																				1.535(3)		
												C(3)-C(13)																				1.538(3)		
												C(4)-C(5)																					1.514(3)		
												C(5)-C(6)																					1.522(4)		
												C(5)-H(5)																					1.0000		
												C(6)-C(8)																					1.537(3)		
												C(6)-H(6)																					1.0000		
												C(8)-C(9)																					1.526(3)		
												C(8)-C(10)																				1.531(3)		
												C(8)-H(8)																					1.0000		
												C(9)-H(9A)																				0.9800		
												C(9)-H(9B)																				0.9800		
												C(9)-H(9C)																				0.9800		
												C(10)-H(10A)																		0.9800		
												C(10)-H(10B)																		0.9800		
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												C(10)-H(10C)																		0.9800		
												C(11)-H(11A)																		0.9800		
												C(11)-H(11B)																		0.9800		
												C(11)-H(11C)																		0.9800		
												C(12)-C(13)																			1.322(3)		
												C(12)-H(12A)																		0.9500		
												C(12)-H(12B)																		0.9500		
												C(13)-C(14)																			1.503(4)		
												C(14)-C(15)																			1.525(4)		
												C(14)-H(14A)																		0.9900		
												C(14)-H(14B)																		0.9900		
												C(15)-H(15A)																		0.9900		
												C(15)-H(15B)																		0.9900		
												C(7)-O(1)-C(5)														108.42(18)		
												C(7)-C(1)-C(6)															99.6(2)		
												C(7)-C(1)-C(2)														110.90(19)		
												C(6)-C(1)-C(2)														111.36(18)		
												C(7)-C(1)-H(1)														111.5		
												C(6)-C(1)-H(1)														111.5		
												C(2)-C(1)-H(1)														111.5		
												C(15)-C(2)-C(1)													113.2(2)		
												C(15)-C(2)-C(3)													103.98(19)		
												C(1)-C(2)-C(3)														114.9(2)		
												C(15)-C(2)-H(2)													108.1		
												C(1)-C(2)-H(2)														108.1		
												C(3)-C(2)-H(2)														108.1		
												C(4)-C(3)-C(11)													110.21(19)		
												C(4)-C(3)-C(13)													108.13(19)		
												C(11)-C(3)-C(13)												109.37(18)		
												C(4)-C(3)-C(2)														113.62(18)		
												C(11)-C(3)-C(2)													110.8(2)		
												C(13)-C(3)-C(2)													104.50(18)		
												O(3)-C(4)-C(5)														120.7(2)		
												O(3)-C(4)-C(3)														122.6(2)		
												C(5)-C(4)-C(3)														116.6(2)		
												O(1)-C(5)-C(4)														110.49(17)		
												O(1)-C(5)-C(6)														103.51(18)		
												C(4)-C(5)-C(6)														108.66(19)		
												O(1)-C(5)-H(5)														111.3		
												C(4)-C(5)-H(5)														111.3		
												C(6)-C(5)-H(5)														111.3		
												C(5)-C(6)-C(1)															98.07(18)		
												C(5)-C(6)-C(8)														116.4(2)		
												C(1)-C(6)-C(8)														117.3(2)		
												C(5)-C(6)-H(6)														108.1		
												C(1)-C(6)-H(6)														108.1		
												C(8)-C(6)-H(6)														108.1		
												O(2)-C(7)-O(1)														121.1(2)		
												O(2)-C(7)-C(1)														130.6(2)		
												O(1)-C(7)-C(1)														108.30(19)		
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												C(9)-C(8)-C(10)													110.77(19)		
												C(9)-C(8)-C(6)														110.33(19)		
												C(10)-C(8)-C(6)													111.37(19)		
												C(9)-C(8)-H(8)														108.1		
												C(10)-C(8)-H(8)													108.1		
												C(6)-C(8)-H(8)														108.1		
												C(8)-C(9)-H(9A)													109.5		
												C(8)-C(9)-H(9B)													109.5		
												H(9A)-C(9)-H(9B)												109.5		
												C(8)-C(9)-H(9C)													109.5		
												H(9A)-C(9)-H(9C)												109.5		
												H(9B)-C(9)-H(9C)												109.5		
												C(8)-C(10)-H(10A)											109.5		
												C(8)-C(10)-H(10B)											109.5		
												H(10A)-C(10)-H(10B)									109.5		
												C(8)-C(10)-H(10C)											109.5		
												H(10A)-C(10)-H(10C)									109.5		
												H(10B)-C(10)-H(10C)									109.5		
												C(3)-C(11)-H(11A)											109.5		
												C(3)-C(11)-H(11B)											109.5		
												H(11A)-C(11)-H(11B)									109.5		
												C(3)-C(11)-H(11C)											109.5		
												H(11A)-C(11)-H(11C)									109.5		
												H(11B)-C(11)-H(11C)									109.5		
												C(13)-C(12)-H(12A)										120.0		
												C(13)-C(12)-H(12B)										120.0		
												H(12A)-C(12)-H(12B)									120.0		
												C(12)-C(13)-C(14)											127.5(2)		
												C(12)-C(13)-C(3)												123.0(2)		
												C(14)-C(13)-C(3)												109.3(2)		
												C(13)-C(14)-C(15)											106.12(18)		
												C(13)-C(14)-H(14A)										110.5		
												C(15)-C(14)-H(14A)										110.5		
												C(13)-C(14)-H(14B)										110.5		
												C(15)-C(14)-H(14B)										110.5		
												H(14A)-C(14)-H(14B)									108.7		
												C(14)-C(15)-C(2)												105.9(2)		
												C(14)-C(15)-H(15A)										110.6		
												C(2)-C(15)-H(15A)											110.6		
												C(14)-C(15)-H(15B)										110.6		
												C(2)-C(15)-H(15B)											110.6		
												H(15A)-C(15)-H(15B)									108.7		
_____________________________________________________________		
											Symmetry	transformations	used	to	generate	equivalent	atoms:		
				Table	4.		Anisotropic	displacement	parameters	(A^2	x	10^3)	for	s2433lc.		
				The	anisotropic	displacement	factor	exponent	takes	the	form:		
				-2	pi^2	[	h^2	a*^2	U11	+	...	+	2	h	k	a*	b*	U12	]		
________________________________________________________________		
														U11								U22								U33								U23								U13								U12		
________________________________________________________________		
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				O(1)					41(1)						35(1)						25(1)							2(1)							7(1)							5(1)		
				C(1)					31(1)						36(1)						23(1)						-2(1)							6(1)							0(1)		
				O(2)					41(1)						50(1)						22(1)						-2(1)							6(1)							5(1)		
				C(2)					34(1)						30(1)						27(1)							1(1)							6(1)							2(1)		
				O(3)					45(1)						41(1)						33(1)						-8(1)							8(1)						-5(1)		
				C(3)					30(1)						31(1)						26(1)							2(1)							3(1)							2(1)		
				C(4)					33(1)						34(1)						24(1)						-1(1)						10(1)						-4(1)		
				C(5)					39(1)						34(1)						22(1)						-1(1)							8(1)							7(1)		
				C(6)					32(1)						34(1)						23(1)							0(1)							4(1)							3(1)		
				C(7)					29(1)						37(2)						31(1)						-2(1)							2(1)							5(1)		
				C(8)					31(1)						37(1)						23(1)							2(1)							7(1)							4(1)		
				C(9)					38(1)						44(2)						33(1)						-2(1)						10(1)						-5(1)		
				C(10)				38(1)						45(2)						27(1)						-5(1)							9(1)							2(1)		
				C(11)				39(1)						48(2)						28(1)							7(1)							2(1)							0(1)		
				C(12)				31(1)						43(1)						34(1)							9(1)							4(1)							1(1)		
				C(13)				31(1)						38(1)						26(1)							5(1)							4(1)							6(1)		
				C(14)				35(1)						44(2)						31(1)						-4(1)							8(1)							2(1)		
				C(15)				39(1)						36(1)						38(1)							0(1)							9(1)							6(1)		
________________________________________________________________		
									Table	5.		Hydrogen	coordinates	(	x	10^4)	and	isotropic		
									displacement	parameters	(A^2	x	10^3)	for	s2433lc.		
________________________________________________________________		
																									x													y													z											U(eq)		
________________________________________________________________		
										H(1)									9563										3194										3844										36		
										H(2)									7830										3644										2221										36		
										H(5)									9437									-2783										2767										38		
										H(6)								10861											143										3338										36		
										H(8)									9386										1515										1173										36		
										H(9A)							11695										3377											903										57		
										H(9B)							12272										2702										2199										57		
										H(9C)							10829										4202										2023										57		
										H(10A)						12008									-1123										1406										55		
										H(10B)						11344										-205											182										55		
										H(10C)						10378									-1860											896										55		
										H(11A)							5260											419											708										58		
										H(11B)							6725										1829											503										58		
										H(11C)							5303										2798										1145										58		
										H(12A)							3577									-1434										3452										43		
										H(12B)							4540									-2235										2326										43		
										H(14A)							5588										1513										4771										44		
										H(14B)							4217										2614										4030										44		
										H(15A)							6846										4444										4287										45		
										H(15B)							5784										4835										3125										45		
________________________________________________________________		
Table	6.		Torsion	angles	[deg]	for	s2433lc.		
________________________________________________________________		
										C(7)-C(1)-C(2)-C(15)																																	56.6(3)		
										C(6)-C(1)-C(2)-C(15)																																166.60(19)		
										C(7)-C(1)-C(2)-C(3)																																	-62.7(3)		
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										C(6)-C(1)-C(2)-C(3)																																		47.3(3)		
										C(15)-C(2)-C(3)-C(4)																															-144.2(2)		
										C(1)-C(2)-C(3)-C(4)																																	-19.9(3)		
										C(15)-C(2)-C(3)-C(11)																																91.1(2)		
										C(1)-C(2)-C(3)-C(11)																															-144.56(19)		
										C(15)-C(2)-C(3)-C(13)																															-26.6(2)		
										C(1)-C(2)-C(3)-C(13)																																	97.8(2)		
										C(11)-C(3)-C(4)-O(3)																																-27.9(3)		
										C(13)-C(3)-C(4)-O(3)																																	91.6(2)		
										C(2)-C(3)-C(4)-O(3)																																-152.9(2)		
										C(11)-C(3)-C(4)-C(5)																																149.1(2)		
										C(13)-C(3)-C(4)-C(5)																																-91.4(2)		
										C(2)-C(3)-C(4)-C(5)																																		24.1(3)		
										C(7)-O(1)-C(5)-C(4)																																	-93.5(2)		
										C(7)-O(1)-C(5)-C(6)																																		22.7(2)		
										O(3)-C(4)-C(5)-O(1)																																-125.1(2)		
										C(3)-C(4)-C(5)-O(1)																																		57.8(3)		
										O(3)-C(4)-C(5)-C(6)																																	121.9(2)		
										C(3)-C(4)-C(5)-C(6)																																	-55.1(3)		
										O(1)-C(5)-C(6)-C(1)																																	-41.7(2)		
										C(4)-C(5)-C(6)-C(1)																																		75.8(2)		
										O(1)-C(5)-C(6)-C(8)																																-167.62(18)		
										C(4)-C(5)-C(6)-C(8)																																	-50.2(3)		
										C(7)-C(1)-C(6)-C(5)																																		44.2(2)		
										C(2)-C(1)-C(6)-C(5)																																	-72.9(2)		
										C(7)-C(1)-C(6)-C(8)																																	169.6(2)		
										C(2)-C(1)-C(6)-C(8)																																		52.5(3)		
										C(5)-O(1)-C(7)-O(2)																																-173.6(2)		
										C(5)-O(1)-C(7)-C(1)																																			7.0(2)		
										C(6)-C(1)-C(7)-O(2)																																	147.2(2)		
										C(2)-C(1)-C(7)-O(2)																																	-95.4(3)		
										C(6)-C(1)-C(7)-O(1)																																	-33.4(2)		
										C(2)-C(1)-C(7)-O(1)																																		84.0(2)		
										C(5)-C(6)-C(8)-C(9)																																-179.5(2)		
										C(1)-C(6)-C(8)-C(9)																																		64.9(3)		
										C(5)-C(6)-C(8)-C(10)																																-56.1(3)		
										C(1)-C(6)-C(8)-C(10)																															-171.7(2)		
										C(4)-C(3)-C(13)-C(12)																															-50.7(3)		
										C(11)-C(3)-C(13)-C(12)																															69.4(3)		
										C(2)-C(3)-C(13)-C(12)																														-172.0(2)		
										C(4)-C(3)-C(13)-C(14)																															132.6(2)		
										C(11)-C(3)-C(13)-C(14)																													-107.4(2)		
										C(2)-C(3)-C(13)-C(14)																																11.2(2)		
										C(12)-C(13)-C(14)-C(15)																												-167.8(2)		
										C(3)-C(13)-C(14)-C(15)																																8.8(3)		
										C(13)-C(14)-C(15)-C(2)																														-25.9(3)		
										C(1)-C(2)-C(15)-C(14)																															-92.8(2)		
										C(3)-C(2)-C(15)-C(14)																																32.6(2)		
________________________________________________________________		
									Symmetry	transformations	used	to	generate	equivalent	atoms:		
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X-Ray	crystal	data	of	compound	(-)-3.107:	
	
	
	
	
	
	
	
	
	
	
	
	
	
Table	1.		Crystal	data	and	structure	refinement	for	s2644lc.		
						Identification	code															s2644lc	-	Sample:	GL-VII-081-3	
						Empirical	formula																	C15	H24	O3		
						Formula	weight																				252.34		
						Temperature																							130(2)	K		
						Wavelength																								1.54178	A		
						Crystal	system,	space	group							Monoclinic,		C	2		
						Unit	cell	dimensions														a	=	45.5324(12)	A		alpha	=		90°		
																																								b	=	10.8332(3)	A				beta	=	112.449(2)°	
																																								c	=	18.3881(5)	A			gamma	=		90°	
						Volume																												8382.8(4)	A^3		
						Z,	Calculated	density													24,		1.200	Mg/m^3		
						Absorption	coefficient												0.652	mm^-1		
						F(000)																												3312		
						Crystal	size																						0.13	x	0.08	x	0.06	mm		
			
						Theta	range	for	data	collection			2.10	to	66.49	deg.		
						Limiting	indices																		-53<=h<=53,	-12<=k<=12,	-21<=l<=21		
						Reflections	collected	/	unique				59155	/	14082	[R(int)	=	0.0976]		
						Completeness	to	theta	=	66.49					98.1	%		
						Absorption	correction													Semi-empirical	from	equivalents		
						Max.	and	min.	transmission								0.7140	and	0.6407		
						Refinement	method																	Full-matrix	least-squares	on	F^2		
						Data	/	restraints	/	parameters				14082	/	2	/	1046		
						Goodness-of-fit	on	F^2												1.010		
						Final	R	indices	[I>2sigma(I)]					R1	=	0.0478,	wR2	=	0.0929		
						R	indices	(all	data)														R1	=	0.0833,	wR2	=	0.1030		
						Absolute	structure	parameter						0.10(13)		
						Extinction	coefficient												0.000145(13)		
						Largest	diff.	peak	and	hole							0.258	and	-0.193	e.A^-3		
		
									Table	2.		Atomic	coordinates	(	x	10^4)	and	equivalent	isotropic		
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									displacement	parameters	(A^2	x	10^3)	for	s2644lc.		
									U(eq)	is	defined	as	one	third	of	the	trace	of	the	orthogonalized		
									Uij	tensor.		
									________________________________________________________________		
													x																		y																					z														U(eq)		
									________________________________________________________________		
										O(1A)								1060(1)							9363(2)							3913(1)							30(1)		
										C(1A)									805(1)							9963(3)							3295(2)							24(1)		
										O(2A)								-148(1)							8005(2)							2571(1)							27(1)		
										C(2A)									505(1)							9873(2)							3491(2)							21(1)		
										O(3A)									245(1)						10460(2)							2854(1)							23(1)		
										C(3A)									400(1)							8516(3)							3441(2)							23(1)		
										C(4A)									160(1)							8326(3)							2589(2)							23(1)		
										C(5A)									155(1)							9595(3)							2192(2)							23(1)		
										C(6A)									416(1)							9684(3)							1873(2)							25(1)		
										C(7A)									740(1)							9414(3)							2499(2)							23(1)		
										C(8A)									920(1)							8763(3)							2216(2)							27(1)		
										C(9A)									744(1)							8428(3)							1364(2)							37(1)		
										C(10A)								399(1)							8823(3)							1187(2)							34(1)		
										C(11A)								539(1)						10505(3)							4264(2)							24(1)		
										C(12A)								223(1)						10626(3)							4367(2)							36(1)		
										C(13A)								693(1)						11787(3)							4370(2)							30(1)		
										C(14A)							-167(1)							9999(3)							1599(2)							30(1)		
										C(15A)							1266(1)							8422(3)							2606(2)							36(1)		
										O(1B)									653(1)							9302(2)							7219(1)							31(1)		
										C(1B)									903(1)							8424(3)							7530(2)							23(1)		
										O(2B)								1859(1)							9343(2)							7408(1)							25(1)		
										C(2B)								1217(1)							9136(2)							7944(2)							21(1)		
										O(3B)								1462(1)							8210(2)							8293(1)							20(1)		
										C(3B)								1316(1)							9756(3)							7320(2)							24(1)		
										C(4B)								1542(1)							8849(2)							7163(2)							20(1)		
										C(5B)								1534(1)							7695(3)							7644(2)							22(1)		
										C(6B)								1252(1)							6863(3)							7190(2)							24(1)		
										C(7B)									944(1)							7584(3)							6925(2)							23(1)		
										C(8B)									764(1)							7361(3)							6174(2)							31(1)		
										C(9B)									920(1)							6475(3)							5805(2)							39(1)		
										C(10B)							1255(1)							6263(3)							6433(2)							33(1)		
										C(11B)							1209(1)						10009(3)							8590(2)							26(1)		
										C(12B)							1545(1)						10510(3)							9090(2)							37(1)		
										C(13B)							1072(1)							9438(3)							9144(2)							33(1)		
										C(14B)							1843(1)							6989(3)							8003(2)							28(1)		
										C(15B)								432(1)							7813(3)							5685(2)							47(1)		
										O(1C)								2315(1)							4645(2)							3949(1)							31(1)		
										C(1C)								2559(1)							5085(3)							3710(2)							22(1)		
										O(2C)								3498(1)							6283(2)							5595(1)							26(1)		
										C(2C)								2882(1)							4628(3)							4309(2)							22(1)		
										O(3C)								3121(1)							5033(2)							4012(1)							22(1)		
										C(3C)								2966(1)							5347(3)							5086(2)							24(1)		
										C(4C)								3176(1)							6426(3)							5030(2)							22(1)		
										C(5C)								3168(1)							6358(2)							4191(2)							21(1)		
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										C(6C)								2874(1)							6992(3)							3598(2)							25(1)		
										C(7C)								2571(1)							6462(3)							3645(2)							25(1)		
										C(8C)								2368(1)							7338(3)							3641(2)							27(1)		
										C(9C)								2495(1)							8620(3)							3592(2)							37(1)		
										C(10C)							2843(1)							8397(3)							3688(2)							30(1)		
										C(11C)							2905(1)							3223(3)							4414(2)							26(1)		
										C(12C)							3250(1)							2812(3)							4863(2)							35(1)		
										C(13C)							2762(1)							2486(3)							3649(2)							34(1)		
										C(14C)							3469(1)							6736(3)							4092(2)							29(1)		
										C(15C)							2037(1)							7216(3)							3630(2)							39(1)		
										O(1D)								2712(1)							5759(2)							1304(1)							30(1)		
										C(1D)								2433(1)							5903(3)							1477(2)							22(1)		
										O(2D)								1486(1)							6483(2)							-570(1)							24(1)		
										C(2D)								2151(1)							5198(3)								859(2)							21(1)		
										O(3D)								1880(1)							5336(2)							1084(1)							20(1)		
										C(3D)								2047(1)							5862(3)									64(2)							24(1)		
										C(4D)								1786(1)							6768(3)									51(2)							23(1)		
										C(5D)								1766(1)							6584(3)								867(2)							22(1)		
										C(6D)								2010(1)							7427(3)							1475(2)							25(1)		
										C(7D)								2338(1)							7233(3)							1474(2)							24(1)		
										C(8D)								2481(1)							8289(3)							1448(2)							31(1)		
										C(9D)								2273(1)							9387(3)							1416(2)							41(1)		
										C(10D)							1954(1)							8840(3)							1357(2)							36(1)		
										C(11D)							2217(1)							3820(3)								814(2)							27(1)		
										C(12D)							1921(1)							3109(3)								287(2)							41(1)		
										C(13D)							2347(1)							3185(3)							1607(2)							33(1)		
										C(14D)							1439(1)							6670(3)								889(2)							28(1)		
										C(15D)							2809(1)							8508(3)							1465(2)							48(1)		
										O(1E)								3944(1)							9483(2)							1060(1)							30(1)		
										C(1E)								4195(1)							9976(3)							1729(2)							23(1)		
										O(2E)								5143(1)							7973(2)							2535(1)							29(1)		
										C(2E)								4511(1)							9842(3)							1600(2)							21(1)		
										O(3E)								4759(1)						10385(2)							2288(1)							23(1)		
										C(3E)								4600(1)							8467(3)							1644(2)							25(1)		
										C(4E)								4829(1)							8244(3)							2497(2)							25(1)		
										C(5E)								4824(1)							9474(3)							2915(2)							24(1)		
										C(6E)								4542(1)							9536(3)							3174(2)							27(1)		
										C(7E)								4228(1)							9352(3)							2484(2)							25(1)		
										C(8E)								4030(1)							8654(3)							2679(2)							28(1)		
										C(9E)								4179(1)							8204(3)							3516(2)							34(1)		
										C(10E)							4530(1)							8596(3)							3791(2)							38(1)		
										C(11E)							4506(1)						10486(3)								855(2)							26(1)		
										C(12E)							4363(1)						11773(3)								734(2)							30(1)		
										C(13E)							4840(1)						10555(3)								836(2)							36(1)		
										C(14E)							5134(1)							9832(3)							3569(2)							34(1)		
										C(15E)							3687(1)							8357(3)							2204(2)							38(1)		
										O(1F)									593(1)							4110(2)							2076(1)							37(1)		
										C(1F)									849(1)							3249(3)							2393(2)							28(1)		
										O(2F)								1816(1)							4447(2)							2454(1)							25(1)		
										C(2F)								1153(1)							3922(3)							2926(2)							26(1)		
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										O(3F)								1399(1)							2979(2)							3216(1)							26(1)		
										C(3F)								1283(1)							4757(3)							2453(2)							26(1)		
										C(4F)								1499(1)							3949(2)							2185(2)							21(1)		
										C(5F)								1493(1)							2673(3)							2562(2)							24(1)		
										C(6F)								1225(1)							1873(3)							2013(2)							25(1)		
										C(7F)									910(1)							2545(3)							1762(2)							27(1)		
										C(8F)									737(1)							2390(3)							1006(2)							34(1)		
										C(9F)									908(1)							1634(3)								605(2)							40(1)		
										C(10F)							1245(1)							1472(3)							1230(2)							32(1)		
										C(11F)							1112(1)							4506(3)							3644(2)							35(1)		
										C(12F)							1417(1)							4606(4)							4345(2)							58(1)		
										C(13F)								956(1)							5789(3)							3465(2)							46(1)		
										C(14F)							1808(1)							1998(3)							2896(2)							29(1)		
										C(15F)								400(1)							2785(4)								534(2)							50(1)		
									________________________________________________________________		
	
											Table	3.		Bond	lengths	[A]	and	angles	[deg]	for	s2644lc.		
											_____________________________________________________________		
			
												O(1A)-C(1A)																			1.435(3)		
												O(1A)-H(1AA)																		0.80(4)		
												C(1A)-C(7A)																			1.501(4)		
												C(1A)-C(2A)																			1.541(4)		
												C(1A)-H(1A)																			1.0000		
												O(2A)-C(4A)																			1.434(3)		
												O(2A)-H(2A)																			0.95(4)		
												C(2A)-O(3A)																			1.457(3)		
												C(2A)-C(11A)																		1.531(4)		
												C(2A)-C(3A)																			1.538(4)		
												O(3A)-C(5A)																			1.465(3)		
												C(3A)-C(4A)																			1.543(4)		
												C(3A)-H(3A1)																		0.9900		
												C(3A)-H(3A2)																		0.9900		
												C(4A)-C(5A)																			1.552(4)		
												C(4A)-H(4A)																			1.0000		
												C(5A)-C(6A)																			1.516(4)		
												C(5A)-C(14A)																		1.518(4)		
												C(6A)-C(7A)																			1.516(4)		
												C(6A)-C(10A)																		1.547(4)		
												C(6A)-H(6A)																			1.0000		
												C(7A)-C(8A)																			1.327(4)		
												C(8A)-C(9A)																			1.506(4)		
												C(8A)-C(15A)																		1.507(4)		
												C(9A)-C(10A)																		1.538(4)		
												C(9A)-H(9A1)																		0.9900		
												C(9A)-H(9A2)																		0.9900		
												C(10A)-H(10A)																	0.9900		
												C(10A)-H(10B)																	0.9900		
												C(11A)-C(12A)																	1.525(4)		
												C(11A)-C(13A)																	1.535(4)		
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												C(11A)-H(11A)																	1.0000		
												C(12A)-H(12A)																	0.9800		
												C(12A)-H(12B)																	0.9800		
												C(12A)-H(12C)																	0.9800		
												C(13A)-H(13A)																	0.9800		
												C(13A)-H(13B)																	0.9800		
												C(13A)-H(13C)																	0.9800		
												C(14A)-H(14A)																	0.9800		
												C(14A)-H(14B)																	0.9800		
												C(14A)-H(14C)																	0.9800		
												C(15A)-H(15A)																	0.9800		
												C(15A)-H(15B)																	0.9800		
												C(15A)-H(15C)																	0.9800		
												O(1B)-C(1B)																			1.428(3)		
												O(1B)-H(1BB)																		0.94(4)		
												C(1B)-C(7B)																			1.503(4)		
												C(1B)-C(2B)																			1.542(4)		
												C(1B)-H(1B)																			1.0000		
												O(2B)-C(4B)																			1.438(3)		
												O(2B)-H(2B)																			0.80(3)		
												C(2B)-O(3B)																			1.456(3)		
												C(2B)-C(11B)																		1.529(4)		
												C(2B)-C(3B)																			1.538(4)		
												O(3B)-C(5B)																			1.464(3)		
												C(3B)-C(4B)																			1.529(4)		
												C(3B)-H(3B1)																		0.9900		
												C(3B)-H(3B2)																		0.9900		
												C(4B)-C(5B)																			1.539(4)		
												C(4B)-H(4B)																			1.0000		
												C(5B)-C(14B)																		1.510(4)		
												C(5B)-C(6B)																			1.532(4)		
												C(6B)-C(7B)																			1.513(4)		
												C(6B)-C(10B)																		1.541(4)		
												C(6B)-H(6B)																			1.0000		
												C(7B)-C(8B)																			1.332(4)		
												C(8B)-C(9B)																			1.502(4)		
												C(8B)-C(15B)																		1.514(4)		
												C(9B)-C(10B)																		1.537(4)		
												C(9B)-H(9B1)																		0.9900		
												C(9B)-H(9B2)																		0.9900		
												C(10B)-H(10C)																	0.9900		
												C(10B)-H(10D)																	0.9900		
												C(11B)-C(13B)																	1.517(4)		
												C(11B)-C(12B)																	1.550(4)		
												C(11B)-H(11B)																	1.0000		
												C(12B)-H(12D)																	0.9800		
												C(12B)-H(12E)																	0.9800		
												C(12B)-H(12F)																	0.9800		
												C(13B)-H(13D)																	0.9800		
												C(13B)-H(13E)																	0.9800		
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												C(13B)-H(13F)																	0.9800		
												C(14B)-H(14D)																	0.9800		
												C(14B)-H(14E)																	0.9800		
												C(14B)-H(14F)																	0.9800		
												C(15B)-H(15D)																	0.9800		
												C(15B)-H(15E)																	0.9800		
												C(15B)-H(15F)																	0.9800		
												O(1C)-C(1C)																			1.425(3)		
												O(1C)-H(1CC)																		0.880(19)		
												C(1C)-C(7C)																			1.498(4)		
												C(1C)-C(2C)																			1.544(4)		
												C(1C)-H(1C)																			1.0000		
												O(2C)-C(4C)																			1.443(3)		
												O(2C)-H(2C)																			0.85(4)		
												C(2C)-O(3C)																			1.456(3)		
												C(2C)-C(11C)																		1.534(4)		
												C(2C)-C(3C)																			1.541(4)		
												O(3C)-C(5C)																			1.469(3)		
												C(3C)-C(4C)																			1.539(4)		
												C(3C)-H(3C1)																		0.9900		
												C(3C)-H(3C2)																		0.9900		
												C(4C)-C(5C)																			1.530(4)		
												C(4C)-H(4C)																			1.0000		
												C(5C)-C(14C)																		1.508(4)		
												C(5C)-C(6C)																			1.529(4)		
												C(6C)-C(7C)																			1.529(4)		
												C(6C)-C(10C)																		1.543(4)		
												C(6C)-H(6C)																			1.0000		
												C(7C)-C(8C)																			1.321(4)		
												C(8C)-C(15C)																		1.507(4)		
												C(8C)-C(9C)																			1.521(4)		
												C(9C)-C(10C)																		1.546(4)		
												C(9C)-H(9C1)																		0.9900		
												C(9C)-H(9C2)																		0.9900		
												C(10C)-H(10E)																	0.9900		
												C(10C)-H(10F)																	0.9900		
												C(11C)-C(13C)																	1.529(4)		
												C(11C)-C(12C)																	1.534(4)		
												C(11C)-H(11C)																	1.0000		
												C(12C)-H(12G)																	0.9800		
												C(12C)-H(12H)																	0.9800		
												C(12C)-H(12I)																	0.9800		
												C(13C)-H(13G)																	0.9800		
												C(13C)-H(13H)																	0.9800		
												C(13C)-H(13I)																	0.9800		
												C(14C)-H(14G)																	0.9800		
												C(14C)-H(14H)																	0.9800		
												C(14C)-H(14I)																	0.9800		
												C(15C)-H(15G)																	0.9800		
												C(15C)-H(15H)																	0.9800		
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												C(15C)-H(15I)																	0.9800		
												O(1D)-C(1D)																			1.433(3)		
												O(1D)-H(1DD)																		0.91(4)		
												C(1D)-C(7D)																			1.504(4)		
												C(1D)-C(2D)																			1.552(4)		
												C(1D)-H(1D)																			1.0000		
												O(2D)-C(4D)																			1.439(3)		
												O(2D)-H(2D)																			0.92(3)		
												C(2D)-O(3D)																			1.449(3)		
												C(2D)-C(11D)																		1.531(4)		
												C(2D)-C(3D)																			1.532(4)		
												O(3D)-C(5D)																			1.450(3)		
												C(3D)-C(4D)																			1.536(4)		
												C(3D)-H(3D1)																		0.9900		
												C(3D)-H(3D2)																		0.9900		
												C(4D)-C(5D)																			1.550(4)		
												C(4D)-H(4D)																			1.0000		
												C(5D)-C(14D)																		1.508(4)		
												C(5D)-C(6D)																			1.537(4)		
												C(6D)-C(7D)																			1.513(4)		
												C(6D)-C(10D)																		1.553(4)		
												C(6D)-H(6D)																			1.0000		
												C(7D)-C(8D)																			1.324(4)		
												C(8D)-C(15D)																		1.501(4)		
												C(8D)-C(9D)																			1.506(4)		
												C(9D)-C(10D)																		1.536(4)		
												C(9D)-H(9D1)																		0.9900		
												C(9D)-H(9D2)																		0.9900		
												C(10D)-H(10G)																	0.9900		
												C(10D)-H(10H)																	0.9900		
												C(11D)-C(13D)																	1.513(4)		
												C(11D)-C(12D)																	1.536(4)		
												C(11D)-H(11D)																	1.0000		
												C(12D)-H(12J)																	0.9800		
												C(12D)-H(12K)																	0.9800		
												C(12D)-H(12L)																	0.9800		
												C(13D)-H(13J)																	0.9800		
												C(13D)-H(13K)																	0.9800		
												C(13D)-H(13L)																	0.9800		
												C(14D)-H(14J)																	0.9800		
												C(14D)-H(14K)																	0.9800		
												C(14D)-H(14L)																	0.9800		
												C(15D)-H(15J)																	0.9800		
												C(15D)-H(15K)																	0.9800		
												C(15D)-H(15L)																	0.9800		
												O(1E)-C(1E)																			1.425(3)		
												O(1E)-H(1EE)																		0.92(4)		
												C(1E)-C(7E)																			1.499(4)		
												C(1E)-C(2E)																			1.550(4)		
												C(1E)-H(1E)																			1.0000		
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												O(2E)-C(4E)																			1.434(3)		
												O(2E)-H(2E)																			0.88(3)		
												C(2E)-O(3E)																			1.461(3)		
												C(2E)-C(11E)																		1.529(4)		
												C(2E)-C(3E)																			1.538(4)		
												O(3E)-C(5E)																			1.459(3)		
												C(3E)-C(4E)																			1.534(4)		
												C(3E)-H(3E1)																		0.9900		
												C(3E)-H(3E2)																		0.9900		
												C(4E)-C(5E)																			1.543(4)		
												C(4E)-H(4E)																			1.0000		
												C(5E)-C(14E)																		1.515(4)		
												C(5E)-C(6E)																			1.531(4)		
												C(6E)-C(7E)																			1.519(4)		
												C(6E)-C(10E)																		1.541(4)		
												C(6E)-H(6E)																			1.0000		
												C(7E)-C(8E)																			1.326(4)		
												C(8E)-C(15E)																		1.505(4)		
												C(8E)-C(9E)																			1.506(4)		
												C(9E)-C(10E)																		1.540(4)		
												C(9E)-H(9E1)																		0.9900		
												C(9E)-H(9E2)																		0.9900		
												C(10E)-H(10I)																	0.9900		
												C(10E)-H(10J)																	0.9900		
												C(11E)-C(12E)																	1.519(4)		
												C(11E)-C(13E)																	1.537(4)		
												C(11E)-H(11E)																	1.0000		
												C(12E)-H(12M)																	0.9800		
												C(12E)-H(12N)																	0.9800		
												C(12E)-H(12O)																	0.9800		
												C(13E)-H(13M)																	0.9800		
												C(13E)-H(13N)																	0.9800		
												C(13E)-H(13O)																	0.9800		
												C(14E)-H(14M)																	0.9800		
												C(14E)-H(14N)																	0.9800		
												C(14E)-H(14O)																	0.9800		
												C(15E)-H(15M)																	0.9800		
												C(15E)-H(15N)																	0.9800		
												C(15E)-H(15O)																	0.9800		
												O(1F)-C(1F)																			1.429(3)		
												O(1F)-H(1FF)																		0.95(4)		
												C(1F)-C(7F)																			1.500(4)		
												C(1F)-C(2F)																			1.540(4)		
												C(1F)-H(1F)																			1.0000		
												O(2F)-C(4F)																			1.438(3)		
												O(2F)-H(2F)																			0.86(3)		
												C(2F)-O(3F)																			1.461(3)		
												C(2F)-C(3F)																			1.524(4)		
												C(2F)-C(11F)																		1.537(4)		
												O(3F)-C(5F)																			1.459(3)		
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												C(3F)-C(4F)																			1.533(4)		
												C(3F)-H(3F1)																		0.9900		
												C(3F)-H(3F2)																		0.9900		
												C(4F)-C(5F)																			1.552(4)		
												C(4F)-H(4F)																			1.0000		
												C(5F)-C(14F)																		1.512(4)		
												C(5F)-C(6F)																			1.525(4)		
												C(6F)-C(7F)																			1.513(4)		
												C(6F)-C(10F)																		1.539(4)		
												C(6F)-H(6F)																			1.0000		
												C(7F)-C(8F)																			1.321(4)		
												C(8F)-C(9F)																			1.501(5)		
												C(8F)-C(15F)																		1.509(4)		
												C(9F)-C(10F)																		1.535(4)		
												C(9F)-H(9F1)																		0.9900		
												C(9F)-H(9F2)																		0.9900		
												C(10F)-H(10K)																	0.9900		
												C(10F)-H(10L)																	0.9900		
												C(11F)-C(12F)																	1.496(4)		
												C(11F)-C(13F)																	1.538(5)		
												C(11F)-H(11F)																	1.0000		
												C(12F)-H(12P)																	0.9800		
												C(12F)-H(12Q)																	0.9800		
												C(12F)-H(12R)																	0.9800		
												C(13F)-H(13P)																	0.9800		
												C(13F)-H(13Q)																	0.9800		
												C(13F)-H(13R)																	0.9800		
												C(14F)-H(14P)																	0.9800		
												C(14F)-H(14Q)																	0.9800		
												C(14F)-H(14R)																	0.9800		
												C(15F)-H(15P)																	0.9800		
												C(15F)-H(15Q)																	0.9800		
												C(15F)-H(15R)																	0.9800		
												C(1A)-O(1A)-H(1AA)										106(3)		
												O(1A)-C(1A)-C(7A)											113.0(2)		
												O(1A)-C(1A)-C(2A)											108.0(2)		
												C(7A)-C(1A)-C(2A)											110.0(2)		
												O(1A)-C(1A)-H(1A)											108.6		
												C(7A)-C(1A)-H(1A)											108.6		
												C(2A)-C(1A)-H(1A)											108.6		
												C(4A)-O(2A)-H(2A)											107(2)		
												O(3A)-C(2A)-C(11A)										108.3(2)		
												O(3A)-C(2A)-C(3A)											103.3(2)		
												C(11A)-C(2A)-C(3A)										113.8(2)		
												O(3A)-C(2A)-C(1A)											107.8(2)		
												C(11A)-C(2A)-C(1A)										113.9(2)		
												C(3A)-C(2A)-C(1A)											109.1(2)		
												C(2A)-O(3A)-C(5A)											105.81(19)		
												C(2A)-C(3A)-C(4A)											105.8(2)		
												C(2A)-C(3A)-H(3A1)										110.6		
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												C(4A)-C(3A)-H(3A1)										110.6		
												C(2A)-C(3A)-H(3A2)										110.6		
												C(4A)-C(3A)-H(3A2)										110.6		
												H(3A1)-C(3A)-H(3A2)									108.7		
												O(2A)-C(4A)-C(3A)											111.2(2)		
												O(2A)-C(4A)-C(5A)											111.3(2)		
												C(3A)-C(4A)-C(5A)											103.7(2)		
												O(2A)-C(4A)-H(4A)											110.1		
												C(3A)-C(4A)-H(4A)											110.1		
												C(5A)-C(4A)-H(4A)											110.1		
												O(3A)-C(5A)-C(6A)											105.7(2)		
												O(3A)-C(5A)-C(14A)										107.4(2)		
												C(6A)-C(5A)-C(14A)										112.8(2)		
												O(3A)-C(5A)-C(4A)											103.1(2)		
												C(6A)-C(5A)-C(4A)											111.3(2)		
												C(14A)-C(5A)-C(4A)										115.5(2)		
												C(7A)-C(6A)-C(5A)											111.9(2)		
												C(7A)-C(6A)-C(10A)										103.5(2)		
												C(5A)-C(6A)-C(10A)										118.4(2)		
												C(7A)-C(6A)-H(6A)											107.5		
												C(5A)-C(6A)-H(6A)											107.5		
												C(10A)-C(6A)-H(6A)										107.5		
												C(8A)-C(7A)-C(1A)											132.3(3)		
												C(8A)-C(7A)-C(6A)											111.8(3)		
												C(1A)-C(7A)-C(6A)											115.8(2)		
												C(7A)-C(8A)-C(9A)											112.0(3)		
												C(7A)-C(8A)-C(15A)										129.2(3)		
												C(9A)-C(8A)-C(15A)										118.7(3)		
												C(8A)-C(9A)-C(10A)										104.3(2)		
												C(8A)-C(9A)-H(9A1)										110.9		
												C(10A)-C(9A)-H(9A1)									110.9		
												C(8A)-C(9A)-H(9A2)										110.9		
												C(10A)-C(9A)-H(9A2)									110.9		
												H(9A1)-C(9A)-H(9A2)									108.9		
												C(9A)-C(10A)-C(6A)										105.5(2)		
												C(9A)-C(10A)-H(10A)									110.6		
												C(6A)-C(10A)-H(10A)									110.6		
												C(9A)-C(10A)-H(10B)									110.6		
												C(6A)-C(10A)-H(10B)									110.6		
												H(10A)-C(10A)-H(10B)								108.8		
												C(12A)-C(11A)-C(2A)									112.8(2)		
												C(12A)-C(11A)-C(13A)								108.3(2)		
												C(2A)-C(11A)-C(13A)									113.6(2)		
												C(12A)-C(11A)-H(11A)								107.3		
												C(2A)-C(11A)-H(11A)									107.3		
												C(13A)-C(11A)-H(11A)								107.3		
												C(11A)-C(12A)-H(12A)								109.5		
												C(11A)-C(12A)-H(12B)								109.5		
												H(12A)-C(12A)-H(12B)								109.5		
												C(11A)-C(12A)-H(12C)								109.5		
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												H(12A)-C(12A)-H(12C)								109.5		
												H(12B)-C(12A)-H(12C)								109.5		
												C(11A)-C(13A)-H(13A)								109.5		
												C(11A)-C(13A)-H(13B)								109.5		
												H(13A)-C(13A)-H(13B)								109.5		
												C(11A)-C(13A)-H(13C)								109.5		
												H(13A)-C(13A)-H(13C)								109.5		
												H(13B)-C(13A)-H(13C)								109.5		
												C(5A)-C(14A)-H(14A)									109.5		
												C(5A)-C(14A)-H(14B)									109.5		
												H(14A)-C(14A)-H(14B)								109.5		
												C(5A)-C(14A)-H(14C)									109.5		
												H(14A)-C(14A)-H(14C)								109.5		
												H(14B)-C(14A)-H(14C)								109.5		
												C(8A)-C(15A)-H(15A)									109.5		
												C(8A)-C(15A)-H(15B)									109.5		
												H(15A)-C(15A)-H(15B)								109.5		
												C(8A)-C(15A)-H(15C)									109.5		
												H(15A)-C(15A)-H(15C)								109.5		
												H(15B)-C(15A)-H(15C)								109.5		
												C(1B)-O(1B)-H(1BB)										109(2)		
												O(1B)-C(1B)-C(7B)											114.3(2)		
												O(1B)-C(1B)-C(2B)											108.2(2)		
												C(7B)-C(1B)-C(2B)											108.4(2)		
												O(1B)-C(1B)-H(1B)											108.6		
												C(7B)-C(1B)-H(1B)											108.6		
												C(2B)-C(1B)-H(1B)											108.6		
												C(4B)-O(2B)-H(2B)											107(2)		
												O(3B)-C(2B)-C(11B)										109.0(2)		
												O(3B)-C(2B)-C(3B)											103.6(2)		
												C(11B)-C(2B)-C(3B)										114.1(2)		
												O(3B)-C(2B)-C(1B)											106.4(2)		
												C(11B)-C(2B)-C(1B)										113.7(2)		
												C(3B)-C(2B)-C(1B)											109.3(2)		
												C(2B)-O(3B)-C(5B)											106.10(18)		
												C(4B)-C(3B)-C(2B)											105.7(2)		
												C(4B)-C(3B)-H(3B1)										110.6		
												C(2B)-C(3B)-H(3B1)										110.6		
												C(4B)-C(3B)-H(3B2)										110.6		
												C(2B)-C(3B)-H(3B2)										110.6		
												H(3B1)-C(3B)-H(3B2)									108.7		
												O(2B)-C(4B)-C(3B)											111.6(2)		
												O(2B)-C(4B)-C(5B)											111.2(2)		
												C(3B)-C(4B)-C(5B)											104.4(2)		
												O(2B)-C(4B)-H(4B)											109.8		
												C(3B)-C(4B)-H(4B)											109.8		
												C(5B)-C(4B)-H(4B)											109.8		
												O(3B)-C(5B)-C(14B)										107.3(2)		
												O(3B)-C(5B)-C(6B)											105.3(2)		
												C(14B)-C(5B)-C(6B)										112.8(2)		
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												O(3B)-C(5B)-C(4B)											102.7(2)		
												C(14B)-C(5B)-C(4B)										116.2(2)		
												C(6B)-C(5B)-C(4B)											111.4(2)		
												C(7B)-C(6B)-C(5B)											110.7(2)		
												C(7B)-C(6B)-C(10B)										104.6(2)		
												C(5B)-C(6B)-C(10B)										116.4(2)		
												C(7B)-C(6B)-H(6B)											108.3		
												C(5B)-C(6B)-H(6B)											108.3		
												C(10B)-C(6B)-H(6B)										108.3		
												C(8B)-C(7B)-C(1B)											132.6(3)		
												C(8B)-C(7B)-C(6B)											111.6(3)		
												C(1B)-C(7B)-C(6B)											115.8(2)		
												C(7B)-C(8B)-C(9B)											111.9(3)		
												C(7B)-C(8B)-C(15B)										129.5(3)		
												C(9B)-C(8B)-C(15B)										118.5(3)		
												C(8B)-C(9B)-C(10B)										105.1(2)		
												C(8B)-C(9B)-H(9B1)										110.7		
												C(10B)-C(9B)-H(9B1)									110.7		
												C(8B)-C(9B)-H(9B2)										110.7		
												C(10B)-C(9B)-H(9B2)									110.7		
												H(9B1)-C(9B)-H(9B2)									108.8		
												C(9B)-C(10B)-C(6B)										105.5(3)		
												C(9B)-C(10B)-H(10C)									110.6		
												C(6B)-C(10B)-H(10C)									110.6		
												C(9B)-C(10B)-H(10D)									110.6		
												C(6B)-C(10B)-H(10D)									110.6		
												H(10C)-C(10B)-H(10D)								108.8		
												C(13B)-C(11B)-C(2B)									114.0(2)		
												C(13B)-C(11B)-C(12B)								108.1(2)		
												C(2B)-C(11B)-C(12B)									111.6(2)		
												C(13B)-C(11B)-H(11B)								107.6		
												C(2B)-C(11B)-H(11B)									107.6		
												C(12B)-C(11B)-H(11B)								107.6		
												C(11B)-C(12B)-H(12D)								109.5		
												C(11B)-C(12B)-H(12E)								109.5		
												H(12D)-C(12B)-H(12E)								109.5		
												C(11B)-C(12B)-H(12F)								109.5		
												H(12D)-C(12B)-H(12F)								109.5		
												H(12E)-C(12B)-H(12F)								109.5		
												C(11B)-C(13B)-H(13D)								109.5		
												C(11B)-C(13B)-H(13E)								109.5		
												H(13D)-C(13B)-H(13E)								109.5		
												C(11B)-C(13B)-H(13F)								109.5		
												H(13D)-C(13B)-H(13F)								109.5		
												H(13E)-C(13B)-H(13F)								109.5		
												C(5B)-C(14B)-H(14D)									109.5		
												C(5B)-C(14B)-H(14E)									109.5		
												H(14D)-C(14B)-H(14E)								109.5		
												C(5B)-C(14B)-H(14F)									109.5		
												H(14D)-C(14B)-H(14F)								109.5		
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												H(14E)-C(14B)-H(14F)								109.5		
												C(8B)-C(15B)-H(15D)									109.5		
												C(8B)-C(15B)-H(15E)									109.5		
												H(15D)-C(15B)-H(15E)								109.5		
												C(8B)-C(15B)-H(15F)									109.5		
												H(15D)-C(15B)-H(15F)								109.5		
												H(15E)-C(15B)-H(15F)								109.5		
												C(1C)-O(1C)-H(1CC)										105(3)		
												O(1C)-C(1C)-C(7C)											114.3(2)		
												O(1C)-C(1C)-C(2C)											108.4(2)		
												C(7C)-C(1C)-C(2C)											108.9(2)		
												O(1C)-C(1C)-H(1C)											108.4		
												C(7C)-C(1C)-H(1C)											108.4		
												C(2C)-C(1C)-H(1C)											108.4		
												C(4C)-O(2C)-H(2C)											108(2)		
												O(3C)-C(2C)-C(11C)										108.7(2)		
												O(3C)-C(2C)-C(3C)											103.8(2)		
												C(11C)-C(2C)-C(3C)										113.8(2)		
												O(3C)-C(2C)-C(1C)											106.2(2)		
												C(11C)-C(2C)-C(1C)										114.1(2)		
												C(3C)-C(2C)-C(1C)											109.3(2)		
												C(2C)-O(3C)-C(5C)											106.1(2)		
												C(4C)-C(3C)-C(2C)											105.2(2)		
												C(4C)-C(3C)-H(3C1)										110.7		
												C(2C)-C(3C)-H(3C1)										110.7		
												C(4C)-C(3C)-H(3C2)										110.7		
												C(2C)-C(3C)-H(3C2)										110.7		
												H(3C1)-C(3C)-H(3C2)									108.8		
												O(2C)-C(4C)-C(5C)											110.4(2)		
												O(2C)-C(4C)-C(3C)											110.8(2)		
												C(5C)-C(4C)-C(3C)											104.7(2)		
												O(2C)-C(4C)-H(4C)											110.3		
												C(5C)-C(4C)-H(4C)											110.3		
												C(3C)-C(4C)-H(4C)											110.3		
												O(3C)-C(5C)-C(14C)										107.5(2)		
												O(3C)-C(5C)-C(6C)											105.4(2)		
												C(14C)-C(5C)-C(6C)										112.4(2)		
												O(3C)-C(5C)-C(4C)											102.6(2)		
												C(14C)-C(5C)-C(4C)										115.8(2)		
												C(6C)-C(5C)-C(4C)											112.0(2)		
												C(7C)-C(6C)-C(5C)											110.8(2)		
												C(7C)-C(6C)-C(10C)										104.1(2)		
												C(5C)-C(6C)-C(10C)										117.2(2)		
												C(7C)-C(6C)-H(6C)											108.1		
												C(5C)-C(6C)-H(6C)											108.1		
												C(10C)-C(6C)-H(6C)										108.1		
												C(8C)-C(7C)-C(1C)											132.1(3)		
												C(8C)-C(7C)-C(6C)											111.9(3)		
												C(1C)-C(7C)-C(6C)											115.9(2)		
												C(7C)-C(8C)-C(15C)										129.1(3)		
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												C(7C)-C(8C)-C(9C)											112.1(3)		
												C(15C)-C(8C)-C(9C)										118.7(3)		
												C(8C)-C(9C)-C(10C)										104.3(2)		
												C(8C)-C(9C)-H(9C1)										110.9		
												C(10C)-C(9C)-H(9C1)									110.9		
												C(8C)-C(9C)-H(9C2)										110.9		
												C(10C)-C(9C)-H(9C2)									110.9		
												H(9C1)-C(9C)-H(9C2)									108.9		
												C(6C)-C(10C)-C(9C)										105.8(2)		
												C(6C)-C(10C)-H(10E)									110.6		
												C(9C)-C(10C)-H(10E)									110.6		
												C(6C)-C(10C)-H(10F)									110.6		
												C(9C)-C(10C)-H(10F)									110.6		
												H(10E)-C(10C)-H(10F)								108.7		
												C(13C)-C(11C)-C(2C)									114.7(2)		
												C(13C)-C(11C)-C(12C)								109.4(2)		
												C(2C)-C(11C)-C(12C)									111.3(2)		
												C(13C)-C(11C)-H(11C)								107.0		
												C(2C)-C(11C)-H(11C)									107.0		
												C(12C)-C(11C)-H(11C)								107.0		
												C(11C)-C(12C)-H(12G)								109.5		
												C(11C)-C(12C)-H(12H)								109.5		
												H(12G)-C(12C)-H(12H)								109.5		
												C(11C)-C(12C)-H(12I)								109.5		
												H(12G)-C(12C)-H(12I)								109.5		
												H(12H)-C(12C)-H(12I)								109.5		
												C(11C)-C(13C)-H(13G)								109.5		
												C(11C)-C(13C)-H(13H)								109.5		
												H(13G)-C(13C)-H(13H)								109.5		
												C(11C)-C(13C)-H(13I)								109.5		
												H(13G)-C(13C)-H(13I)								109.5		
												H(13H)-C(13C)-H(13I)								109.5		
												C(5C)-C(14C)-H(14G)									109.5		
												C(5C)-C(14C)-H(14H)									109.5		
												H(14G)-C(14C)-H(14H)								109.5		
												C(5C)-C(14C)-H(14I)									109.5		
												H(14G)-C(14C)-H(14I)								109.5		
												H(14H)-C(14C)-H(14I)								109.5		
												C(8C)-C(15C)-H(15G)									109.5		
												C(8C)-C(15C)-H(15H)									109.5		
												H(15G)-C(15C)-H(15H)								109.5		
												C(8C)-C(15C)-H(15I)									109.5		
												H(15G)-C(15C)-H(15I)								109.5		
												H(15H)-C(15C)-H(15I)								109.5		
												C(1D)-O(1D)-H(1DD)										109(3)		
												O(1D)-C(1D)-C(7D)											112.3(2)		
												O(1D)-C(1D)-C(2D)											109.9(2)		
												C(7D)-C(1D)-C(2D)											108.3(2)		
												O(1D)-C(1D)-H(1D)											108.8		
												C(7D)-C(1D)-H(1D)											108.8		
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												C(2D)-C(1D)-H(1D)											108.8		
												C(4D)-O(2D)-H(2D)											105.2(19)		
												O(3D)-C(2D)-C(11D)										108.8(2)		
												O(3D)-C(2D)-C(3D)											103.8(2)		
												C(11D)-C(2D)-C(3D)										113.7(2)		
												O(3D)-C(2D)-C(1D)											107.2(2)		
												C(11D)-C(2D)-C(1D)										113.1(2)		
												C(3D)-C(2D)-C(1D)											109.5(2)		
												C(2D)-O(3D)-C(5D)											105.8(2)		
												C(2D)-C(3D)-C(4D)											105.6(2)		
												C(2D)-C(3D)-H(3D1)										110.6		
												C(4D)-C(3D)-H(3D1)										110.6		
												C(2D)-C(3D)-H(3D2)										110.6		
												C(4D)-C(3D)-H(3D2)										110.6		
												H(3D1)-C(3D)-H(3D2)									108.8		
												O(2D)-C(4D)-C(3D)											111.7(2)		
												O(2D)-C(4D)-C(5D)											110.7(2)		
												C(3D)-C(4D)-C(5D)											103.5(2)		
												O(2D)-C(4D)-H(4D)											110.2		
												C(3D)-C(4D)-H(4D)											110.2		
												C(5D)-C(4D)-H(4D)											110.2		
												O(3D)-C(5D)-C(14D)										107.7(2)		
												O(3D)-C(5D)-C(6D)											105.7(2)		
												C(14D)-C(5D)-C(6D)										112.9(2)		
												O(3D)-C(5D)-C(4D)											103.8(2)		
												C(14D)-C(5D)-C(4D)										116.1(2)		
												C(6D)-C(5D)-C(4D)											109.6(2)		
												C(7D)-C(6D)-C(5D)											110.9(2)		
												C(7D)-C(6D)-C(10D)										104.2(2)		
												C(5D)-C(6D)-C(10D)										116.8(2)		
												C(7D)-C(6D)-H(6D)											108.2		
												C(5D)-C(6D)-H(6D)											108.2		
												C(10D)-C(6D)-H(6D)										108.2		
												C(8D)-C(7D)-C(1D)											133.2(3)		
												C(8D)-C(7D)-C(6D)											112.3(3)		
												C(1D)-C(7D)-C(6D)											114.5(2)		
												C(7D)-C(8D)-C(15D)										129.3(3)		
												C(7D)-C(8D)-C(9D)											112.0(3)		
												C(15D)-C(8D)-C(9D)										118.7(3)		
												C(8D)-C(9D)-C(10D)										105.1(3)		
												C(8D)-C(9D)-H(9D1)										110.7		
												C(10D)-C(9D)-H(9D1)									110.7		
												C(8D)-C(9D)-H(9D2)										110.7		
												C(10D)-C(9D)-H(9D2)									110.7		
												H(9D1)-C(9D)-H(9D2)									108.8		
												C(9D)-C(10D)-C(6D)										105.7(3)		
												C(9D)-C(10D)-H(10G)									110.6		
												C(6D)-C(10D)-H(10G)									110.6		
												C(9D)-C(10D)-H(10H)									110.6		
												C(6D)-C(10D)-H(10H)									110.6		
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												H(10G)-C(10D)-H(10H)								108.7		
												C(13D)-C(11D)-C(2D)									113.8(2)		
												C(13D)-C(11D)-C(12D)								107.8(3)		
												C(2D)-C(11D)-C(12D)									112.3(2)		
												C(13D)-C(11D)-H(11D)								107.6		
												C(2D)-C(11D)-H(11D)									107.6		
												C(12D)-C(11D)-H(11D)								107.6		
												C(11D)-C(12D)-H(12J)								109.5		
												C(11D)-C(12D)-H(12K)								109.5		
												H(12J)-C(12D)-H(12K)								109.5		
												C(11D)-C(12D)-H(12L)								109.5		
												H(12J)-C(12D)-H(12L)								109.5		
												H(12K)-C(12D)-H(12L)								109.5		
												C(11D)-C(13D)-H(13J)								109.5		
												C(11D)-C(13D)-H(13K)								109.5		
												H(13J)-C(13D)-H(13K)								109.5		
												C(11D)-C(13D)-H(13L)								109.5		
												H(13J)-C(13D)-H(13L)								109.5		
												H(13K)-C(13D)-H(13L)								109.5		
												C(5D)-C(14D)-H(14J)									109.5		
												C(5D)-C(14D)-H(14K)									109.5		
												H(14J)-C(14D)-H(14K)								109.5		
												C(5D)-C(14D)-H(14L)									109.5		
												H(14J)-C(14D)-H(14L)								109.5		
												H(14K)-C(14D)-H(14L)								109.5		
												C(8D)-C(15D)-H(15J)									109.5		
												C(8D)-C(15D)-H(15K)									109.5		
												H(15J)-C(15D)-H(15K)								109.5		
												C(8D)-C(15D)-H(15L)									109.5		
												H(15J)-C(15D)-H(15L)								109.5		
												H(15K)-C(15D)-H(15L)								109.5		
												C(1E)-O(1E)-H(1EE)										111(2)		
												O(1E)-C(1E)-C(7E)											113.3(2)		
												O(1E)-C(1E)-C(2E)											108.4(2)		
												C(7E)-C(1E)-C(2E)											109.1(2)		
												O(1E)-C(1E)-H(1E)											108.6		
												C(7E)-C(1E)-H(1E)											108.6		
												C(2E)-C(1E)-H(1E)											108.6		
												C(4E)-O(2E)-H(2E)											109(2)		
												O(3E)-C(2E)-C(11E)										109.5(2)		
												O(3E)-C(2E)-C(3E)											104.0(2)		
												C(11E)-C(2E)-C(3E)										113.7(2)		
												O(3E)-C(2E)-C(1E)											106.6(2)		
												C(11E)-C(2E)-C(1E)										113.3(2)		
												C(3E)-C(2E)-C(1E)											109.1(2)		
												C(5E)-O(3E)-C(2E)											105.59(19)		
												C(4E)-C(3E)-C(2E)											105.6(2)		
												C(4E)-C(3E)-H(3E1)										110.6		
												C(2E)-C(3E)-H(3E1)										110.6		
												C(4E)-C(3E)-H(3E2)										110.6		
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												C(2E)-C(3E)-H(3E2)										110.6		
												H(3E1)-C(3E)-H(3E2)									108.7		
												O(2E)-C(4E)-C(3E)											110.8(2)		
												O(2E)-C(4E)-C(5E)											110.9(2)		
												C(3E)-C(4E)-C(5E)											103.9(2)		
												O(2E)-C(4E)-H(4E)											110.4		
												C(3E)-C(4E)-H(4E)											110.4		
												C(5E)-C(4E)-H(4E)											110.4		
												O(3E)-C(5E)-C(14E)										107.5(2)		
												O(3E)-C(5E)-C(6E)											105.9(2)		
												C(14E)-C(5E)-C(6E)										112.5(2)		
												O(3E)-C(5E)-C(4E)											103.1(2)		
												C(14E)-C(5E)-C(4E)										115.4(2)		
												C(6E)-C(5E)-C(4E)											111.5(2)		
												C(7E)-C(6E)-C(5E)											111.5(2)		
												C(7E)-C(6E)-C(10E)										103.9(2)		
												C(5E)-C(6E)-C(10E)										118.0(2)		
												C(7E)-C(6E)-H(6E)											107.6		
												C(5E)-C(6E)-H(6E)											107.6		
												C(10E)-C(6E)-H(6E)										107.6		
												C(8E)-C(7E)-C(1E)											132.0(3)		
												C(8E)-C(7E)-C(6E)											111.6(3)		
												C(1E)-C(7E)-C(6E)											116.4(3)		
												C(7E)-C(8E)-C(15E)										128.8(3)		
												C(7E)-C(8E)-C(9E)											112.0(3)		
												C(15E)-C(8E)-C(9E)										119.0(3)		
												C(8E)-C(9E)-C(10E)										104.5(2)		
												C(8E)-C(9E)-H(9E1)										110.9		
												C(10E)-C(9E)-H(9E1)									110.9		
												C(8E)-C(9E)-H(9E2)										110.9		
												C(10E)-C(9E)-H(9E2)									110.9		
												H(9E1)-C(9E)-H(9E2)									108.9		
												C(9E)-C(10E)-C(6E)										105.4(2)		
												C(9E)-C(10E)-H(10I)									110.7		
												C(6E)-C(10E)-H(10I)									110.7		
												C(9E)-C(10E)-H(10J)									110.7		
												C(6E)-C(10E)-H(10J)									110.7		
												H(10I)-C(10E)-H(10J)								108.8		
												C(12E)-C(11E)-C(2E)									114.2(2)		
												C(12E)-C(11E)-C(13E)								108.9(3)		
												C(2E)-C(11E)-C(13E)									111.5(2)		
												C(12E)-C(11E)-H(11E)								107.3		
												C(2E)-C(11E)-H(11E)									107.3		
												C(13E)-C(11E)-H(11E)								107.3		
												C(11E)-C(12E)-H(12M)								109.5		
												C(11E)-C(12E)-H(12N)								109.5		
												H(12M)-C(12E)-H(12N)								109.5		
												C(11E)-C(12E)-H(12O)								109.5		
												H(12M)-C(12E)-H(12O)								109.5		
												H(12N)-C(12E)-H(12O)								109.5		
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												C(11E)-C(13E)-H(13M)								109.5		
												C(11E)-C(13E)-H(13N)								109.5		
												H(13M)-C(13E)-H(13N)								109.5		
												C(11E)-C(13E)-H(13O)								109.5		
												H(13M)-C(13E)-H(13O)								109.5		
												H(13N)-C(13E)-H(13O)								109.5		
												C(5E)-C(14E)-H(14M)									109.5		
												C(5E)-C(14E)-H(14N)									109.5		
												H(14M)-C(14E)-H(14N)								109.5		
												C(5E)-C(14E)-H(14O)									109.5		
												H(14M)-C(14E)-H(14O)								109.5		
												H(14N)-C(14E)-H(14O)								109.5		
												C(8E)-C(15E)-H(15M)									109.5		
												C(8E)-C(15E)-H(15N)									109.5		
												H(15M)-C(15E)-H(15N)								109.5		
												C(8E)-C(15E)-H(15O)									109.5		
												H(15M)-C(15E)-H(15O)								109.5		
												H(15N)-C(15E)-H(15O)								109.5		
												C(1F)-O(1F)-H(1FF)										108(2)		
												O(1F)-C(1F)-C(7F)											112.3(2)		
												O(1F)-C(1F)-C(2F)											110.0(2)		
												C(7F)-C(1F)-C(2F)											110.2(2)		
												O(1F)-C(1F)-H(1F)											108.0		
												C(7F)-C(1F)-H(1F)											108.0		
												C(2F)-C(1F)-H(1F)											108.0		
												C(4F)-O(2F)-H(2F)											111(2)		
												O(3F)-C(2F)-C(3F)											102.1(2)		
												O(3F)-C(2F)-C(11F)										107.6(2)		
												C(3F)-C(2F)-C(11F)										116.5(3)		
												O(3F)-C(2F)-C(1F)											106.2(2)		
												C(3F)-C(2F)-C(1F)											111.7(2)		
												C(11F)-C(2F)-C(1F)										111.6(3)		
												C(5F)-O(3F)-C(2F)											106.61(19)		
												C(2F)-C(3F)-C(4F)											106.5(2)		
												C(2F)-C(3F)-H(3F1)										110.4		
												C(4F)-C(3F)-H(3F1)										110.4		
												C(2F)-C(3F)-H(3F2)										110.4		
												C(4F)-C(3F)-H(3F2)										110.4		
												H(3F1)-C(3F)-H(3F2)									108.6		
												O(2F)-C(4F)-C(3F)											110.9(2)		
												O(2F)-C(4F)-C(5F)											111.5(2)		
												C(3F)-C(4F)-C(5F)											104.0(2)		
												O(2F)-C(4F)-H(4F)											110.1		
												C(3F)-C(4F)-H(4F)											110.1		
												C(5F)-C(4F)-H(4F)											110.1		
												O(3F)-C(5F)-C(14F)										107.7(2)		
												O(3F)-C(5F)-C(6F)											105.2(2)		
												C(14F)-C(5F)-C(6F)										112.9(2)		
												O(3F)-C(5F)-C(4F)											103.1(2)		
												C(14F)-C(5F)-C(4F)										115.9(2)		
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												C(6F)-C(5F)-C(4F)											110.9(2)		
												C(7F)-C(6F)-C(5F)											110.8(2)		
												C(7F)-C(6F)-C(10F)										103.8(2)		
												C(5F)-C(6F)-C(10F)										117.4(2)		
												C(7F)-C(6F)-H(6F)											108.1		
												C(5F)-C(6F)-H(6F)											108.1		
												C(10F)-C(6F)-H(6F)										108.1		
												C(8F)-C(7F)-C(1F)											131.8(3)		
												C(8F)-C(7F)-C(6F)											111.9(3)		
												C(1F)-C(7F)-C(6F)											116.3(2)		
												C(7F)-C(8F)-C(9F)											112.0(3)		
												C(7F)-C(8F)-C(15F)										129.4(3)		
												C(9F)-C(8F)-C(15F)										118.4(3)		
												C(8F)-C(9F)-C(10F)										104.6(3)		
												C(8F)-C(9F)-H(9F1)										110.8		
												C(10F)-C(9F)-H(9F1)									110.8		
												C(8F)-C(9F)-H(9F2)										110.8		
												C(10F)-C(9F)-H(9F2)									110.8		
												H(9F1)-C(9F)-H(9F2)									108.9		
												C(9F)-C(10F)-C(6F)										105.5(3)		
												C(9F)-C(10F)-H(10K)									110.6		
												C(6F)-C(10F)-H(10K)									110.6		
												C(9F)-C(10F)-H(10L)									110.6		
												C(6F)-C(10F)-H(10L)									110.6		
												H(10K)-C(10F)-H(10L)								108.8		
												C(12F)-C(11F)-C(2F)									113.2(3)		
												C(12F)-C(11F)-C(13F)								108.7(3)		
												C(2F)-C(11F)-C(13F)									112.7(3)		
												C(12F)-C(11F)-H(11F)								107.3		
												C(2F)-C(11F)-H(11F)									107.3		
												C(13F)-C(11F)-H(11F)								107.3		
												C(11F)-C(12F)-H(12P)								109.5		
												C(11F)-C(12F)-H(12Q)								109.5		
												H(12P)-C(12F)-H(12Q)								109.5		
												C(11F)-C(12F)-H(12R)								109.5		
												H(12P)-C(12F)-H(12R)								109.5		
												H(12Q)-C(12F)-H(12R)								109.5		
												C(11F)-C(13F)-H(13P)								109.5		
												C(11F)-C(13F)-H(13Q)								109.5		
												H(13P)-C(13F)-H(13Q)								109.5		
												C(11F)-C(13F)-H(13R)								109.5		
												H(13P)-C(13F)-H(13R)								109.5		
												H(13Q)-C(13F)-H(13R)								109.5		
												C(5F)-C(14F)-H(14P)									109.5		
												C(5F)-C(14F)-H(14Q)									109.5		
												H(14P)-C(14F)-H(14Q)								109.5		
												C(5F)-C(14F)-H(14R)									109.5		
												H(14P)-C(14F)-H(14R)								109.5		
												H(14Q)-C(14F)-H(14R)								109.5		
												C(8F)-C(15F)-H(15P)									109.5		
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												C(8F)-C(15F)-H(15Q)									109.5		
												H(15P)-C(15F)-H(15Q)								109.5		
												C(8F)-C(15F)-H(15R)									109.5		
												H(15P)-C(15F)-H(15R)								109.5		
												H(15Q)-C(15F)-H(15R)								109.5		
											_____________________________________________________________		
			
											Symmetry	transformations	used	to	generate	equivalent	atoms:		
													
	
				Table	4.		Anisotropic	displacement	parameters	(A^2	x	10^3)	for	s2644lc.		
				The	anisotropic	displacement	factor	exponent	takes	the	form:		
				-2	pi^2	[	h^2	a*^2	U11	+	...	+	2	h	k	a*	b*	U12	]		
			
_______________________________________________________________________		
														U11								U22								U33								U23								U13								U12		
_______________________________________________________________________		
				O(1A)				19(1)						30(1)						34(1)							3(1)							2(1)							4(1)		
				C(1A)				22(2)						22(2)						27(2)						-2(1)							7(1)							0(1)		
				O(2A)				17(1)						26(1)						37(1)						-2(1)							9(1)						-4(1)		
				C(2A)				19(2)						17(2)						25(2)							5(1)							5(1)							5(1)		
				O(3A)				20(1)						19(1)						25(1)							2(1)							3(1)							1(1)		
				C(3A)				20(2)						22(2)						26(2)							3(1)							6(1)							0(1)		
				C(4A)				17(2)						23(2)						31(2)							0(1)						11(1)							2(1)		
				C(5A)				17(2)						25(2)						24(2)							0(1)							5(1)						-1(1)		
				C(6A)				21(2)						27(2)						25(2)							0(1)							7(1)						-3(1)		
				C(7A)				21(2)						21(2)						28(2)							1(1)						11(1)						-3(1)		
				C(8A)				29(2)						24(2)						33(2)							0(1)						17(2)						-1(1)		
				C(9A)				46(2)						37(2)						35(2)						-6(2)						23(2)						-3(2)		
				C(10A)			35(2)						42(2)						29(2)						-4(2)						16(2)						-8(2)		
				C(11A)			22(2)						22(2)						26(2)							2(1)							7(1)							0(1)		
				C(12A)			37(2)						41(2)						37(2)							0(2)						23(2)							3(2)		
				C(13A)			31(2)						31(2)						27(2)						-4(1)						10(1)							2(2)		
				C(14A)			24(2)						30(2)						31(2)							4(1)							5(1)						-3(1)		
				C(15A)			38(2)						29(2)						49(2)							0(2)						25(2)							5(2)		
				O(1B)				19(1)						32(1)						39(1)							6(1)							9(1)							4(1)		
				C(1B)				19(2)						23(2)						28(2)							5(1)						11(1)							4(1)		
				O(2B)				21(1)						31(1)						21(1)							4(1)							7(1)						-6(1)		
				C(2B)				18(2)						20(2)						24(2)							3(1)							8(1)							4(1)		
				O(3B)				20(1)						20(1)						22(1)							4(1)						10(1)							1(1)		
				C(3B)				27(2)						19(2)						25(2)							6(1)							9(1)							1(1)		
				C(4B)				16(2)						22(2)						21(2)							1(1)							6(1)						-4(1)		
				C(5B)				22(2)						24(2)						23(2)							3(1)						13(1)						-1(1)		
				C(6B)				26(2)						18(2)						32(2)							3(1)						15(1)						-5(1)		
				C(7B)				23(2)						22(2)						24(2)							4(1)						10(1)						-5(1)		
				C(8B)				35(2)						28(2)						28(2)							1(1)						10(2)						-6(2)		
				C(9B)				54(2)						37(2)						27(2)						-5(2)						16(2)						-3(2)		
				C(10B)			40(2)						29(2)						35(2)						-6(2)						20(2)					-10(2)		
				C(11B)			29(2)						20(2)						30(2)							1(1)						13(1)						-2(1)		
				C(12B)			40(2)						32(2)						34(2)						-8(2)						10(2)						-7(2)		
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				C(13B)			40(2)						33(2)						29(2)							0(2)						16(2)							0(2)		
				C(14B)			29(2)						27(2)						32(2)							7(1)						17(1)							3(1)		
				C(15B)			43(2)						57(2)						28(2)							7(2)						-1(2)						-1(2)		
				O(1C)				21(1)						42(1)						29(1)							3(1)							9(1)						-6(1)		
				C(1C)				22(2)						27(2)						18(1)						-2(1)							7(1)						-2(1)		
				O(2C)				21(1)						31(1)						21(1)						-6(1)							1(1)							4(1)		
				C(2C)				18(2)						28(2)						21(1)						-1(1)							9(1)						-2(1)		
				O(3C)				22(1)						24(1)						20(1)						-4(1)							9(1)						-2(1)		
				C(3C)				26(2)						28(2)						17(1)						-1(1)							7(1)							1(1)		
				C(4C)				17(2)						25(2)						21(2)						-1(1)							4(1)							3(1)		
				C(5C)				20(2)						20(2)						23(2)						-5(1)							6(1)						-5(1)		
				C(6C)				27(2)						27(2)						18(2)							1(1)							5(1)							1(1)		
				C(7C)				20(2)						34(2)						16(2)						-2(1)							3(1)							1(2)		
				C(8C)				26(2)						35(2)						16(2)						-6(1)							4(1)						-1(2)		
				C(9C)				38(2)						31(2)						37(2)						-6(2)							9(2)							3(2)		
				C(10C)			31(2)						24(2)						28(2)							2(1)							4(1)							0(1)		
				C(11C)			27(2)						28(2)						24(2)							1(1)						12(1)							1(1)		
				C(12C)			36(2)						34(2)						33(2)							8(2)						13(2)							7(2)		
				C(13C)			38(2)						25(2)						36(2)						-4(1)						13(2)						-2(2)		
				C(14C)			28(2)						34(2)						25(2)						-5(1)							9(1)						-6(1)		
				C(15C)			33(2)						50(2)						35(2)					-10(2)						13(2)							5(2)		
				O(1D)				20(1)						37(1)						36(1)							8(1)						11(1)							2(1)		
				C(1D)				19(2)						26(2)						20(2)							5(1)							6(1)						-1(1)		
				O(2D)				20(1)						32(1)						18(1)							4(1)							3(1)						-4(1)		
				C(2D)				18(2)						23(2)						23(2)							1(1)						11(1)							1(1)		
				O(3D)				19(1)						22(1)						20(1)							4(1)							8(1)							2(1)		
				C(3D)				22(2)						32(2)						19(2)							2(1)							8(1)							2(1)		
				C(4D)				21(2)						24(2)						19(2)							3(1)							4(1)						-1(1)		
				C(5D)				20(2)						24(2)						19(2)							2(1)							5(1)							3(1)		
				C(6D)				31(2)						25(2)						16(1)						-2(1)							6(1)							4(1)		
				C(7D)				23(2)						25(2)						19(2)							1(1)							2(1)							0(1)		
				C(8D)				35(2)						29(2)						27(2)							1(1)						10(1)						-7(2)		
				C(9D)				57(2)						25(2)						38(2)							2(2)						16(2)						-1(2)		
				C(10D)			42(2)						29(2)						28(2)							0(1)							4(2)							6(2)		
				C(11D)			27(2)						31(2)						23(2)						-4(1)							9(1)							0(1)		
				C(12D)			43(2)						30(2)						43(2)						-8(2)							7(2)						-6(2)		
				C(13D)			33(2)						30(2)						35(2)							4(2)						12(2)							1(2)		
				C(14D)			28(2)						34(2)						23(2)							6(1)						11(1)							6(1)		
				C(15D)			55(2)						41(2)						53(2)							2(2)						26(2)					-18(2)		
				O(1E)				22(1)						28(1)						32(1)						-1(1)							1(1)							0(1)		
				C(1E)				22(2)						20(2)						25(2)							0(1)							6(1)							3(1)		
				O(2E)				19(1)						21(1)						48(1)							6(1)						16(1)							6(1)		
				C(2E)				19(2)						20(2)						23(2)						-3(1)							5(1)						-1(1)		
				O(3E)				22(1)						21(1)						23(1)						-1(1)							4(1)							0(1)		
				C(3E)				22(2)						19(2)						33(2)						-2(1)						10(1)							3(1)		
				C(4E)				20(2)						24(2)						32(2)							2(1)						11(1)							2(1)		
				C(5E)				22(2)						24(2)						23(2)							2(1)							6(1)							5(1)		
				C(6E)				26(2)						30(2)						26(2)							2(1)						12(1)							5(2)		
				C(7E)				23(2)						23(2)						29(2)							2(1)						12(1)							9(1)		
				C(8E)				28(2)						23(2)						33(2)							2(1)						13(2)							5(1)		
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				C(9E)				44(2)						28(2)						38(2)							9(2)						23(2)							7(2)		
				C(10E)			39(2)						46(2)						35(2)						11(2)						22(2)						16(2)		
				C(11E)			27(2)						28(2)						24(2)							1(1)						11(1)						-1(1)		
				C(12E)			32(2)						27(2)						29(2)							4(1)							9(2)							0(1)		
				C(13E)			36(2)						38(2)						38(2)							3(2)						19(2)							1(2)		
				C(14E)			27(2)						36(2)						32(2)						-2(2)							4(1)							5(2)		
				C(15E)			36(2)						30(2)						49(2)						-5(2)						18(2)						-9(2)		
				O(1F)				25(1)						37(1)						51(1)						18(1)						18(1)						16(1)		
				C(1F)				25(2)						29(2)						36(2)						14(2)						16(1)							8(2)		
				O(2F)				19(1)						32(1)						23(1)							2(1)							7(1)						-7(1)		
				C(2F)				29(2)						23(2)						29(2)						10(1)						14(1)						11(1)		
				O(3F)				26(1)						29(1)						26(1)							8(1)						12(1)							9(1)		
				C(3F)				25(2)						18(2)						32(2)							4(1)							9(1)							1(1)		
				C(4F)				18(2)						21(2)						22(2)							2(1)							6(1)						-2(1)		
				C(5F)				21(2)						27(2)						24(2)							2(1)						10(1)							0(1)		
				C(6F)				19(2)						21(2)						37(2)							8(1)						14(1)							1(1)		
				C(7F)				19(2)						22(2)						41(2)							8(1)						13(2)						-2(1)		
				C(8F)				25(2)						37(2)						38(2)						11(2)						10(2)							0(2)		
				C(9F)				36(2)						36(2)						41(2)						-4(2)							8(2)						-1(2)		
				C(10F)			29(2)						27(2)						41(2)						-9(2)						13(2)						-3(2)		
				C(11F)			38(2)						36(2)						36(2)							4(2)						19(2)						10(2)		
				C(12F)			72(3)						43(2)						47(2)					-13(2)						10(2)							5(2)		
				C(13F)			60(3)						42(2)						41(2)							0(2)						25(2)						16(2)		
				C(14F)			26(2)						30(2)						31(2)							6(1)						12(1)							3(1)		
				C(15F)			35(2)						68(3)						39(2)							9(2)							7(2)						10(2)		
_______________________________________________________________________		
		
		
	
									Table	5.		Hydrogen	coordinates	(	x	10^4)	and	isotropic		
									displacement	parameters	(A^2	x	10^3)	for	s2644lc.		
									________________________________________________________________		
																									x													y													z											U(eq)		
									________________________________________________________________		
			
										H(1AA)							1197(9)							9870(40)						4080(20)						66(15)		
										H(1A)									860									10854										3284										29		
										H(2A)								-170(9)							7130(40)						2490(20)						80(14)		
										H(3A1)								299										8347										3820										28		
										H(3A2)								585										7959										3557										28		
										H(4A)									238										7671										2324										27		
										H(6A)									419									10553										1693										30		
										H(9A1)								757										7530										1282										45		
										H(9A2)								832										8877										1023										45		
										H(10A)								264										8095										1163										41		
										H(10B)								309										9266											678										41		
										H(11A)								680										9973										4703										28		
										H(12A)									88									11224										3986										54		
										H(12B)								262									10910										4902										54		
										H(12C)								117										9822										4279										54		
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										H(13A)								572									12309										3919										45		
										H(13B)								912									11707										4403										45		
										H(13C)								693									12165										4854										45		
										H(14A)							-317									10081										1863										45		
										H(14B)							-247										9381										1180										45		
										H(14C)							-145									10795										1372										45		
										H(15A)							1344										8647										3164										54		
										H(15B)							1388										8866										2350										54		
										H(15C)							1290										7531										2556										54		
										H(1BB)								461(8)							8950(30)						7200(20)						52(11)		
										H(1B)									861										7907										7930										27		
										H(2B)								1884(7)							9560(30)						7017(17)						25(9)		
										H(3B1)							1128										9912										6832										29		
										H(3B2)							1424									10551										7518										29		
										H(4B)								1461										8639										6590										24		
										H(6B)								1240										6190										7551										29		
										H(9B1)								932										6831										5321										47		
										H(9B2)								800										5689										5669										47		
										H(10C)							1417										6656										6273										39		
										H(10D)							1301										5370										6513										39		
										H(11B)							1073									10730										8327										31		
										H(12D)							1677										9837										9402										55		
										H(12E)							1527									11159										9442										55		
										H(12F)							1642									10852										8741										55		
										H(13D)								849										9217										8850										50		
										H(13E)							1085									10033										9557										50		
										H(13F)							1193										8695										9385										50		
										H(14D)							2007										7530										8362										42		
										H(14E)							1909										6700										7585										42		
										H(14F)							1811										6278										8295										42		
										H(15D)								353										8319										6014										70		
										H(15E)								291										7104										5480										70		
										H(15F)								438										8310										5245										70		
										H(1CC)							2137(7)							4750(40)						3537(19)						99(17)		
										H(1C)								2526										4720										3184										27		
										H(2C)								3525(8)							6790(30)						5970(20)						56(12)		
										H(3C1)							2772										5657										5142										29		
										H(3C2)							3083										4813										5542										29		
										H(4C)								3086										7229										5115										26		
										H(6C)								2869										6830										3058										30		
										H(9C1)							2485										9157										4018										44		
										H(9C2)							2372										9010										3078										44		
										H(10E)							2892										8850										3280										36		
										H(10F)							2991										8678										4213										36		
										H(11C)							2783										2997										4746										31		
										H(12G)							3375										2973										4541										52		
										H(12H)							3255										1927										4977										52		
										H(12I)							3341										3274										5357										52		
										H(13G)							2535										2671										3395										50		
										H(13H)							2791										1602										3767										50		
Notes	and	References		
	
183	
										H(13I)							2869										2714										3296										50		
										H(14G)							3643										6192										4407										44		
										H(14H)							3521										7591										4268										44		
										H(14I)							3439										6669										3536										44		
										H(15G)							1895										6896										3118										59		
										H(15H)							1961										8027										3719										59		
										H(15I)							2039										6646										4046										59		
										H(1DD)							2833(9)							5150(40)						1610(20)						76(14)		
										H(1D)								2475										5546										2009										27		
										H(2D)								1476(7)							6990(30)						-980(20)						42(10)		
										H(3D1)							1964										5265										-375										29		
										H(3D2)							2228										6311												16										29		
										H(4D)								1850										7634												-4										27		
										H(6D)								2015										7207										2008										30		
										H(9D1)							2246										9906											951										49		
										H(9D2)							2368										9897										1896										49		
										H(10G)							1786										9019											836										43		
										H(10H)							1889										9190										1770										43		
										H(11D)							2380										3742											576										33		
										H(12J)							1982										2273											195										62		
										H(12K)							1822										3538										-218										62		
										H(12L)							1769										3060											546										62		
										H(13J)							2196										3279										1866										50		
										H(13K)							2550										3560										1935										50		
										H(13L)							2378										2306										1534										50		
										H(14J)							1304										6020											557										42		
										H(14K)							1347										7479											691										42		
										H(14L)							1454										6566										1431										42		
										H(15J)							2914										7714										1482										72		
										H(15K)							2932										8992										1932										72		
										H(15L)							2795										8961											991										72		
										H(1EE)							3778(8)						10030(30)							880(20)						55(11)		
										H(1E)								4153									10874										1772										28		
										H(2E)								5182(7)							7190(30)						2640(18)						41(10)		
										H(3E1)							4409										7942										1510										30		
										H(3E2)							4706										8278										1275										30		
										H(4E)								4749										7556										2736										30		
										H(6E)								4539									10381										3391										32		
										H(9E1)							4160										7296										3541										41		
										H(9E2)							4076										8592										3845										41		
										H(10I)							4666										7875										3813										45		
										H(10J)							4602										8979										4319										45		
										H(11E)							4372										9972											396										32		
										H(12M)							4477									12283										1196										45		
										H(12N)							4138									11721											661										45		
										H(12O)							4380									12146											267										45		
										H(13M)							4825									10866											323										54		
										H(13N)							4935										9729											922										54		
										H(13O)							4972									11112										1252										54		
										H(14M)							5305										9834										3366										51		
Notes	and	References		
	
184	
										H(14N)							5185										9234										4000										51		
										H(14O)							5114									10657										3763										51		
										H(15M)							3629										8670										1666										57		
										H(15N)							3553										8748										2446										57		
										H(15O)							3657										7461										2189										57		
										H(1FF)								429(10)						3870(40)						2240(20)						81(15)		
										H(1F)									789										2642										2723										34		
										H(2F)								1858(7)							4740(30)						2070(20)						44(11)		
										H(3F1)							1405										5447										2783										31		
										H(3F2)							1107										5103										1993										31		
										H(4F)								1409										3877										1598										25		
										H(6F)								1210										1113										2306										29		
										H(9F1)								913										2070											137										48		
										H(9F2)								803											824											439										48		
										H(10K)							1398										1994										1106										39		
										H(10L)							1313											600										1257										39		
										H(11F)								968										3957										3793										42		
										H(12P)							1499										3777										4525										86		
										H(12Q)							1380										5042										4769										86		
										H(12R)							1573										5064										4202										86		
										H(13P)							1109										6390										3418										68		
										H(13Q)								891										6037										3893										68		
										H(13R)								769										5758										2970										68		
										H(14P)							1962										2501										3309										43		
										H(14Q)							1886										1845										2476										43		
										H(14R)							1778										1208										3120										43		
										H(15P)								306										3127											889										74		
										H(15Q)								276										2070											256										74		
										H(15R)								400										3415											151										74		
									________________________________________________________________		
		
	
	
	
		
									Table	6.		Torsion	angles	[deg]	for	s2644lc.		
									________________________________________________________________		
										O(1A)-C(1A)-C(2A)-O(3A)																												-178.8(2)		
										C(7A)-C(1A)-C(2A)-O(3A)																													-55.1(3)		
										O(1A)-C(1A)-C(2A)-C(11A)																													61.0(3)		
										C(7A)-C(1A)-C(2A)-C(11A)																											-175.3(2)		
										O(1A)-C(1A)-C(2A)-C(3A)																													-67.3(3)		
										C(7A)-C(1A)-C(2A)-C(3A)																														56.4(3)		
										C(11A)-C(2A)-O(3A)-C(5A)																											-162.0(2)		
										C(3A)-C(2A)-O(3A)-C(5A)																													-41.0(3)		
										C(1A)-C(2A)-O(3A)-C(5A)																														74.4(2)		
										O(3A)-C(2A)-C(3A)-C(4A)																														22.7(3)		
										C(11A)-C(2A)-C(3A)-C(4A)																												139.9(2)		
										C(1A)-C(2A)-C(3A)-C(4A)																													-91.8(3)		
										C(2A)-C(3A)-C(4A)-O(2A)																												-117.4(2)		
Notes	and	References		
	
185	
										C(2A)-C(3A)-C(4A)-C(5A)																															2.4(3)		
										C(2A)-O(3A)-C(5A)-C(6A)																													-74.2(2)		
										C(2A)-O(3A)-C(5A)-C(14A)																												165.2(2)		
										C(2A)-O(3A)-C(5A)-C(4A)																														42.7(2)		
										O(2A)-C(4A)-C(5A)-O(3A)																														93.2(2)		
										C(3A)-C(4A)-C(5A)-O(3A)																													-26.5(3)		
										O(2A)-C(4A)-C(5A)-C(6A)																												-153.9(2)		
										C(3A)-C(4A)-C(5A)-C(6A)																														86.4(3)		
										O(2A)-C(4A)-C(5A)-C(14A)																												-23.6(3)		
										C(3A)-C(4A)-C(5A)-C(14A)																											-143.3(3)		
										O(3A)-C(5A)-C(6A)-C(7A)																														56.7(3)		
										C(14A)-C(5A)-C(6A)-C(7A)																												173.7(2)		
										C(4A)-C(5A)-C(6A)-C(7A)																													-54.6(3)		
										O(3A)-C(5A)-C(6A)-C(10A)																												176.9(2)		
										C(14A)-C(5A)-C(6A)-C(10A)																											-66.0(3)		
										C(4A)-C(5A)-C(6A)-C(10A)																													65.7(3)		
										O(1A)-C(1A)-C(7A)-C(8A)																													-23.0(5)		
										C(2A)-C(1A)-C(7A)-C(8A)																												-143.8(3)		
										O(1A)-C(1A)-C(7A)-C(6A)																													160.4(2)		
										C(2A)-C(1A)-C(7A)-C(6A)																														39.6(3)		
										C(5A)-C(6A)-C(7A)-C(8A)																													141.1(3)		
										C(10A)-C(6A)-C(7A)-C(8A)																													12.5(3)		
										C(5A)-C(6A)-C(7A)-C(1A)																													-41.5(3)		
										C(10A)-C(6A)-C(7A)-C(1A)																											-170.1(2)		
										C(1A)-C(7A)-C(8A)-C(9A)																												-179.5(3)		
										C(6A)-C(7A)-C(8A)-C(9A)																														-2.8(4)		
										C(1A)-C(7A)-C(8A)-C(15A)																													-4.4(6)		
										C(6A)-C(7A)-C(8A)-C(15A)																												172.4(3)		
										C(7A)-C(8A)-C(9A)-C(10A)																													-8.3(4)		
										C(15A)-C(8A)-C(9A)-C(10A)																											176.0(3)		
										C(8A)-C(9A)-C(10A)-C(6A)																													15.4(3)		
										C(7A)-C(6A)-C(10A)-C(9A)																												-16.7(3)		
										C(5A)-C(6A)-C(10A)-C(9A)																											-141.3(3)		
										O(3A)-C(2A)-C(11A)-C(12A)																												48.8(3)		
										C(3A)-C(2A)-C(11A)-C(12A)																											-65.4(3)		
										C(1A)-C(2A)-C(11A)-C(12A)																											168.7(2)		
										O(3A)-C(2A)-C(11A)-C(13A)																											-74.9(3)		
										C(3A)-C(2A)-C(11A)-C(13A)																											170.9(2)		
										C(1A)-C(2A)-C(11A)-C(13A)																												45.0(3)		
										O(1B)-C(1B)-C(2B)-O(3B)																													176.7(2)		
										C(7B)-C(1B)-C(2B)-O(3B)																													-58.8(3)		
										O(1B)-C(1B)-C(2B)-C(11B)																													56.7(3)		
										C(7B)-C(1B)-C(2B)-C(11B)																											-178.8(2)		
										O(1B)-C(1B)-C(2B)-C(3B)																													-72.1(3)		
										C(7B)-C(1B)-C(2B)-C(3B)																														52.4(3)		
										C(11B)-C(2B)-O(3B)-C(5B)																											-160.6(2)		
										C(3B)-C(2B)-O(3B)-C(5B)																													-38.8(2)		
										C(1B)-C(2B)-O(3B)-C(5B)																														76.4(2)		
										O(3B)-C(2B)-C(3B)-C(4B)																														19.3(3)		
										C(11B)-C(2B)-C(3B)-C(4B)																												137.7(2)		
Notes	and	References		
	
186	
										C(1B)-C(2B)-C(3B)-C(4B)																													-93.8(3)		
										C(2B)-C(3B)-C(4B)-O(2B)																												-114.6(2)		
										C(2B)-C(3B)-C(4B)-C(5B)																															5.6(3)		
										C(2B)-O(3B)-C(5B)-C(14B)																												165.4(2)		
										C(2B)-O(3B)-C(5B)-C(6B)																													-74.2(2)		
										C(2B)-O(3B)-C(5B)-C(4B)																														42.5(2)		
										O(2B)-C(4B)-C(5B)-O(3B)																														92.1(2)		
										C(3B)-C(4B)-C(5B)-O(3B)																													-28.5(3)		
										O(2B)-C(4B)-C(5B)-C(14B)																												-24.7(3)		
										C(3B)-C(4B)-C(5B)-C(14B)																											-145.2(2)		
										O(2B)-C(4B)-C(5B)-C(6B)																												-155.7(2)		
										C(3B)-C(4B)-C(5B)-C(6B)																														83.8(3)		
										O(3B)-C(5B)-C(6B)-C(7B)																														56.6(3)		
										C(14B)-C(5B)-C(6B)-C(7B)																												173.3(2)		
										C(4B)-C(5B)-C(6B)-C(7B)																													-54.0(3)		
										O(3B)-C(5B)-C(6B)-C(10B)																												175.9(2)		
										C(14B)-C(5B)-C(6B)-C(10B)																											-67.4(3)		
										C(4B)-C(5B)-C(6B)-C(10B)																													65.3(3)		
										O(1B)-C(1B)-C(7B)-C(8B)																													-12.2(5)		
										C(2B)-C(1B)-C(7B)-C(8B)																												-133.0(3)		
										O(1B)-C(1B)-C(7B)-C(6B)																													165.6(2)		
										C(2B)-C(1B)-C(7B)-C(6B)																														44.9(3)		
										C(5B)-C(6B)-C(7B)-C(8B)																													133.5(3)		
										C(10B)-C(6B)-C(7B)-C(8B)																														7.3(3)		
										C(5B)-C(6B)-C(7B)-C(1B)																													-44.8(3)		
										C(10B)-C(6B)-C(7B)-C(1B)																											-170.9(2)		
										C(1B)-C(7B)-C(8B)-C(9B)																													177.0(3)		
										C(6B)-C(7B)-C(8B)-C(9B)																														-0.9(4)		
										C(1B)-C(7B)-C(8B)-C(15B)																													-6.4(6)		
										C(6B)-C(7B)-C(8B)-C(15B)																												175.7(3)		
										C(7B)-C(8B)-C(9B)-C(10B)																													-6.0(4)		
										C(15B)-C(8B)-C(9B)-C(10B)																											177.0(3)		
										C(8B)-C(9B)-C(10B)-C(6B)																													10.0(3)		
										C(7B)-C(6B)-C(10B)-C(9B)																												-10.4(3)		
										C(5B)-C(6B)-C(10B)-C(9B)																											-133.0(3)		
										O(3B)-C(2B)-C(11B)-C(13B)																											-72.1(3)		
										C(3B)-C(2B)-C(11B)-C(13B)																											172.7(2)		
										C(1B)-C(2B)-C(11B)-C(13B)																												46.4(3)		
										O(3B)-C(2B)-C(11B)-C(12B)																												50.7(3)		
										C(3B)-C(2B)-C(11B)-C(12B)																											-64.5(3)		
										C(1B)-C(2B)-C(11B)-C(12B)																											169.2(2)		
										O(1C)-C(1C)-C(2C)-O(3C)																													176.5(2)		
										C(7C)-C(1C)-C(2C)-O(3C)																													-58.7(3)		
										O(1C)-C(1C)-C(2C)-C(11C)																													56.6(3)		
										C(7C)-C(1C)-C(2C)-C(11C)																											-178.5(2)		
										O(1C)-C(1C)-C(2C)-C(3C)																													-72.1(3)		
										C(7C)-C(1C)-C(2C)-C(3C)																														52.8(3)		
										C(11C)-C(2C)-O(3C)-C(5C)																											-160.1(2)		
										C(3C)-C(2C)-O(3C)-C(5C)																													-38.6(3)		
										C(1C)-C(2C)-O(3C)-C(5C)																														76.7(2)		
Notes	and	References		
	
187	
										O(3C)-C(2C)-C(3C)-C(4C)																														18.7(3)		
										C(11C)-C(2C)-C(3C)-C(4C)																												136.7(2)		
										C(1C)-C(2C)-C(3C)-C(4C)																													-94.3(3)		
										C(2C)-C(3C)-C(4C)-O(2C)																												-112.5(2)		
										C(2C)-C(3C)-C(4C)-C(5C)																															6.6(3)		
										C(2C)-O(3C)-C(5C)-C(14C)																												165.3(2)		
										C(2C)-O(3C)-C(5C)-C(6C)																													-74.6(2)		
										C(2C)-O(3C)-C(5C)-C(4C)																														42.8(2)		
										O(2C)-C(4C)-C(5C)-O(3C)																														90.1(2)		
										C(3C)-C(4C)-C(5C)-O(3C)																													-29.2(3)		
										O(2C)-C(4C)-C(5C)-C(14C)																												-26.6(3)		
										C(3C)-C(4C)-C(5C)-C(14C)																											-145.9(2)		
										O(2C)-C(4C)-C(5C)-C(6C)																												-157.3(2)		
										C(3C)-C(4C)-C(5C)-C(6C)																														83.4(3)		
										O(3C)-C(5C)-C(6C)-C(7C)																														55.7(3)		
										C(14C)-C(5C)-C(6C)-C(7C)																												172.5(2)		
										C(4C)-C(5C)-C(6C)-C(7C)																													-55.1(3)		
										O(3C)-C(5C)-C(6C)-C(10C)																												175.0(2)		
										C(14C)-C(5C)-C(6C)-C(10C)																											-68.2(3)		
										C(4C)-C(5C)-C(6C)-C(10C)																													64.2(3)		
										O(1C)-C(1C)-C(7C)-C(8C)																													-13.0(4)		
										C(2C)-C(1C)-C(7C)-C(8C)																												-134.3(3)		
										O(1C)-C(1C)-C(7C)-C(6C)																													165.0(2)		
										C(2C)-C(1C)-C(7C)-C(6C)																														43.7(3)		
										C(5C)-C(6C)-C(7C)-C(8C)																													135.1(3)		
										C(10C)-C(6C)-C(7C)-C(8C)																														8.2(3)		
										C(5C)-C(6C)-C(7C)-C(1C)																													-43.3(3)		
										C(10C)-C(6C)-C(7C)-C(1C)																											-170.2(2)		
										C(1C)-C(7C)-C(8C)-C(15C)																													-5.9(5)		
										C(6C)-C(7C)-C(8C)-C(15C)																												176.0(3)		
										C(1C)-C(7C)-C(8C)-C(9C)																													177.9(3)		
										C(6C)-C(7C)-C(8C)-C(9C)																														-0.2(3)		
										C(7C)-C(8C)-C(9C)-C(10C)																													-7.9(3)		
										C(15C)-C(8C)-C(9C)-C(10C)																											175.4(2)		
										C(7C)-C(6C)-C(10C)-C(9C)																												-12.5(3)		
										C(5C)-C(6C)-C(10C)-C(9C)																											-135.3(3)		
										C(8C)-C(9C)-C(10C)-C(6C)																													12.5(3)		
										O(3C)-C(2C)-C(11C)-C(13C)																											-76.3(3)		
										C(3C)-C(2C)-C(11C)-C(13C)																											168.6(2)		
										C(1C)-C(2C)-C(11C)-C(13C)																												42.1(3)		
										O(3C)-C(2C)-C(11C)-C(12C)																												48.6(3)		
										C(3C)-C(2C)-C(11C)-C(12C)																											-66.5(3)		
										C(1C)-C(2C)-C(11C)-C(12C)																											167.0(2)		
										O(1D)-C(1D)-C(2D)-O(3D)																													177.7(2)		
										C(7D)-C(1D)-C(2D)-O(3D)																													-59.3(3)		
										O(1D)-C(1D)-C(2D)-C(11D)																													57.7(3)		
										C(7D)-C(1D)-C(2D)-C(11D)																											-179.3(2)		
										O(1D)-C(1D)-C(2D)-C(3D)																													-70.3(3)		
										C(7D)-C(1D)-C(2D)-C(3D)																														52.7(3)		
										C(11D)-C(2D)-O(3D)-C(5D)																											-161.7(2)		
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										C(3D)-C(2D)-O(3D)-C(5D)																													-40.3(2)		
										C(1D)-C(2D)-O(3D)-C(5D)																														75.6(2)		
										O(3D)-C(2D)-C(3D)-C(4D)																														22.5(3)		
										C(11D)-C(2D)-C(3D)-C(4D)																												140.6(2)		
										C(1D)-C(2D)-C(3D)-C(4D)																													-91.7(3)		
										C(2D)-C(3D)-C(4D)-O(2D)																												-117.2(2)		
										C(2D)-C(3D)-C(4D)-C(5D)																															1.9(3)		
										C(2D)-O(3D)-C(5D)-C(14D)																												165.3(2)		
										C(2D)-O(3D)-C(5D)-C(6D)																													-73.7(2)		
										C(2D)-O(3D)-C(5D)-C(4D)																														41.7(2)		
										O(2D)-C(4D)-C(5D)-O(3D)																														94.1(2)		
										C(3D)-C(4D)-C(5D)-O(3D)																													-25.7(3)		
										O(2D)-C(4D)-C(5D)-C(14D)																												-23.9(3)		
										C(3D)-C(4D)-C(5D)-C(14D)																											-143.7(2)		
										O(2D)-C(4D)-C(5D)-C(6D)																												-153.3(2)		
										C(3D)-C(4D)-C(5D)-C(6D)																														86.9(3)		
										O(3D)-C(5D)-C(6D)-C(7D)																														58.0(3)		
										C(14D)-C(5D)-C(6D)-C(7D)																												175.5(2)		
										C(4D)-C(5D)-C(6D)-C(7D)																													-53.3(3)		
										O(3D)-C(5D)-C(6D)-C(10D)																												177.1(2)		
										C(14D)-C(5D)-C(6D)-C(10D)																											-65.4(3)		
										C(4D)-C(5D)-C(6D)-C(10D)																													65.8(3)		
										O(1D)-C(1D)-C(7D)-C(8D)																													-10.5(4)		
										C(2D)-C(1D)-C(7D)-C(8D)																												-132.0(3)		
										O(1D)-C(1D)-C(7D)-C(6D)																													167.3(2)		
										C(2D)-C(1D)-C(7D)-C(6D)																														45.7(3)		
										C(5D)-C(6D)-C(7D)-C(8D)																													132.0(3)		
										C(10D)-C(6D)-C(7D)-C(8D)																														5.6(3)		
										C(5D)-C(6D)-C(7D)-C(1D)																													-46.2(3)		
										C(10D)-C(6D)-C(7D)-C(1D)																											-172.6(2)		
										C(1D)-C(7D)-C(8D)-C(15D)																													-4.5(5)		
										C(6D)-C(7D)-C(8D)-C(15D)																												177.7(3)		
										C(1D)-C(7D)-C(8D)-C(9D)																													177.0(3)		
										C(6D)-C(7D)-C(8D)-C(9D)																														-0.7(3)		
										C(7D)-C(8D)-C(9D)-C(10D)																													-4.5(3)		
										C(15D)-C(8D)-C(9D)-C(10D)																											176.8(3)		
										C(8D)-C(9D)-C(10D)-C(6D)																														7.6(3)		
										C(7D)-C(6D)-C(10D)-C(9D)																													-7.9(3)		
										C(5D)-C(6D)-C(10D)-C(9D)																											-130.5(3)		
										O(3D)-C(2D)-C(11D)-C(13D)																											-69.8(3)		
										C(3D)-C(2D)-C(11D)-C(13D)																											175.0(2)		
										C(1D)-C(2D)-C(11D)-C(13D)																												49.2(3)		
										O(3D)-C(2D)-C(11D)-C(12D)																												52.9(3)		
										C(3D)-C(2D)-C(11D)-C(12D)																											-62.3(3)		
										C(1D)-C(2D)-C(11D)-C(12D)																											172.0(2)		
										O(1E)-C(1E)-C(2E)-O(3E)																													178.6(2)		
										C(7E)-C(1E)-C(2E)-O(3E)																													-57.6(3)		
										O(1E)-C(1E)-C(2E)-C(11E)																													58.1(3)		
										C(7E)-C(1E)-C(2E)-C(11E)																											-178.1(2)		
										O(1E)-C(1E)-C(2E)-C(3E)																													-69.7(3)		
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										C(7E)-C(1E)-C(2E)-C(3E)																														54.1(3)		
										C(11E)-C(2E)-O(3E)-C(5E)																											-160.4(2)		
										C(3E)-C(2E)-O(3E)-C(5E)																													-38.5(3)		
										C(1E)-C(2E)-O(3E)-C(5E)																														76.6(2)		
										O(3E)-C(2E)-C(3E)-C(4E)																														18.6(3)		
										C(11E)-C(2E)-C(3E)-C(4E)																												137.7(2)		
										C(1E)-C(2E)-C(3E)-C(4E)																													-94.8(3)		
										C(2E)-C(3E)-C(4E)-O(2E)																												-112.5(3)		
										C(2E)-C(3E)-C(4E)-C(5E)																															6.6(3)		
										C(2E)-O(3E)-C(5E)-C(14E)																												165.2(2)		
										C(2E)-O(3E)-C(5E)-C(6E)																													-74.4(3)		
										C(2E)-O(3E)-C(5E)-C(4E)																														42.9(2)		
										O(2E)-C(4E)-C(5E)-O(3E)																														89.6(2)		
										C(3E)-C(4E)-C(5E)-O(3E)																													-29.5(3)		
										O(2E)-C(4E)-C(5E)-C(14E)																												-27.3(3)		
										C(3E)-C(4E)-C(5E)-C(14E)																											-146.4(3)		
										O(2E)-C(4E)-C(5E)-C(6E)																												-157.2(2)		
										C(3E)-C(4E)-C(5E)-C(6E)																														83.8(3)		
										O(3E)-C(5E)-C(6E)-C(7E)																														54.9(3)		
										C(14E)-C(5E)-C(6E)-C(7E)																												172.0(2)		
										C(4E)-C(5E)-C(6E)-C(7E)																													-56.6(3)		
										O(3E)-C(5E)-C(6E)-C(10E)																												175.1(2)		
										C(14E)-C(5E)-C(6E)-C(10E)																											-67.8(3)		
										C(4E)-C(5E)-C(6E)-C(10E)																													63.6(3)		
										O(1E)-C(1E)-C(7E)-C(8E)																													-18.5(5)		
										C(2E)-C(1E)-C(7E)-C(8E)																												-139.4(3)		
										O(1E)-C(1E)-C(7E)-C(6E)																													162.1(2)		
										C(2E)-C(1E)-C(7E)-C(6E)																														41.2(3)		
										C(5E)-C(6E)-C(7E)-C(8E)																													139.7(3)		
										C(10E)-C(6E)-C(7E)-C(8E)																													11.5(3)		
										C(5E)-C(6E)-C(7E)-C(1E)																													-40.7(3)		
										C(10E)-C(6E)-C(7E)-C(1E)																											-169.0(2)		
										C(1E)-C(7E)-C(8E)-C(15E)																													-6.5(6)		
										C(6E)-C(7E)-C(8E)-C(15E)																												172.9(3)		
										C(1E)-C(7E)-C(8E)-C(9E)																													178.2(3)		
										C(6E)-C(7E)-C(8E)-C(9E)																														-2.3(4)		
										C(7E)-C(8E)-C(9E)-C(10E)																													-7.9(4)		
										C(15E)-C(8E)-C(9E)-C(10E)																											176.3(3)		
										C(8E)-C(9E)-C(10E)-C(6E)																													14.4(3)		
										C(7E)-C(6E)-C(10E)-C(9E)																												-15.6(3)		
										C(5E)-C(6E)-C(10E)-C(9E)																											-139.7(3)		
										O(3E)-C(2E)-C(11E)-C(12E)																											-74.2(3)		
										C(3E)-C(2E)-C(11E)-C(12E)																											169.9(2)		
										C(1E)-C(2E)-C(11E)-C(12E)																												44.6(3)		
										O(3E)-C(2E)-C(11E)-C(13E)																												49.7(3)		
										C(3E)-C(2E)-C(11E)-C(13E)																											-66.2(3)		
										C(1E)-C(2E)-C(11E)-C(13E)																											168.6(2)		
										O(1F)-C(1F)-C(2F)-O(3F)																												-179.6(2)		
										C(7F)-C(1F)-C(2F)-O(3F)																													-55.1(3)		
										O(1F)-C(1F)-C(2F)-C(3F)																													-69.1(3)		
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										C(7F)-C(1F)-C(2F)-C(3F)																														55.3(3)		
										O(1F)-C(1F)-C(2F)-C(11F)																													63.4(3)		
										C(7F)-C(1F)-C(2F)-C(11F)																											-172.2(2)		
										C(3F)-C(2F)-O(3F)-C(5F)																													-42.1(3)		
										C(11F)-C(2F)-O(3F)-C(5F)																											-165.3(2)		
										C(1F)-C(2F)-O(3F)-C(5F)																														75.0(3)		
										O(3F)-C(2F)-C(3F)-C(4F)																														26.3(3)		
										C(11F)-C(2F)-C(3F)-C(4F)																												143.2(2)		
										C(1F)-C(2F)-C(3F)-C(4F)																													-86.8(3)		
										C(2F)-C(3F)-C(4F)-O(2F)																												-122.6(2)		
										C(2F)-C(3F)-C(4F)-C(5F)																														-2.7(3)		
										C(2F)-O(3F)-C(5F)-C(14F)																												163.7(2)		
										C(2F)-O(3F)-C(5F)-C(6F)																													-75.6(2)		
										C(2F)-O(3F)-C(5F)-C(4F)																														40.6(3)		
										O(2F)-C(4F)-C(5F)-O(3F)																														97.5(2)		
										C(3F)-C(4F)-C(5F)-O(3F)																													-22.1(3)		
										O(2F)-C(4F)-C(5F)-C(14F)																												-19.9(3)		
										C(3F)-C(4F)-C(5F)-C(14F)																											-139.5(2)		
										O(2F)-C(4F)-C(5F)-C(6F)																												-150.4(2)		
										C(3F)-C(4F)-C(5F)-C(6F)																														90.0(3)		
										O(3F)-C(5F)-C(6F)-C(7F)																														56.9(3)		
										C(14F)-C(5F)-C(6F)-C(7F)																												174.1(2)		
										C(4F)-C(5F)-C(6F)-C(7F)																													-53.8(3)		
										O(3F)-C(5F)-C(6F)-C(10F)																												175.9(2)		
										C(14F)-C(5F)-C(6F)-C(10F)																											-66.8(3)		
										C(4F)-C(5F)-C(6F)-C(10F)																													65.2(3)		
										O(1F)-C(1F)-C(7F)-C(8F)																													-16.1(5)		
										C(2F)-C(1F)-C(7F)-C(8F)																												-139.2(3)		
										O(1F)-C(1F)-C(7F)-C(6F)																													164.1(2)		
										C(2F)-C(1F)-C(7F)-C(6F)																														41.0(3)		
										C(5F)-C(6F)-C(7F)-C(8F)																													137.8(3)		
										C(10F)-C(6F)-C(7F)-C(8F)																													10.8(3)		
										C(5F)-C(6F)-C(7F)-C(1F)																													-42.4(3)		
										C(10F)-C(6F)-C(7F)-C(1F)																											-169.3(2)		
										C(1F)-C(7F)-C(8F)-C(9F)																													177.9(3)		
										C(6F)-C(7F)-C(8F)-C(9F)																														-2.3(4)		
										C(1F)-C(7F)-C(8F)-C(15F)																													-6.4(6)		
										C(6F)-C(7F)-C(8F)-C(15F)																												173.4(3)		
										C(7F)-C(8F)-C(9F)-C(10F)																													-7.2(4)		
										C(15F)-C(8F)-C(9F)-C(10F)																											176.5(3)		
										C(8F)-C(9F)-C(10F)-C(6F)																													13.4(3)		
										C(7F)-C(6F)-C(10F)-C(9F)																												-14.5(3)		
										C(5F)-C(6F)-C(10F)-C(9F)																											-137.2(3)		
										O(3F)-C(2F)-C(11F)-C(12F)																												35.2(4)		
										C(3F)-C(2F)-C(11F)-C(12F)																											-78.6(4)		
										C(1F)-C(2F)-C(11F)-C(12F)																											151.5(3)		
										O(3F)-C(2F)-C(11F)-C(13F)																											159.1(3)		
										C(3F)-C(2F)-C(11F)-C(13F)																												45.3(4)		
										C(1F)-C(2F)-C(11F)-C(13F)																											-84.7(3)		
									________________________________________________________________		
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